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Abstract  
 
Background and objectives 
Mortality is higher in people with severe mental illness than others. An important policy goal 
is to reduce this ‘mortality gap’. The objectives of this thesis were to investigate whether the 
gap has reduced in recent years in people with bipolar disorder or schizophrenia, to quantify 
the extent of ‘avoidable mortality’ in these people, and to investigate whether the excess 




Three separate record linkage studies were undertaken study using Hospital Episode 
Statistics and death registration data about patients discharged from inpatient care in 
England between 1999 and 2007.  
 
Results 
Findings showed that the mortality gap widened over the last decade for people with bipolar 
disorder and schizophrenia. For people discharged with bipolar disorder the SMR increased 
from 1.3 to 1.9 between 1999 and 2006 (Poisson test of trend, P=0.06). Whilst for people 
discharged with schizophrenia the SMR increased from 1.6 to 2.2 (P<.001). Potentially 
avoidable deaths comprised 59·2% and 60.2% of all deaths in people with a diagnosis of 
bipolar disorder and schizophrenia respectively. The results showed that comorbidity with 
mental illness in people with a main diagnosis of CVD causes between 12-46% excess 
deaths compared with those without mental comorbidity, and between 43-68% excess 
deaths in people with a main diagnosis of Diabetes.  
 
Conclusion 
The total burden of premature deaths in these populations is substantial and increasing. 
Current approaches to reduce mortality would be expected to reduce the overall mortality 
    7 
excess in SMI by about 50%, but not eliminate it entirely. These results strongly point to the 
need for better understanding of the reasons for the persistent mortality gap; and for 
continued action to target risk factors for both natural and unnatural causes of death in 
people with SMI. 
 
Word count for main text:  
 
48,527 words including abstract, references, tables and figures. Excludes appendices, and 
bibliography.  
 
Abstract: 300 words. 
 
Key words:   
 
bipolar disorder, schizophrenia, comorbidity,  
mortality, avoidable mortality 
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Outline of the thesis 
 
The thesis starts with an introduction to mental illness, including a review of the terms used 
in this thesis, and the conditions - bipolar disorder and schizophrenia - that are the focus of 
this work. 
 
In chapter 2, I review the relevant literature pertaining to mortality in people with severe 
mental illness, especially focusing on studies undertaken within the last decade in people 
with bipolar disorder and schizophrenia.  
 
Chapter 3 lays out the gaps in the literature, and chapter 4 states the specific objectives of 
this thesis and the hypotheses that will be explored.  
 
Chapter 5 outlines the core methods that will be used to undertake the studies within this 
thesis, including a consideration of the use of routinely collected data, especially hospital 
episode statistics (HES) and death certification records for psychiatric mortality research, the 
diagnostic codes used to specify the study groups, the mortality outcomes explored and the 
statistical analysis employed to quantify trends in mortality. 
 
Chapter 6 presents the first study looking at recent trends in all-cause mortality for those who 
have recently been discharged from inpatient care with a main diagnosis of bipolar disorder 
or schizophrenia in England and explores the mortality gap between these people and the 
general population.  
 
Chapter 7 presents the contribution of avoidable causes of death to the mortality gap, namely 
deaths that are currently considered to be amenable to high quality medical care and those 
that are preventable given access to public health interventions that are currently available in 
England. By introducing the concept of the hypothetical standardised mortality ratio (SMR), 
    23 
this chapter seeks to answer the question about what is possible with current medical and 
public health interventions. 
 
Chapter 8 explores the risk of death in those who are discharged from hospital with bipolar 
disorder or schizophrenia not as the main reason for admission, but rather as a comorbid 
condition in combination with another illness. 
 
Chapter 9 summaries the findings from this thesis, and touches on the implications for 
current mental health policy and future research  
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Chapter 1 - Introduction 
 
Mental health and mental disorder 
 
According to the World Health Organisation (WHO) health is defined as ‘a state of complete 
physical, mental, and social well-being and not merely the absence of disease or 
infirmity’(1946). This holistic definition incorporates attributes of the individual such as their 
ability to cope with stressors and their resilience to adverse life events, as well as the social 
and environmental context in which they live. It acknowledges the close relationship between 
physical and mental health, and recognises that the risks to mental health are influenced by 
a wide range of socio-economic, interpersonal and hereditary factors (Rutter 1985; Secker 
1998; Ewles 2005). It gives justification for the use of public health tools and health policy 
research to better understand and influence mental health (2001). Importantly, as the 
definition does not draw a distinction between mental health and mental disorder, it suggests 
that anyone can have good mental health, regardless of whether or not they have a mental 
disorder. 
 
For clinical practice, mental disorders have been defined as ‘conditions in which reduced 
mental, emotional and/or intellectual capacity renders individuals unable to function fully, or 
normally in society’ (Thornicroft 2001; Patel 2002; Last 2006).This definition includes 
disorders such as mental retardation which are present from early life, as well as those 
conditions where there is an identifiable onset of illness preceded by normal functioning 
(Katona and Robertson 2000). Two well recognised taxonomic systems are currently used to 
group these conditions into categories based upon the profile of symptoms presented by 
people themselves, and signs elicited by clinicians (King 1999; Katona and Robertson 2000; 
Dalal and Sivakumar 2009). The first is the International Classification of Diseases revision 
10 (ICD10), produced by the WHO, in which the fifth chapter covers mental and behavioural 
disorders. The ICD10 taxonomy as a whole relies on the clinician matching symptoms and 
signs from the presenting client with descriptions of over 14,000 different, separate and 
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mutually exclusive conditions, including physical illnesses. Under this alpha-numeric 
classification system, every health condition can be assigned to a unique category and given 
a code, up to six characters long (WHO website). Mental disorders are classified into ten 
main groups: 
F0: Organic, including symptomatic, mental disorders 
F1: Mental and behavioural disorders due to use of psychoactive substances 
F2: Schizophrenia, schizotypal and delusional disorders 
F3: Mood [affective] disorders 
F4: Neurotic, stress-related and somatoform disorders 
F5: Behavioural syndromes associated with physiological disturbances and physical factors 
F6: Disorders of personality and behaviour in adult persons 
F7: Mental retardation 
F8: Disorders of psychological development 
F9: Behavioural and emotional disorders with onset usually occurring in childhood and 
adolescence 
 
In addition, there is a residual group of "unspecified mental disorders".  ICD10 is an example 
of a categorical classification system in which conditions are grouped separately and 
hierarchically, so that a person can receive only one main diagnosis (WHO ; Kessler 2002; 
Rosenman, Korten et al. 2003).  
 
The second taxonomy for mental health is the Diagnostic and Statistical Manual of Mental 
Disorders version 4 (DSM-IV) produced by the American Psychiatric Association (APA) and 
currently used in its fourth version (DSM-IV). This classification relies on an evaluation of the 
client along five operational criteria or axes: clinical disorder, excluding personality and 
mental retardation (axis 1), personality disorders and mental retardation (axis 2), somatic 
conditions connected to the mental disorder (axis 3), psychosocial and environmental 
problems (axis 4), global assessment of functioning (axis 5). In order to categorise a 
condition, clinicians are required to note which symptoms are present within each axis, 
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including the time they are present, and the presence of exclusion criteria (APA ; Stein, 
Phillips et al. 2010). This multiaxial classification system rates clients’ presenting complaints 
along several weighted categorical scales each measuring a different aspect of the 
presentation (Katona and Robertson 2000). The main categories of disorder in the DSM are: 
• Disorders usually first diagnosed in infancy, childhood or adolescence 
• Delirium, dementia, and amnesia and other cognitive disorders 
• Mental disorders due to a general medical condition not elsewhere classified 
• Psychoactive substance-related disorders 
• Schizophrenia and other psychotic disorders 
• Mood disorders 
• Anxiety disorders 
• Somatoform, factitious and dissociative disorders 
• Eating disorders 
• Sleeping disorders 
• Impulse control disorders not elsewhere classified 
• Adjustment disorders 
 
There has been substantial convergence between the two classification systems in recent 
years, but diagnoses recorded using older versions of these classification systems are 
harder to compare (Berrios 1999; Dalal and Sivakumar 2009). 
 
Specific criticisms of these taxonomies have been raised by proponents of a dimensional 
system of classification as they argue that attempts to demonstrate natural boundaries 
between related syndromes, or between a common syndrome and normality have failed 
(Kessler 2002; Rosenman, Korten et al. 2003; Craddock and Owen 2007). Still others have 
argued that these definitions of mental disorder lack applicability across cultures, as the 
diagnosis is so dependent on the ability to function fully, or normally in one’s own society 
(Kleinman, Eisenberg et al. 1978; Alarcon, Becker et al. 2009). Others have observed that 
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psychiatric diagnoses are not stable over time, and suggest that they may be susceptible to 
diagnostic fashions (Paris 2004; Baca-Garcia, Perez-Rodriguez et al. 2007). Lastly concerns 
have been raised that these classifications give no objective indication of the severity of the 
mental disorder and the need for mental health services (1999). Despite the ongoing criticism 
of the validity and reliability of psychiatric taxonomies, these diagnoses are still widely used 
in clinical practice, and attempts have been made to improve inter-rater reliability for 
epidemiological research (Kendell and Jablensky 2003; Aboraya 2007). 
 
A pragmatic classification based on symptom severity, disability and health service use has 
been proposed to classify mental disorders into mild, moderate and severe (1999; 
Charlwood, Mason et al. 1999). Examples of severe mental illness include schizophrenia, 
bipolar affective disorder (manic depression), organic mental disorder (dementia), severe 
anxiety disorders, severe eating disorders, severe depression, and severe panic disorder. 
However there is little consistency in how these pragmatic categories especially severe 
mental illness (SMI), the most frequently used category, are defined in practice (Schinnar, 
Rothbard et al. 1990; Slade, Powell et al. 1997; Ruggeri, Leese et al. 2000). This limits the 
usefulness of this taxonomy for epidemiological research. 
 
Bipolar disorder and schizophrenia  
 
These conditions are classified as psychotic disorders as they are characterised by a 
noticeable separation of the normal links between perception, mood, thinking, behaviour and 
contact with reality. People experiencing severe episodes of these disorders can present with 
delusions (i.e. fixed, false, unshakable beliefs), hallucinations (i.e. perceptions without 
stimuli, for example hearing voices), and disorganised thinking/ speech or behaviour. People 
with bipolar disorder may also present with these symptoms, although recurrent swings of 
mood is a more cardinal feature of this condition (Katona and Robertson 2000; Gelder, 
Andreasen et al. 2009). 
 
    28 
Emil Kraepelin first classified psychosis into organic psychosis, where a physiological 
disturbance can be shown, and functional psychosis, where no such disturbance can be 
demonstrated (Kraepelin 1893). This classification corresponds broadly to the current 
taxonomy for schizophrenia used in ICD10 and DSM-IV (see Table 1-1). Bipolar disorder has 
traditionally been classified according to the pattern of mood disturbance. People with bipolar 
disorder I have one or more manic or mixed episodes, and one or more major depressive 
episodes, whereas people with bipolar II have recurrent depressive and hypomanic 
episodes, but no manic episodes. People with cyclothymia have chronic mood fluctuations 
with no evidence of mania or depressive episode sufficient to meet criteria for major 
depression (Katona and Robertson 2000; Gelder, Andreasen et al. 2009). This classification 
is adopted by the DSM-IV taxonomy. 
 
Aetiology and pathophysiology 
The exact aetiology of both of these conditions has not currently been elucidated, but it is 
thought to be multifactorial, with evidence for important genetic/ familial and environmental 
contributions (Belmaker 2004; Picchioni and Murray 2007; Van Os and Kapur 2009), see 
Table 1-2. 
 
A number of structural and physiological changes have been reported in both conditions. In 
schizophrenia, structural brain imaging studies have found associations with subtle 
decreases in grey matter, enlargement of ventricles, and focal alteration of white matter 
tracts (Vita, De Peri et al. 2006; Glahn, Laird et al. 2008; Ellison-Wright and Bullmore 2009). 
Neurochemical studies have found that the acute psychotic state in schizophrenia is 
associated with an increase in dopamine synthesis, dopamine release, and resting-state 
synaptic dopamine concentrations (Laruelle 1998; Guillin, Abi-Dargham et al. 2007) and the 
‘dopamine hypothesis’ attributes psychosis to faulty interpretations arising from misfiring 
dopaminergic neurons (Van Os and Kapur 2009). In contrast bipolar disorder has been found 
to be associated with abnormalities in the lateral ventricular and globus pallidus, and with 
deep white matter hyperintensities (Kempton, Geddes et al. 2008; Arnone, Cavanagh et al. 
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2009). Evidence of neuroendocrine abnormalities has been inconsistent but suggest 
abnormalities in the hypothalamic-pituitary-adrenal axis (HPA axis) may be an important 
(Katona and Robertson 2000; Plocka-Lewandowska, Araszkiewicz et al. 2001; Watson, 
Gallagher et al. 2004). 
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Table 1-1 - ICD10 and DSM-IV codes for bipolar disorder and schizophrenia 
Bipolar disorder Schizophrenia 
International Classification of Diseases version 10 (ICD10) 
F31 – Bipolar affective disorder 
 
• F31.0 - Bipolar affective disorder, current 
episode hypomanic 
• F31.1 - Bipolar affective disorder, current 
episode manic without psychotic symptoms 
• F31.2 - Bipolar affective disorder, current 
episode manic with psychotic symptoms 
• F31.3 - Bipolar affective disorder, current 
episode mild or moderate depression 
• F31.4 - Bipolar affective disorder, current 
episode severe depression without psychotic 
symptoms 
• F31.5 - Bipolar affective disorder, current 
episode severe depression with psychotic 
symptoms 
• F31.6 - Bipolar affective disorder, current 
episode mixed 
• F31.7 - Bipolar affective disorder, currently in 
remission 
• F31.8 - Other bipolar affective disorders 
• F31.9 - Bipolar affective disorder, unspecified 
 
F20 to F29 – Schizophrenia, schizotypal and 
delusional disorders 
 
• F20 – Schizophrenia 
• F21 – Schizotypal disorder 
• F22 - Persistent delusional disorders 
• F23 - Acute and transient psychotic disorders 
• F24 - Induced delusional disorder 
• F25 - Schizoaffective disorders 
• F28 - Other nonorganic psychotic disorders 
• F29 – Unspecified nonorganic psychosis 
Diagnostic and Statistical Manual of Mental Disorders version 4 (DSM-IV) 
Bipolar I disorder, single manic episode 
 
• 296.00 Unspecified 
• 296.01 Mild 
• 296.02 Moderate 
• 296.03 Severe without psychotic features 
• 296.04 Severe with psychotic features 
• 296.05 In partial remission 
• 296.06 In full remission 
 
Bipolar I disorder, most recent episode manic 
 
• 296.40 Unspecified 
• 296.41 Mild 
• 296.42 Moderate 
• 296.43 Severe without psychotic features 
• 296.44 Severe with psychotic features 
• 296.45 In partial remission 
• 296.46 In full remission 
 
Bipolar I disorder, most recent episode depressed 
 
• 296.50 Unspecified 
• 296.51 Mild 
• 296.52 Moderate 
• 296.53 Severe without psychotic features 
• 296.54 Severe with psychotic features 
• 296.56 In full remission 
• 296.55 In partial remission 
• Psychotic disorder secondary to general 
medical condition 
 
o 293.81 With delusions 
o 293.82 With hallucinations 
 
• 295.10 Disorganized type 
• 295.20 Catatonic type 
• 295.30 Paranoid type 
• 295.40 Schizophreniform disorder 
• 295.60 Residual type 
• 295.70 Schizoaffective disorder 
• 295.90 Undifferentiated type 
• 297.1 Delusional disorder 
• 297.3 Shared psychotic disorder 
• 298.8 Brief psychotic disorder 
• 298.9 Psychotic disorder NOS 
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Bipolar I disorder, most recent episode mixed 
 
• 296.60 Unspecified 
• 296.61 Mild 
• 296.62 Moderate 
• 296.63 Severe without psychotic features 
• 296.64 Severe with psychotic features 
• 296.65 In partial remission 
• 296.66 In full remission 
• 296.7 Bipolar I disorder, most recent episode 
unspecified 
• 296.80 Bipolar disorder NOS 
• 296.89 Bipolar II disorder 
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Table 1-2 - Aetiology of bipolar disorder and schizophrenia 
Bipolar Disorder Schizophrenia 
Evidence for genetic contributions 
• Bipolar disorder is reported with increased 
frequency in first degrees relatives of those 
with the condition, but the findings are 
inconsistent (Kato 2007; Burmeister, 
McInnis et al. 2008) 
• Schizophrenia is reported with increased 
frequency in relatives of people with 
schizophrenia (O'Donovan, Williams et al. 
2003; Picchioni and Murray 2007) 
 
• Twin studies have found high concordance 
in monozygotic twins and low concordance 
in dizygotic twins brought up together, 
however studies have been limited by small 
sample sizes (Reich, Clayton et al. 1969) 
• Concordance rates are higher in 
monozygotic twins (Katona and Robertson 
2000; O'Donovan, Williams et al. 2003; 




 • Adopted-away offspring of people with 
schizophrenia have an increased risk of 
developing schizophrenia (Katona and 
Robertson 2000; O'Donovan, Williams et al. 
2003; Picchioni and Murray 2007) 
Evidence for environmental contributions 
• Consistent evidence of high frequency of 
early life stressors (Leverich and Post 2006) 
• Links to season of birth (Torrey, Miller et al. 
1997), low birth weight (Rifkin, Lewis et al. 
1994; Smith, Flynn et al. 2001), maternal 
viral infection (Kirch 1993; Yolken and 
Torrey 1995; Brown 2006) and other early 
life exposures has been found (Khashan, 
Abel et al. 2008) 
 
• Evidence that recent life events and 
interpersonal relationships contribute to the 
likelihood of onsets and recurrences of 
bipolar mood episodes (Alloy, Abramson et 
al. 2005) 
• Tentative associations have been found 
with abnormal family processes including 
problem parenting, and acute life stressors 





    33 
Epidemiology 
Both bipolar disorder and schizophrenia are relatively rare conditions, with the incidence of 
schizophrenia reported to be 15-20/ 100,000 per year, and the lifetime morbidity risk to be 
0.85% (McGrath, Saha et al. 2008; Van Os and Kapur 2009), whilst for bipolar disorder the 
lifetime prevalence is 1 - 2% (bipolar disorder I) (Ketter 2010). Late adolescence and early 
adulthood are peak years for the onset of both conditions (Belmaker 2004; Picchioni and 
Murray 2007; Van Os and Kapur 2009), with a long tail of later onset cases extending into old 
age (Howard, Rabins et al. 2000; Howard 2010). Schizophrenia is seen more frequently in 
men where it often appears at an earlier age (Castle, Wessely et al. 1993; Roy, Maziade et 
al. 2001; Picchioni and Murray 2007; Van Os and Kapur 2009), in contrast to bipolar 
disorder, which has a slight excess in women (Belmaker 2004).  
 
Clinical presentation 
Kurt Schneider described a list of first-rank symptoms that he considered pathognomonic of 
schizophrenia, that could be used to distinguish the condition from other psychotic disorders. 
These include audible thoughts (or thought echo), thought withdrawal, thought insertion, 
thought broadcasting, somatic/thought passivity, and delusional perception (Schneider 
1959). However, recent evidence suggests that these symptoms lack specificity (Nordgaard, 
Arnfred et al. 2008). 
 
The symptoms originally described by Schneider, with subsequent modifications, are also 
often characterised as positive symptoms, which are judged typically to respond well to anti-
psychotic medications (Picchioni and Murray 2007; Van Os and Kapur 2009). In addition, 
people with schizophrenia can often experience deficits in their normal emotional response, 
such as flat or blunted affect and emotion, poverty of speech (alogia), inability to experience 
pleasure (anhedonia), lack of desire to form relationships (asociality), and lack of motivation 
(avolition), symptoms which respond less well to anti-psychotic medications (Andreasen, 
Flaum et al. 1990; Murphy, Chung et al. 2006). 
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Table 1-3 - ICD-10 diagnostic criteria for a diagnosis of schizophrenia  
 
At least one present for most of 
the time for a month 
 
• Thought echo, insertion or withdrawal, or thought broadcast 
• Delusions of control referred to body parts, actions, or 
sensations 
• Delusional perception 
• Hallucinatory voices giving a running commentary, discussing 
the patient, or coming from some part of the patient’s body 
• Persistent bizarre or culturally inappropriate delusions 
 
Or at least two present most of 
the time for a month 
• Persistent daily hallucinations accompanied by delusions 
• Incoherent or irrelevant speech 
• Catatonic behaviour such as stupor or posturing 
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Bipolar disorder is characterised by alterations of mood rather than being primarily a disorder 
of thought processing, as described above. Distinct periods of elevated, expansive mood 
known as mania, and commonly associated with increased psychomotor activity, seen as 
rapid thinking, pressured speech, distractibility, and decreased need for sleep; reduced 
social inhibition, which can be result in sexual over-activity, overspending, substance abuse 
and inappropriate business, religious or political activity can occur in some clients with this 
disorder. Mood congruent thought disorders such as grandiose delusions/ hallucinations are 
also common and are reflective of the client’s elevated mood and exaggerated optimism. 
Equally severe anxiety or irritability are also commonly experienced by people during an 
acute manic episode. Mood incongruent psychotic features may also be found, and may 
indicate a schizoaffective disorder. The elevated symptoms must last for at least one week if 
the diagnosis of bipolar I disorder is to be considered. In comparison, hypomania is generally 
a mild to moderate level of mood elevation, characterized by optimism, pressure of speech 
and activity, and decreased need for sleep, which does not limit functioning. ICD10 
diagnostic criteria stipulate that a diagnosis of bipolar disorder can only be made when there 
is evidence of two or more episodes in which the patient's mood and activity levels are 
significantly disturbed, this disturbance consisting on some occasions of an elevation of 
mood and increased energy and activity (hypomania or mania) and on others of a lowering of 
mood and decreased energy and activity (depression)(WHO). During the depressive phase 
of bipolar disorder clients may experience persistent feelings 
of sadness, anxiety, guilt, anger, isolation, or hopelessness; disturbances in sleep and 
appetite; fatigue and loss of interest in usually enjoyable activities; problems concentrating; 
loneliness, self-loathing, apathy or indifference; depersonalization; loss of interest in sexual 
activity; shyness or social anxiety; irritability, chronic pain (with or without a known cause); 
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Clinical management and current public health approaches in the UK 
Unfortunately there is no objective test for either condition, thus diagnosis is based upon 
confirmation of the key symptoms, and the exclusion of the most likely differential diagnoses. 
There is currently no cure for these disorders, and both are considered long-term conditions. 
However recent longitudinal studies with long follow-up periods have found that up to 50% of 
people diagnosed with schizophrenia have a moderately good long-term global outlook with 
extended periods of stable mental health, and that people who never experience complete 
recovery can still manage to sustain an acceptable quality of life with adequate support and 
help (Gaebel and Frommann 2000; Harrison, Hopper et al. 2001; Jobe and Harrow 2005). 
The long-term outlook for clients with bipolar disorder is similar to schizophrenia and is very 
dependent upon successful ongoing care and engagement (Coryell, Turvey et al. 1998; 
Turvey, Coryell et al. 1999; Angst and Sellaro 2000). Thus clinical management of both 
conditions revolves around early diagnosis, the prompt treatment of acute psychiatric 
episodes, reintegration into the community, and the prevention of further acute psychiatric 
events and complications including physical ill-health (Katona and Robertson 2000; 
Belmaker 2004; Picchioni and Murray 2007; Gelder, Andreasen et al. 2009; Van Os and 
Kapur 2009).  
 
There are a number of options for the treatment of acute psychiatric events depending on the 
severity of symptoms, however pharmacological treatment is still the mainstay of acute 
management (Health 2010). Hospitalisation is often necessary for the first or subsequent 
severe episodes. There is substantial overlap between the pharmacological treatments used 
to treat acute episodes of each condition, namely acute psychosis and mania with the use of 
anti-psychotic drugs, which block dopamine D2 receptors being the drugs of choice for acute 
management as a result of their non-specific sedative effects, as well as their specific effects 
on decreasing positive symptoms (Kapur and Mamo 2003; El-Mallakh, Elmaadawi et al. 
2010). 
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Over the last decade there has been a growing number of so-called ‘second-generation’ or 
‘atypical’ anti-psychotics, which have been introduced into clinical practice (Agid, Kapur et al. 
2008; Kane and Correll 2010). These drugs have been said to have a better side effect 
profile than older ‘first generation’ anti-psychotics, especially reduced occurrence of motor 
side-effects, and to be better tolerated by clients (Keck, Strakowski et al. 2000; Leucht, 
Corves et al. 2009), although this has been disputed (Jones, Barnes et al. 2006; Lewis, 
Davies et al. 2006). They are also thought to have an effect on reducing negative symptoms 
(McElroy, Guerdjikova et al. 2010). However there is increasing evidence that anti-psychotic 
drugs, including second generation anti-psychotics have wide-ranging adverse effects on 
physical health, by inducing metabolic side-effects such as increased triglyceride/ cholesterol 
levels (De Hert, Schreurs et al. 2009), weight gain (Faulkner, Soundy et al. 2003),  as well as 
increased risk of type 2 diabetes (Group 2004; Group 2004; McIntyre, Konarski et al. 2005; 
Suvisaari, Perala et al. 2008; Kessing, Thomsen et al. 2010; Schoepf, Potluri et al. 2012) and 
cardiovascular disease (Glassman 2005; Hennekens, Hennekens et al. 2005). 
 
Anti-psychotic medications are only part of the treatment regime. The combination of new 
medications, community case management and wider psychosocial interventions, including 
supportive psychotherapy, occupational therapy, counselling and family therapy can help 
ameliorate symptoms, reduce the length and cost of hospital stay, increase compliance with 
medical treatments, improve functioning and client satisfaction, and prevent relapse, 
although the availability of these complementary services is often limited (Falloon, Boyd et al. 
1985; Leff, Berkowitz et al. 1990; Pilling, Bebbington et al. 2002; Burns, Catty et al. 2007; 
Picchioni and Murray 2007; Van Os and Kapur 2009; Marshall and Lockwood 2011) and 
controversial, especially when combined with ‘minimal medication’ or ‘whole body’ 
approaches to the treatment of SMI (Carpenter 1997; Calton and Spandler 2009). 
 
Depressive episodes in clients with bipolar disorder generally respond well to anti-depressant 
therapy, although caution is needed to avoid a switch from depression to mania, especially in 
people with a history of severe manic episodes (Kusumakar 2002).  
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After recovery from an acute episode of schizophrenia, current guidance from the National 
Institute of Clinical Excellence (NICE) recommends prophylactic doses of anti-psychotics for 
one or two years with continued specialist supervision (2009) and intra-muscular 
administration if there are problems with non-compliance (McEvoy 2006).  
 
For people with bipolar disorder long-term management also relies on pharmacological and 
non-pharmacological strategies. ‘Mood stabilising’ drugs, such as lithium, sodium valproate 
carbamazepine or lamotrigine are the mainstay of long-term pharmacological management 
(Bauer and Mitchner 2004; Geddes, Burgess et al. 2004). These drugs act too slowly 
(Verdoux, Gonzales et al. 1996), but have a better side-effect profile for long-term therapy 
than anti-psychotic drugs and are better tolerated by clients (Kusumakar 2002; Belmaker 
2004). Psychotherapy is aimed at recognizing episode triggers including prodromal 
symptoms before full-blown recurrence, reducing negative expressed emotion in 
relationships, and, practicing the factors that lead to maintenance of remission (Zaretsky, 
Rizvi et al. 2007). 
 
Physical illness and mortality in people with severe mental illness, including bipolar 
disorder and schizophrenia 
 
Growing evidence has suggested a close relationship between physical and mental health, 
especially in people with severe mental illness (SMI) such as bipolar disorder and 
schizophrenia, who are at increased risk from a wide range of physical illnesses, including 
coronary heart disease, diabetes, respiratory disease and infections (Barr 2001; Phelan, 
Stradins et al. 2001; Leucht, Burkard et al. 2007; 2009). although the association between 
these conditions and cancer is less clear (Goldacre, Kurina et al. 2005; Hodgson, Wildgust et 
al. 2010). The  underlying reasons for these relationships is complex, and not yet fully 
understood, but are thought to include; 1) factors related to the mental disorder, such as 
unhealthy behaviours (e.g. high levels of smoking, substance abuse, unhealthy diets and 
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inactivity) which have been found to be increased in these populations (Brown, Birtwistle et 
al. 1999); 2) factors related to the treatment of the mental disorder, including the metabolic 
side effects of anti-psychotic medications (De Hert, Schreurs et al. 2009); and 3) factors 
unrelated to the mental disorder or treatment, but connected to the social context in which 
the client with severe mental illness live. For example, an increasing amount of recent 
research shows that people with severe mental illness experience stigma (Fink and Tasman 
1992; Byrne 1999; Sartorius 2002), and discrimination (Wahl and Lefkowits 1989; Coverdale, 
Nairn et al. 2002; Sieff 2003; Stuart 2006; Thornicroft 2006) which may result in them having 
difficulty accessing appropriate treatments, including preventative health measures 
(Lawrence and Kisely 2010), and difficulty with engaging in physical healthcare treatment. 
Previous research that has investigated the effect of inequality on health has found that how 
individuals and communities feel, their levels of trust, tolerance and participation, may be 
critical in determining health (Wilkinson 1996; Kawachi, Kennedy et al. 1997; Wilkinson 
2000). 4) factors related to the prenatal period, or early development, with some authors 
suggesting that schizophrenia may be the expression of genetic predisposition or other 
downstream influences such as low-birth weight, maternal smoking/ alcohol use and 
maternal virus infections which is shared with other physical illnesses (Leucht, Burkard et al. 
2007). 
 
People with SMI have also been found to be at higher risk of mortality than the general 
population, both as a result of natural causes (Goldacre, Seagroatt et al. 1993; Harris and 
Barraclough 1997; Hall, O'Brien et al. 1998; 1999; Hiroeh, Appleby et al. 2001; Osby, Brandt 
et al. 2001; 2002; 2002; Gau and Cheng 2004; Goff, Cather et al. 2005; Tsai, Lee et al. 2005; 
2008; Hiroeh, Kapur et al. 2008; Roshanaei-Moghaddam and Katon 2009; Chang, Hayes et 
al. 2011) and unnatural causes (Goldacre, Seagroatt et al. 1993; Harris and Barraclough 
1997; Hall, O'Brien et al. 1998; Hiroeh, Appleby et al. 2001; 2002; 2002; Gau and Cheng 
2004; Dutta, Boydell et al. 2007; Simon, Hunkeler et al. 2007). In fact researchers have 
suggested that these conditions should be described as ‘life-shortening diseases’ (Allebeck 
1989). Studies that have attempted to compare the mortality risk profiles of people with 
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bipolar disorder and schizophrenia have typically found a mortality excess of between 218 
and 283% from all-causes of death in these populations (Saha, Chant et al. 2007), with a 
reduced life expectancy of between 10-20 years (Chang, Hayes et al. 2010). 
 
The high level of physical illness and the mortality risk has been increasingly recognised by 
healthcare policy makers, and over the past decade several strategies have been 
implemented in England and Wales aimed at reducing the ‘mortality gap’ between people 
with SMI and the general population. This has included strategies aimed at reducing 
deliberate self-harm and suicide (1999; 2002; 2002), smoking (2008; 2008; 2009; Banham 
and Gilbody 2010; Tsoi, Porwal et al. 2010; 2011), alcoholism, and drug misuse (2007; 
2007), and other lifestyles associated with increased mortality (2004; 2011). 
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Recent studies have suggested that the rate of suicide and unnatural deaths has been 
stabilising among people with mental disorders as a whole (2005; Griffiths, Wright et al. 
2006; Kapur, Hunt et al. 2006; Biddle, Brock et al. 2008; Bowers, Banda et al. 2010). 
However, recent trends in all-cause mortality for people with schizophrenia and bipolar 
disorder in England have remained poorly characterised, and there is evidence from other 
countries that the overall mortality risk for these populations may be increasing (Saha, Chant 
et al. 2007; Lawrence, Kisely et al. 2010).There are a number of reasons to believe that the 
mortality risk in these populations (or at least the characteristics of the mortality gap between 
these populations, and the general population) may have changed over the past decade, 
including;  
 
- increasing use of second generation anti-psychotics (Santamaria, Perez et al. 2002; 
Aparasu, Bhatara et al. 2005; Caceres, Penas-Lledo et al. 2008; Ilyas and Moncrieff 
2012) despite better awareness of their adverse effects (Fontaine, Heo et al. 2001; 
Ray, Meredith et al. 2001; Ray, Meredith et al. 2001; Davidson 2002; Witchel, Hancox 
et al. 2003; Casey, Haupt et al. 2004; Straus, Bleumink et al. 2004; Joukamaa, 
Heliovaara et al. 2006; Ucok and Gaebel 2008; De Hert, Dekker et al. 2009; Ray, 
Chung et al. 2009; Correll and Nielsen 2010; Raedler 2010) 
- use of anti-psychotic drugs in vulnerable populations including children (Cheng-
Shannon, McGough et al. 2004; Najjar, Welch et al. 2004; Aparasu and Bhatara 
2005) and older people (Lee, Gill et al. 2004; Rapoport, Mamdani et al. 2005; Citrome 
2007; Chahine, Acar et al. 2010; Leon, Gerretsen et al. 2010; Narang, El-Refai et al. 
2010) who are at greater risk from the side effects 
- increasing evidence that despite the known risk of poor physical health and mortality 
these populations with SMI have difficulty accessing physical health services (Druss, 
Bradford et al. 2000; Plomondon, Ho et al. 2007; Laursen, Munk-Olsen et al. 2009; 
Lawrence and Kisely 2010; Mitchell and Lord 2010; Wildgust and Beary 2010; De 
Hert, Correll et al. 2011; Scott, Platania-Phung et al. 2011) 
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- difficulty in engaging these populations with SMI in health improving public health 
measures that have been implemented over the last decade (Brown, Birtwistle et al. 
1999; Alam 2006; Campion, McNeill et al. 2006) 
 
These risk factors may have resulted in an increased prevalence of physical illness in people 
with bipolar disorder and schizophrenia, or increased the severity of physical illness that 
presents in these populations, both of which could affect the risk of mortality. Equally, there 
may have been health improvements in the general population which have failed to reach 
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Chapter 2 - Literature review of mortality studies in people with bipolar and 
disorder schizophrenia 
 
In this chapter a review of the literature on mortality in people with bipolar disorder and 
schizophrenia is presented, especially focusing on research that has examined the mortality 
experiences of people with these disorders over the last decade. 
 
Saha and colleagues published a systematic review and meta-analysis of mortality in people 
with schizophrenia in 2007, which included studies from 1980 to 2006 (Saha, Chant et al. 
2007) using guidelines outlined by the Meta-analysis of Observational Studies in 
Epidemiology (MOOSE) group (Stroup, Berlin et al. 2000). They searched a range of 
databases (MEDLINE, PsychINFO, Web of Science, and Google Scholar) to identify all 




In preparing this chapter, the methodology adopted by Saha and colleagues was followed, to 
update their literature review on mortality in people with schizophrenia. However the search 
was restricted to publications after 1st January 2000 to focus on evidence elicited on mortality 
outcomes within the last decade, and also restricted to search to English language journals 
given the time and cost constraints of this work. Additional search terms for mortality in 
people with bipolar disorder which was not examined by Saha and colleagues were also 
used in this literature review. The following broad terms were used to identify suitable titles 
and abstracts; (schizo* or psych* or bipolar*) for the disorders of interest, followed by 
(mortality or death) for the outcome of interest. 
 
Potentially relevant articles were accessed and abstracts reviewed. Citations from significant 
articles and review articles were also scrutinised to locate additional relevant references. The 
search was restricted to literature published in peer-reviewed journals and materials from the 
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grey literature or unpublished sources were not sought, and authors were not contacted 
directly to supply further references given the time and cost constraints of this work. 
 
Studies were included if they met the following criteria: (1) published in peer reviewed 
literature between 1st January, 2000, and 31st December, 2010, (2) reported deaths in people 
with bipolar disorder or schizophrenia as diagnosed by any criteria, (3) studied a population 
15 years and older, including studies that only had adult populations (>45 years), or older 
adult populations (>65 years), (4) reported primary data on all-cause mortality and/or specific 
cause mortality. Studies were excluded if they (1) involved people with a diagnosis other than 
bipolar disorder or schizophrenia, (2) reported duplicate data, (3) reported only on 




The initial electronic search identified 3044 articles, of which 2866 were excluded because 
they did not meet the inclusion criteria. The remaining 178 articles possibly meeting inclusion 
criteria were obtained and their abstracts scrutinised. A further 55 were excluded, leaving 





There were 19 systematic literature reviews or meta-analyses which focused on the subject 
of mortality in people with bipolar disorder and schizophrenia. Studies investigating mortality 
outcomes in SMI utilised a number of observation research strategies. 
 
The majority of the references were to cohort studies, 88 out of 133 studies reviewed using 
this study design. This involves the identification of a cohort of people with mental disorder 
from hospital records, community psychiatric registers or community surveys. Data on factors 
    46 
which may be predictive of mortality are then collected from these subjects and they are 
followed-up prospectively until death (Mann 2003; Prince, Stewart et al. 2003; Susser, 
Schwartz et al. 2006; Rothman, Greenland et al. 2008). This follow-up is often undertaken by 
linking the participants’ health records with their death records, using a unique identifying 
number held on both records, or a set of personal identifiers matched across each health 
record (Gill, Goldacre et al. 1993; Leadbeter 2000). Frequently a measure of relative 
mortality risk is calculated by comparing the rate of death in these populations with a suitable 
comparator group of inpatients or matched community controls without schizophrenia or 
bipolar disorder. In other studies, the mortality rates in these populations are compared with 
the mortality rates in the general population to calculate a standardised mortality ratio (SMR). 
 
This methodology has the advantage that the subjects are recruited before the outcome has 
occurred, and a variety of possible covariates can be taken into account independently of 
knowledge of the outcome. This minimises the risk of recall bias, an important consideration 
for case control studies of mortality outcomes (Drew, Kraus et al. 1990). Cohort studies have 
a number of disadvantages including a large sample size required to enable a robust 
estimation of mortality risk where the case prevalence is relatively rare. Additionally the 
follow-up of members of the cohort may require many years and incur considerable cost 
before the outcome of interest occurs (Mann 2003; Rothman, Greenland et al. 2008). 
However the cost of follow-up has been considerably reduced with the use of electronic 
health records and data linkage techniques, enabling outcomes collected from vital statistics 
such as death certificates to be routinely recorded in follow-up studies. These follow-up 
methods also reduce the number of subjects lost to follow-up which can bias the estimate of 
relative risk in cohort studies (Mann 2003; Rothman, Greenland et al. 2008). 
 
Case control studies including nested designs are less often used to study questions 
regarding mortality. The literature review found a total of 11 studies which used this research 
method. This involves the selection of a group of people who have died and a age-sex 
matched group of people who have not died, and calculating the odds of clients with 
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schizophrenia or bipolar disorder being included in the group that died compared with the 
group that did not die (Mann 2003; Rothman, Greenland et al. 2008). As the cases and 
controls are not selected from a general population sample, the absolute risk cannot be 
calculated, and the relative risk can only be approximated; however the odds ratio calculated 
from these studies approximates the relative risk when the outcome, in this case mortality, is 
rare (Greenland and Thomas 1982; Greenland, Thomas et al. 1986; Cummings and Koepsell 
2001). These studies may be quicker and cheaper to undertake as there is no requirement to 
follow-up subjects. However there are considerable weaknesses with this method for 
examining mortality outcomes, notably the difficulties of obtaining information about 
exposures, namely a previous history of mental illness, in people who have died mean that 
these studies are prone to selection and information biases (Drew, Kraus et al. 1990; Mann 
2003; Rothman, Greenland et al. 2008). 
 
The majority of the studies investigated mortality in people with schizophrenia (58 studies), 
followed by broader categories of SMI (33 studies) or psychosis (7 studies), with very few on 
bipolar disorder specifically (7 studies). The literature review confirmed that people with 
schizophrenia or bipolar disorder have a higher risk of death than the general population 
regardless of age or sex. Mortality rates were slightly higher in men than women for both 
bipolar disorder and schizophrenia, largely as a result of the high rates of unnatural deaths in 
men. 
 
Sixteen studies reported on data collected from populations in the UK. The all-cause 
standardised mortality ratios (SMRs) for UK populations with bipolar disorder between 1.2 
(Dutta, Boydell et al. 2007) and 2.0 (Chang, Hayes et al. 2010), and for schizophrenia ranged 
from 1.8 (Dutta, Murray et al. 2010) and 2.9 (Brown, Kim et al. 2010). Deaths from unnatural 
causes such as suicide were greatly elevated in these groups, with SMRs upto 9.8 for people 
with bipolar disorder (Dutta, Boydell et al. 2007) , and 11.7 for people with schizophrenia 
(Dutta, Murray et al. 2010), depending on the cohort sampled and the period of follow-up that 
was investigated. In fact suicide was the focus of more than 40% of the studies reviewed 
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from the UK. Deaths from cardiovascular and respiratory disease accounted for the majority 
of deaths from natural causes in these populations (Brown, Kim et al. 2010). Modifiable or 
avoidable conditions were also considered an important contributor to mortality in these 
populations (Rasanen, Hakko et al. 2005; Amaddeo, Barbui et al. 2007; Wildgust and Beary 
2010). A summary of the studies in the UK is included in Table 2-1. 
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Table 2-1 - Mortality studies in the UK on people with bipolar disorder and 
schizophrenia since 2000 
Reference Summary 
Reassessing the long-term 
risk of suicide after a first 
episode of psychosis 
(Dutta, Murray et al. 2010) 
Retrospective cohort study of 2723 people presenting for the first time 
with symptoms of psychosis to hospitals in various locations within 
the UK over three periods of time between 1965 to 2004, and 
followed-up for a mean time of 11.5 years. They found that the case 
fatality from suicide was considerably lower than in previous 
published research, but the risk of suicide persisted even a decade 
after 1st presentation, with mean time to suicide of 5.6 years. 
 
All-cause mortality among 
people with serious mental 
illness (SMI), substance 
use disorders, and 
depressive disorders in 
southeast London: a cohort 
study (Chang, Hayes et al. 
2010) 
 
Psychiatric case register study in South-East London, between 2007 
to 2009, looked at mortality in people with SMI, including 
schizophrenia and bipolar disorder. Found high all-cause SMRs of 2.2 
for people with SMI who accessed services between 2007 to 2009, 
and also suggested that mortality differs substantially with age, 
diagnosis, gender and ethnicity. 
Suicide amongst psychiatric 
in-patients who abscond 
from the ward: a national 
clinical survey (Hunt, 
Windfuhr et al. 2010) 
Cross-sectional study to describe the social and clinical 
characteristics of people who had absconded from an in-patient 
psychiatric ward prior to suicide, using survey based on a 10-year 
(1997 to 2006) sample of people in England and Wales who had died 
by suicide. Found 1,851 cases of suicide by current psychiatric in-
patients. 469 of these patients died after absconding from the ward. 
Schizophrenia was the most common diagnosis. Found that 
absconders were proportionally more likely than in-patients on agreed 
leave to have been legally detained for treatment, non-compliant with 
medication, and to have died in the first week of admission 
 
Twenty-five year mortality 
of a community cohort with 
schizophrenia (Brown, Kim 
et al. 2010) 
Reports the results from a 25 year follow-up study of a small English 
community cohort of people with schizophrenia followed from 1981 to 
1982. Found a higher rate of all-cause mortality (SMR=2.9), with 
unnatural deaths concentrated in the first five years of follow-up. They 
also found that cardiovascular mortality had increased relative to the 




Risk Factors, and All-Cause 
Mortality: The Scottish 
Health Survey (Hamer, 
Stamatakis et al. 2008) 
Cohort study using Scottish health survey data linked to HES, and 
death records to examine the effects of behavioural risk factors on 
psychiatric hospital use and mortality in people with SMI. They 
included data on 597 admissions to psychiatric hospitals up to 2003, 
and followed for mortality to 2006, for a mean period of 8.5 years. 
They found that mortality was mediated by behavioural risk factors 
such as socioeconomic status (OR=2.2), history of smoking (OR=4.7) 
and poor level of physical activity (OR=2.2). 
 
Suicide in current 
psychiatric in-patients: a 
case-control study The 
National Confidential 
Inquiry into Suicide and 
Homicide (Hunt, Kapur et 
al. 2007) 
 
Case-control study of 222 people who died by suicide between 1999 
to 2000 whilst in psychiatric in-patient care in England and Wales. 
Previous deliberate self-harm (OR=4.3), recent adverse life events 
(OR=2), and symptoms of mental illness at last contact with staff 
(OR=2) were associated with increased risk for suicide. 
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Suicide and other causes of 
mortality in bipolar disorder: 
A longitudinal study (Dutta, 
Boydell et al. 2007) 
Cohort study of 235 patients from South-East London with first 
diagnosis of bipolar disorder between 1965 to 1999. Found that 
suicide is significantly increased (SMR for suicide=9.8), but actual 
case fatality was not as high as previously seen in the literature. 
Alcohol abuse (HR=6.7) and deterioration in premorbid functioning 
(HR=5.2) were associated with increased risk of suicide. 
 
Relative risk of 
cardiovascular and cancer 
mortality in people with 
severe mental illness from 
the United Kingdom's 
General Practice Research 
Database (Osborn, Levy et 
al. 2007) 
 
Cohort study using a community sample of 46,136 people with SMI 
and 300,426 matched comparators from the General practice 
research database. Found high risk of cardiovascular disease (HR = 
1.1 to 3.2), and stroke deaths (HR = 1.3 to 2.5) in people with SMI not 
explained by the presence of common risk factors including anti-
psychotic drug use, smoking or social deprivation 
 
Suicide in psychiatric in-
patients in England, 1997 to 
2003 (Kapur, Hunt et al. 
2006) 
Using data from the national confidential inquiry into suicide linked to 
HES to track trends in in-patient and post-discharge suicide between 
1997 to 2003. Found a fall in rate of inpatient and post-discharge 
suicide over the study period. 
 
Suicide in schizophrenia: 
findings from a national 
clinical survey (Hunt, Kapur 
et al. 2006) 
Case control study in a national sample of completed suicides in the 
UK between 1996-2000. Found that patients with schizophrenia who 
committed suicide were more likely to be young, male, unemployed 
and from ethnic minority. There was a high likelihood of violent 
method of suicide in schizophrenia patients 
 
Psychiatric disorders 
certified on death 
certificates in an English 
population (Goldacre, 
Duncan et al. 2006) 
Cross-sectional study using death certificate data from Oxford and 
England to report trends in the recording of psychiatric diagnosis on 
the death certificates. Found that mortality associated with psychiatric 
illness is greatly under-estimated if only the underlying cause is taken 
into account. Also found that the trend in recording psychiatric 
diagnosis on the death certificates varies between disease over time, 
with a decline in mortality rates for schizophrenia, and an increase for 
depression and dementia recorded on death certificates between 
1979 -1999. 
 
Lifetime suicide rates in 
treated schizophrenia: 
1875-1924 and 1994-1998 
cohorts compared (Healy, 
Harris et al. 2006) 
Small study using inpatient records linked to mortality data, 
comparing the suicide rates before and after introduction of 
chlorpromazine in North-West Wales. Found that suicide rates per 
hospital admission were twenty times higher between the first and 
last surveys 
 
Suicide in schizophrenia: a 
retrospective case-control 
study of 51 suicides 
(Sinclair, Mullee et al. 2004) 
Retrospective case control study of 51 schizophrenia patients and 82 
matched controls in Wessex for factors associated with suicide. 
Found that depressive symptoms (OR=2.6) and previous suicide 
attempts (OR=2.7) are significant predictive factors. 
 
Mortality after discharge 
from long-term psychiatric 
care in Scotland, 1977-94: 
a retrospective cohort study 
(Stark, MacLeod et al. 
2003) 
 
Cohort study of mortality trends in 6776 people discharged from long 
stay psychiatric in-patient care with SMI between 1977 to 1994 and 
followed up to 15 years. Found high SMRs = 1.6 for all-causes and 
for both natural and unnatural causes of death 
Suicide following deliberate 
self-harm: long-term follow-
up of patients who 
presented to a general 




Prospective case register study of 11583 patients who had 
undertaken deliberate self-harm (DSH) between 1978 - 1997. Found 
that there was a significant and persistent risk of subsequent suicide, 
which varies by age and sex. RR of suicide in 1st year after episode of 
DSH = 66 
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Causes of the excess 
mortality of schizophrenia 
(Brown, Inskip et al. 2000) 
Follow-up study of mortality in 370 schizophrenia patients in 
Southampton who used mental health services between 1981 - 1982. 
Used medical records linked to death certificates/ coroners records. 
Found high SMRs for both natural/ unnatural causes of death, 
especially for smoking related diseases 
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Studies have found that the overall mortality for these populations has been increasing over 
the last few decades in several countries (Saha, Chant et al. 2007; Lawrence, Kisely et al. 
2010). At the same time other researchers have found a decreasing mortality trend, 
especially for deaths from unnatural causes or in people living in the community (Capasso, 
Lineberry et al. 2008; Pirkola, Sund et al. 2009; Rantanen, Koivisto et al. 2009), whilst others 
found no change in mortality (Desai and Rosenheck 2003; Heila, Haukka et al. 2005). 
However there were only four studies published in the last decade that also included data 
from 2000 in the UK, two of which focused on recent trends in mortality from suicide in 
people with SMI (Dutta, Murray et al. 2010; Hunt, Windfuhr et al. 2010), one studied all-
cause mortality in people with SMI (Chang, Hayes et al. 2010) and finally one small study 
that tracked the trend in all-cause mortality rates for people with schizophrenia (Brown, Kim 
et al. 2010).  
 
The differences in mortality between the community and inpatient or recently discharged 
samples emphasise that the period of acute illness and immediate community rehabilitation 
for these patient populations remains a time of high risk of death (Goldacre, Seagroatt et al. 
1993), possibly increasingly so. As mentioned above this may be due to a number of reasons 
including; 
- increasing investment in community mental health services and decreasing 
investment in inpatient services  
- increasing concentration of the most sick clients in inpatient care, including people 
with physical comorbidities 
- side-effects of modern anti-psychotics prescribed for acute and ongoing management 
of these clients 
- difficulties accessing physical healthcare services or public health services for people 
recently discharged from inpatient care 
- poor quality physical healthcare offered to people with physical health and severe 
mental health problems 
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Chapter 3 - Gaps in current research 
 
The literature review revealed a number of significant gaps in the evidence base on mortality 
amongst people with bipolar disorder and schizophrenia.  
 
First, there is little recent information about all-cause mortality in people with schizophrenia at 
a national level in the UK, with only two local studies reporting information on all-cause 
mortality rates in these people within the last decade (Brown, Kim et al. 2010; Chang, Hayes 
et al. 2010), and a further two national studies reporting on suicide outcomes only (Dutta, 
Murray et al. 2010; Hunt, Windfuhr et al. 2010).  
 
Second, there is very little information on the mortality outcomes for people with bipolar 
disorder within the last decade in the UK. Only one article has reported all-cause mortality 
rates in these populations utilising data from 2000 onwards (Chang, Hayes et al. 2010), 
whilst the next most recent article reported on data collected between 1965-99 (Dutta, 
Boydell et al. 2007). This limits conclusions about the epidemiology of mortality for these 
populations in the UK as a whole, as the mortality risk is dependent upon the age of the 
population studied, the length of follow up and type of study used to measure the risk 
(Bushe, Taylor et al. 2010). As mentioned earlier, there is good evidence to suggest that the 
mortality risk in these populations will have changed over the last decade. 
 
Third, there is little information on recent time trends in mortality for either population in the 
UK, with only one study that tracked the trend in all-cause mortality rates in these 
populations over the past decade (Brown, Kim et al. 2010). However systematic reviews 
collating information from other countries have suggested that these populations may not be 
benefiting from the decreasing mortality in the general population, resulting in a widening of 
the mortality gap (Saha, Chant et al. 2007; Lawrence, Kisely et al. 2010; Mitchell and Lord 
2010). These deficits in information are particularly relevant to current mental health policy 
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which makes a specific commitment to tackling the well-known ‘mortality gap’ between 
people with mental disorders and the general population. 
 
Fourth, there is little recent information on mortality in populations with schizophrenia or 
bipolar disorder who may be at greater risk of death in the UK including the elderly who are 
at risk of side-effects from anti-psychotics (Citrome 2007; Leon, Gerretsen et al. 2010), 
people who have difficulty accessing health services, such as those who live in rural areas or 
whose first language is not English, and people who present with comorbid physical 
illnesses. Evidence from Australia and elsewhere suggests that these people may also have 
additional risk above that experienced by people without these risk factors (Druss, Bradford 
et al. 2000; Druss, Bradford et al. 2001; Lawrence, Holman et al. 2003; Abrams, Vaughan-
Sarrazin et al. 2008; Abrams, Vaughan-Sarrazin et al. 2009; Laursen, Munk-Olsen et al. 
2009; Lawrence and Kisely 2010; Mitchell and Lord 2010). This information is relevant to 
better characterise mortality for these populations, to identify factors that may be of 
etiological importance, and to allow better targeting of interventions to reduce mortality. 
 
Finally, whilst there is evidence that a proportion of excess mortality in these populations is 
the result of avoidable or modifiable conditions (Rasanen, Hakko et al. 2005; Amaddeo, 
Barbui et al. 2007; Wildgust and Beary 2010; Wildgust, Hodgson et al. 2010), there is little 
information to quantify the effect of these conditions within populations in the UK, or to 
evaluate interventions that could be used to reduce their effects. Knowledge of this 
information could help us better understand the nature of mortality in these populations as 
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Chapter 4 – Objectives and hypothesis 
 
Thus in this thesis, I sought to investigate recent mortality trends in people with 
schizophrenia and bipolar disorder in England over the past decade, and seek to answer the 
following research questions; 
 
1. Has the excess in all-cause mortality for people with bipolar disorder and 
schizophrenia increased or decreased over the last decade in England? 
2. Is the mortality excess of the same magnitude for people with bipolar disorder and 
schizophrenia in England? 
3. Is the trend in mortality consistent for people with bipolar disorder and schizophrenia 
of different ages and genders in England? 
4. Is mortality for people with bipolar disorder and schizophrenia geographically 
consistent across England? 
5. Does comorbid illness with bipolar disorder and schizophrenia in people with another 
main diagnosis, namely cardiovascular disease or diabetes, result in excess 
mortality? 
6. To what extent are causes of excess deaths potentially avoidable in people with 
bipolar disorder and schizophrenia and therefore what would be the impact on the 
mortality excess of equalising those causes in England? 
 
Objective 1 
It is well known that people schizophrenia and bipolar disorder are at increased risk of death 
compared with the general population from all-causes (Allebeck 1989). However, less is 
known about current national trends in mortality, including whether the mortality gap has 
been reducing over the last decade in England. In fact as mentioned in the last chapter only 
one study from the UK gives mortality rates for bipolar disorder (Chang, Hayes et al. 2010) 
and only two give mortality rates for schizophrenia (Brown, Kim et al. 2010; Chang, Hayes et 
al. 2010)  using data collected from local psychiatric registers over the last decade. None 
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provides enough information about national mortality trends for these populations in the last 
decade in England. 
 
Saha and colleagues reviewed 37 studies from 25 countries looking at mortality in people 
with schizophrenia between and found that the mortality gap for all-causes had increased 
over the course of their study between 1980 – 2006 (Saha, Chant et al. 2007). However 
Saha did not include any studies conducted at a national level in the UK using data from the 
last decade.  
 
Based on this evidence I hypothesised that the trend in all-cause mortality in these 
populations in England would have increased over the last decade, with a resultant increase 
in the mortality gap compared with the general population. 
 
Objective 2 
As explained earlier, schizophrenia and bipolar disorder share a number of features in 
common, including a high risk of mortality. Previous studies have compared the mortality gap 
in people with bipolar disorder and schizophrenia and found that people with schizophrenia 
had a greater mortality gap with the general population than people with bipolar disorder 
(Laursen, Munk-Olsen et al. 2007; Chang, Hayes et al. 2010). However no studies have 
compared the mortality gap for these populations more recently at a national level in 
England. 
 
Thus based on previous evidence I hypothesised that the mortality gap for people with 
bipolar disorder, would be less than the gap seen in people with schizophrenia 
 
Objective 3 
Previous studies have shown that age is an important determinant of death in people with 
SMI, with the mortality gap greatest for the young compared with the elderly (Hawton, Zahl et 
al. 2003; Rasanen, Hakko et al. 2003; Hunt, Kapur et al. 2006; McGirr and Turecki 2008; 
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Reutfors, Brandt et al. 2009). In addition some studies have shown that gender is an 
important determinant of mortality, although the effect of gender on the mortality gap has not 
been consistent (Lawrence, Jablensky et al. 2000; Hansen, Fink et al. 2001; Joukamaa, 
Heliovaara et al. 2001; Osby, Brandt et al. 2001; Politi, Piccinelli et al. 2002; Lawrence, 
Holman et al. 2003; Limosin, Loze et al. 2007; Hiroeh, Kapur et al. 2008). Studies have 
suggested that deaths from suicide and other unnatural causes, common amongst the young 
is falling (Kapur, Hunt et al. 2006), indicating decreasing mortality amongst the young. 
However no studies have shown how age and sex affect recent trends in the mortality gap in 
England. 
 
Given the current evidence of age effects on mortality, I hypothesised that the mortality gap 
for the young (<45 years) is narrowing and the mortality gap for others remains the same. 
Given the conflicting evidence of the gender effects on mortality, I hypothesised that there is 
no difference in trends in the mortality gap for different genders. 
 
Objective 4 
A recent study from Finland by Kiviniemi and colleagues has suggested that geographical 
location may be a determinant of mortality in people with SMI (Kiviniemi, Suvisaari et al. 
2010), and evidence from local studies undertaken in the UK show variation in the mortality 
risk estimates calculated from different disease registers (Brown, Leith et al. 2010; Chang, 
Hayes et al. 2010). However these local studies are difficult to compare directly as they have 
different inclusion criteria and cover different time periods. 
 
Given the lack of evidence on this subject, I hypothesised that there would be no difference 
in the magnitude of the mortality gap for people with bipolar disorder or schizophrenia over 
different geographical locations within the same time period. 
 
Objective 5 
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Previous studies have shown that people with a physical illness and comorbid SMI including 
schizophrenia are at higher risk of death than those without comorbid SMI (Lawrence, 
Holman et al. 2000; Lawrence, Jablensky et al. 2000; Lesperance, Frasure-Smith et al. 2000; 
Jaffe, Krumholz et al. 2006; Lawrence and Kisely 2010). However other researchers have 
shown no such effect of comorbid SMI (Abrams, Vaughan-Sarrazin et al. 2008; Abrams, 
Vaughan-Sarrazin et al. 2009; Abrams, Vaughan-Sarrazin et al. 2010; Abrams, Vaughan-
Sarrazin et al. 2010). Thus far no studies have been undertaken on this subject in the UK. 
 
Given the conflicting evidence I hypothesised that there would be no difference in the 
magnitude of mortality risk for people with comorbid bipolar disorder and schizophrenia, who 
present to inpatient care with a main diagnosis of cardiovascular disease or diabetes, 
compared with those without comorbid mental disorder. 
 
Objective 6 
Avoidable causes of death have recently been estimated to account for 24% of all deaths in 
the general population in the UK (Wheller, Baker et al. 2007). This compares with 30% of all 
deaths in people with SMI in Finland (Rasanen, Hakko et al. 2003). No comparable recent 
data is available for people with SMI in the UK, however this data suggests that reducing the 
extent of avoidable deaths in the people with SMI would reduce the mortality gap, although 
no studies to date have quantified this. 
 
Thus I hypothesised that, if causes of death, in people with bipolar disorder or schizophrenia, 
that are amenable to high quality medical care or preventable by access to public health 
intervention were reduced to levels expected in the general population in these groups, then 
the excess mortality could be eliminated entirely. 
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Chapter 5 – Methods 
 
As shown in chapter 2, studies investigating mortality in people with SMI have previously 
utilised a number of observation research strategies, especially cohort and case-control 
study designs. Thus the main studies in this thesis cohort designs have been used to answer 
the research questions posed. The specific methods used to answer each research question, 
including the methods used to define cohorts, measure exposure, select important co-
variates, and identify and analyse outcomes are outlined separately in each chapter. 
 
Datasets used for this study 
 
A linked dataset created by staff from the UHCE was used to examine the epidemiology of 
mortality within the last decade in England. This linked dataset contains 13 years of 
information from English national Hospital Episode Statistics (HES data, supplied by the NHS 
Information Centre) and death registrations (supplied by the Office for National Statistics) 
from 1st April 1998 to 31st March 2010. Further information regarding the dataset used is 
shown in Table 5-1 and details of the methods used to create this file are included in 
Appendix 3. 
 
The hospital component of the dataset includes statistical abstracts of records of all inpatient 
admissions, including day cases, in NHS acute and psychiatric hospitals in England. 
Information about diagnoses is coded using the International Classification of Diseases (ICD) 
revision 10 (WHO). The hospital records of individual patients are stored as Finished 
Consultant Episodes (FCE), i.e. a period of admitted patient care under a consultant or allied 
healthcare professional within an NHS trust. Data linkage techniques allow FCEs to be 
grouped together into one record of a patient's entire inpatient stay, regardless of any inter-
hospital transfers which may take place, known as a Continuous Inpatient Spell (CIP) (2006). 
A single CIP may contain information from one of more FCEs. Where a CIP consists of more 
than one FCE, information from the first FCE for that individual’s inpatient stay, including 
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details of the diagnosis made, is considered the ‘admission record’, and the last record is 
considered the ‘discharge record’. The dataset containing CIP records was used for this 
study. CIP records will be described as ‘hospital records’ from this point forward. Data 
linkage facilitates the calculation of person based statistics. 
 
In addition to hospital records, the linked dataset contains data derived from death 
certificates collected by the Office for National Statistics (ONS) that covers England (and 
Wales). This information includes the date of death and the causes of death which are coded 
using the International Classification of Diseases revisions 9 (covering the period between 
1998–2000) and 10 (covering the period between 2001-2010). More information about the 
specific variables included in this dataset can be found in Table 5-2 and by reference to the 
HESOnline website (www.hesonline.nhs.uk).  
 





In order to calculate the mortality gap for people with bipolar disorder or schizophrenia, the 
mortality rate prevailing in the general population of equivalent age and sex over the same 
time period was the comparison group used. 
 
Consideration of the feasibility and anticipated limitations of the dataset and methods 
chosen in this study for answering the study objectives 
 
As explained in the previous chapters, studies investigating mortality in SMI have used 
observational research methods, with the majority utilising a prospective cohort design. This 
involves the identification of a cohort of people with SMI from hospital records with follow-up 
undertaken by linking the patient’s health records with their death records to identify study 
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outcomes. This is the method I propose to use to investigate mortality for people with bipolar 
disorder and schizophrenia in England, and is feasible with the national linked health records 
dataset described above. 
 
However investigating the mortality gap and mortality trends for people with SMI using 
observational research methods and routinely collected data has a number of limitations 
which one should expect to encounter and which may affect the study results, or limit the 
conclusions that can be drawn from them (see Table 9-1). Although none of these limitations 
would compromise the feasibility of investigating mortality in people SMI proposed for this 
thesis. 
 
First, the selection of cases is dependent on the inclusion of people with bipolar disorder and 
schizophrenia within the dataset. Given the management of people with SMI being 
increasingly moved to the outpatient and community setting (2000; 2001; Glover, Arts et al. 
2006; Onyett, Linde et al. 2008), records that are not included in this dataset, the likelihood is 
that selection of cases will be biased towards those who have the most severe symptoms or 
are poorly managed in the community. The extent to which the study populations in this 
thesis represents all people with bipolar disorder and schizophrenia could be gauged by 
comparing with data from the mental health minimum dataset (MHMDS), which collates 
information from outpatient and community contacts or the General Practice Quality and 
Outcomes Framework (QOF) SMI registers which collects information from primary care. I 
have not undertaken these comparisons within this thesis, and would suggest that this is 
addressed in future research. 
 
In addition, the follow-up of cases who have recently been discharged from inpatient care, a 
period of high mortality risk is also likely to influence the mortality risk estimates, as 
mentioned earlier. Whilst these factors may circumscribe the conclusions that can be drawn, 
they should not limit the ability to answer the research questions posed. I would suggest that 
future research possibly using other datasets such as the General Practice Research 
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Database (GPRD) or the QOF SMI register which may include people with SMI who have not 
recently attended inpatient care, or variables measuring disease severity may be conducted 
to provide different mortality risk estimates for a wider group of people in these populations 
and for a longer period of time in the community. 
 
Second, the investigation of important explanatory or confounding factors is dependent on 
the recording of these variables in the dataset or else the use of a further dataset that could 
be easily linked to this dataset. Age, sex and geographical location are recorded on this 
dataset and can be examined to investigate their effect on mortality, namely in objectives 3 
and 4. It also contains other variables which may be important in determining mortality such 
as a population level deprivation indicator, the Index of Multiple Deprivation (IMD) which 
assigns a score to each person based upon their postcode address. This variable was not 
used in this thesis. However the dataset does not include information on other important 
confounding or explanatory variables some of which are listed in Figure 1-1 such as mental 
illness severity, the presence of physical illness, smoking, alcohol/ substance abuse, access 
and quality of healthcare services, and the use of anti-psychotic medications. This may result 
in residual confounding and may limit the conclusions that can be drawn.  
 
Methods using data from local psychiatric disease registers, such as the Clinical Record 
Interactive Search (CRIS) database held by the South London and Maudsley NHS Trust 
could provide information on some of these confounding and explanatory variables such as 
smoking status and use of anti-psychotic medications, however they cannot provide a 
nationally representative picture of mortality risks for these groups. Methods can also be 
used to link to information from national datasets such as the MHMDS (Glover 2007) or the 
NHS workforce statistics released by the NHS Information Centre which can provide 
important information on the provision of health services, however they are collected at the 
organisational level and like aggregate measures of deprivation such as the IMD are difficult 
to assign to individual records. 
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Third, the calculation of the mortality gap, a measure of relative risk, will also be influenced 
by the selection of the comparison group. In this thesis the mortality gap is the difference 
between the mortality rate in the populations recently discharged from hospital with SMI and 
the mortality rate prevailing in the general population of equivalent age and sex over the 
same time period. Both of these populations are resident in the community, and the 
assumption is that both are exposed to the same risk factors for mortality, with the only 
difference being a diagnosis of mental illness in our study groups. However as explained 
earlier the period following discharge for those with SMI is known to be a period of 
heightened risk of death which may reflect common risk factors around the management of 
hospital discharge and reintegration into the community that operate following hospital 
discharge and may not be present amongst other people within the community. Thus the use 
of mortality rates in other comparison populations, such as all people discharged from 
hospital, or all people with a diagnosis of mental illness, could possibly be used as 
comparison groups to calculate the mortality gap. Murray and colleagues have suggested 
that the population health effects of individual or groups of risk factors should be quantified 
by ‘comparing the burden of disease due to the observed exposure distribution in a 
population with the burden from a hypothetical distribution or series of distributions, rather 
than a single reference level such as non-exposed’ (Murray, Ezzati et al. 2003). This would 
involve the calculation of a range of values within which the true mortality gap lies and is not 
the approach I have taken in this thesis. However the methods I have used do provide one 
estimate of the mortality excess for these populations and can be added to by other 
researchers using different methods. 
 
Fourth, prospective follow-up is undertaken in our studies by linking hospital records to 
outcomes data contained in death records. The completeness of follow-up is dependent on 
the quality and completeness of data-linkage between the hospital and death records. This in 
turn is dependent on the quality and completeness of recording of data variables used to 
undertake data linkage. Whilst changes in the recording of diagnosis, and variables used for 
data linkage may not affect studies done over a short period of time, studies done over 
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longer periods of time or looking at trends may be affected by changes in the recording of 
diagnosis and the quality of data linkage in routinely collected linked databases.  
 
Table 5-1 shows that there were approximately 3.6 HES records per person in the 13 year 
linked dataset. This is higher than previously reported for a 4 year file covering the period 
from 1st April 1998 to 31st March 2002, which included 51,554,709 HES and death records for 
22,672,262 people, equating to 2.3 HES and death records per person (Gill 2004). The same 
methods for linking have been used by staff at the UHCE over the intervening period and are 
described in Appendix 3 along with the methods used for data extraction. This discrepancy 
could be accounted for by changes in hospital discharge practices over the duration of the 
file, with earlier discharge of patients and more frequent readmissions or changes in the 
quality of data linkage between over the course of the 13 year file may also explain this 
discrepancy, this is suggested by the NHS Information Centre and HESOnline, which 
showed that the recording of valid NHS numbers on HES records increased from 83.2% in 
2000-01 to 96.8% in 2008-09 (2009). This may result in more linked death records being 
identified towards the end of the datafile than at the start, and may cause an inflation of all 
post-discharge mortality rates. Equally, if more records were assigned to each person, 
namely more readmissions were identified then the counting methods used in this thesis, 
namely counting only the first admission in a study period and ceasing follow-up when there 
is a readmission for any diagnosis or death, (described more fully in chapter 6) would be 
expected to decrease the number of deaths included and deflate all post-discharge mortality 
rates. Changes in hospital admission practices for example more frequent use of outpatient 
or community care services for people with mental illness can be gauged from data 
submitted to the MHMDS, as described in chapter 6. 
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Table 5-1 - Number of hospital records included in the dataset* used for this study 
 
All records of admissions in 
England 
England residents only 
(where country = ‘E’) 




































* filename = cips_13yr_v06_newrt (13year cips file) 
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Table 5-2 - Variables in the UHCE CIPs dataset 
Variable Description 
Sysno UHCE ID key 
SQLkey UHCE ID key 
Record Record type; indicates whether the record is a death or hospital record 
Recno Record number 
D1 to D7 For hospital records: 
 
Diagnostic codes used on the discharge hospital record. D1 is the main diagnosis on 
discharge. For this thesis the term ‘main diagnosis’ is used for the diagnostic code 
variable D1 on a hospital record 
 
For death records: 
 
Diagnostic codes used on the death certificate. D1 is the ‘underlying’ cause of death. 
D2 to D12 on death records are any other cause of death recorded on the death 
certificate 
 
D8 to D14 Diagnostic codes used on the admission hospital record. D8 is the main diagnosis on 
admission on a hospital record 
D15 to D18 Other diagnosis not mentioned on the admission or discharge on the hospital record 




Resid Area of residence 
Treat Area of Treatment 
Spa Specialty on admission 
Spd Specialty on discharge 
dis Disposal 
sor Source of admission 
Daycase Record from a daycase, yes or no 
los Length of stay in days 
Age Age 
Daycase Whether the patient was a daycase or not 
Admyear Year of admission 
Admisorc Admission source 
Admimeth Admission method 
Finyear Year of discharge 
Disyear Year of disposal 
Dxed Diagnosis edition 
Oped Operative edition 
Numrecs Record number 
Jdoa Date of admission 
Jdod Date of discharge 
Deathdat Date of death 
Hosp Hospital code 
Trust NHS Trust 
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Ethical approval 
 
The National Health Service Central Office for Research Ethics Committees approved the 
current work programme of analysis using the linked data sets held at the Unit of Health-
Care Epidemiology (reference number 04/Q2006/176). 
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Graduate School, OUCAGS@medsci.ox.ac.uk and a Specialist Registrar in Public Health at 
the Oxford School of Public Health. The work is independent from the funders of this 
research, that is, the funding body had no role in the analysis or interpretation of the data. Uy 
Hoang had full access to the data used to undertake the studies in this thesis, and was not 
paid by any external agency to write the studies that comprise this thesis. 
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Chapter 6 – Recent trends in all-cause mortality following hospital discharge of 




1. Has the excess in all-cause mortality for people with bipolar disorder and 
schizophrenia increased or decreased over the last decade in England? 
2. Is the mortality excess of the same magnitude for people with bipolar disorder and 
schizophrenia in England? 
3. Is the trend in mortality consistent for people with bipolar disorder and schizophrenia 
of different ages and genders in England? 
4. Is mortality for people with bipolar disorder and schizophrenia geographically 




Study inclusion criteria 
In order to examine the research questions posed in this chapter, all records of discharges 
from inpatient care in England between 1st January 1999 and 31st December 2006 with 
either bipolar affective disorder (ICD10 code F31) or schizophrenia (ICD10 codes F20 to 
F29) as the main diagnosis on the hospital discharge record were extracted. Cases that 
occurred after 1st January 2007 were not included as some specific mortality outcomes, such 
as reports of deaths from misadventure and suicide were incomplete towards the end of the 
10 year data file used originally for this study. Note that the 10 year datafile contains 
information from 1st April 1998 until 31st March 2007, unlike the current 13 year file described 
in chapter 5 which contains information until 31st March 2010. This dataset was not available 
at the commencement of the thesis but is the same in every way apart from the additional 3 
years data.  
 
    69 
The first record in each study period with the diagnosis of interest was selected. Follow-up 
time was counted from the time of discharge from this first admission in the study period. 
Follow-up was ceased for the following reasons; 1) The patient died, 2) The patient was 
readmitted as an inpatient for any reason.  
 
Thus for a patient who was admitted multiple times during the study period, then only the first 
admission with the diagnosis of interest would be counted, other readmissions in the study 
period would not be counted. Further information on about the data extraction methods used 
can be found in Appendix 3. 
 
Outcomes 
The primary outcome of the analysis in this chapter was all-cause mortality within 365 days 
following psychiatric inpatient care as defined above. As explained previously, the period 
immediately following hospital discharge is the period of highest risk of death and thus an a 
priori decision was made to focus on mortality outcomes in the first year after hospital 
discharge.  
 
The relative contributions of unnatural and natural causes to all cause mortality was also 
studied. Unnatural deaths were defined on the basis of ICD10 codes V01 to Y98 or ICD9 
codes E800 to E999 recorded anywhere on the death certificate; the remaining deaths were 
classified as natural.  
 
In order to allow more detailed interpretation of deaths under these broad categories data for 
deaths from the following specific causes are also presented where there were sufficient 
deaths to provide a stable estimate of mortality risk, namely deaths from  the following 
conditions; 
• cardiovascular disease (ICD10 codes I00 to I99, ICD9 codes 390 to 459),  
• respiratory disease (ICD10 codes J00 to J99, ICD9 codes 460 to 519),  
• cancer (ICD10 codes C00 to D48, ICD9 codes 140 to 239),  
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• accidents (ICD10 codes V01 to X59, ICD9 codes E800 to E929)  
• suicide/ deaths from undetermined intent (ICD10 codes X60 to X89 and Y10 to Y34, 
ICD9 codes E950 to E959 and E980 to E989). 
 
Analysis 
Number of discharges and discharge trend analysis 
In order to comment on the trend in discharges from hospital for people with a main 
diagnosis of bipolar disorder and schizophrenia over the period of the study, the number of 
discharges was plotted over the course of the study and a line of best fit drawn to describe 
the trend in discharges. The slope of the line was calculated to quantify the direction and 
steepness of the trend. The R-square value was presented to show the proportion of the 
variance in the trend that could be explained by the line of best fit. 
 
Calculating relative mortality rate 
The mortality gap or the relative mortality rate in this chapter is conceptualised as the 
difference between the mortality rate in the populations recently discharged from hospital 
with SMI, and the mortality rate prevailing in the general population of equivalent age and 
sex over the same time period. Both of these populations are resident in the community, and 
the assumption is that both are exposed to the same risk factors for mortality, with the only 
difference being a diagnosis of mental illness in our study groups. In order to quantify the 
extent of excess deaths, mortality rates after hospital discharge as age and sex standardised 
mortality ratios were calculated, comparing mortality in the people with bipolar disorder or 
schizophrenia, with mortality in the general population of England at the same period of time. 
Standardisation was carried out using the indirect method, in five-year age groups, with the 
age- and sex-specific mortality rates of England in the same time periods as the standard. 
These age- and sex-specific rates were applied to the age and sex structure of each of the 
discharge cohorts with bipolar disorder or schizophrenia to calculate an ‘expected’ number of 
deaths. The observed number was compared with the expected number to calculate the 
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SMRs, with confidence intervals calculated as described elsewhere (Higham, Flowers et al. 
2005). 
 
Standardisation allowed an adjusted quantification of the absolute mortality rate for people 
with bipolar disorder or schizophrenia compared to the general population and also, because 
the reference group was the same for each condition, it permits comparisons between the 
two disorders.  
 
Absolute mortality rate 
Any change in relative mortality rates could represent an absolute rise in mortality rates in 
the case populations, or a fall in mortality rates in the general population in conjunction with a 
smaller fall in mortality rates in the psychiatric population. Accordingly, the absolute all-cause 
post-discharge death rates per 100,000 people discharged with bipolar disorder and 
schizophrenia were also calculated. 
 
Sex-specific and age-truncated analysis 
In order to comment on mortality for people with a main diagnosis of bipolar disorder and 
schizophrenia of different ages and different genders, separate analyses for males and 
females were undertaken, and age-truncated analysis using the following three broad groups 
selected a priori: working age young adults (< 45 years), middle aged adults (45 to 64 years), 
and older adults (65 to 84 years). Children equal to, or under 15 years were excluded, and 
data on people >85 years is not presented due to small numbers. 
 
Geographical variations in mortality rates 
In order to comment on the question of geographical variations in mortality, the SMRs for 
each regional health authority area were calculated separately, comparing mortality in people 
with bipolar disorder or schizophrenia admitted to inpatient care in each Regional Office (RO) 
area, using the configuration as of 2006, with the mortality rates in the general population of 
England as a whole, using the method described above.  
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Mortality excess trend analysis 
In order to examine trends in excess mortality, SMRs for each annual discharge cohort were 
calculated, taking mortality in the general population during the year of discharge in question 
as the reference mortality rate. This analysis allows the variation in mortality excess over 
time to be analysed taking into account variations in the mortality rate of the general 
population over the same time period. The Poisson test of trend was used to test whether the 




Total number of discharges with bipolar disorder and schizophrenia  
This study included a total of 100,851 discharges from hospital with a main diagnosis of 
bipolar disorder; and 272,248 discharges with a main diagnosis of schizophrenia in England 
between 1999 and 2006. Table 6-1 and Table 6-2 show the basic demographic 
characteristics of the populations. Over the course of the study, the total number of 
discharges with a main diagnosis of bipolar disorder decreased by 3.9% (from 12,369 to 
11,888) between 1999 and 2006. The total number of people with a main diagnosis of bipolar 
disorder decreased by 2.4% (from 9,312 to 9,086) during the same time period. For those 
with a main diagnosis of schizophrenia, the number of discharges decreased by 10.9% (from 
35,348 to 31,486) between 1999 and 2006, whilst the number of people decreased by 10.7% 
(from 27,133 to 24,205) over the same period.  The percentage of men discharged was 
substantially higher amongst people with a main diagnosis of schizophrenia than bipolar 
disorder, and the proportion of men increased for both disorders over the period of the study. 
The median age of the discharge cohorts also increased slightly for both conditions. 
 
Table 6-1 and Table 6-2 shows that there were approximately 1.3 HES records per person 
where the main diagnosis was bipolar disorder or schizophrenia. This is lower than the ratio 
of all HES records per person of 3.6 shown in Table 5-1, although it is in line with recent data 
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showing that approximately 33% of psychiatric admissions between 2003-09 were 
readmissions (Barker, Taylor et al. 2011). The ratio of HES records to people is dependent 
on two factors; 
 
Firstly the ratio is dependent on the hospital admission practices for the particular condition, 
and the balance between treatment in inpatient settings and other settings such as 
outpatients or community treatment teams. This can be checked against other datasets that 
collect information on hospital inpatient, outpatient and community care, so that the relative 
proportions of care undertaken in each setting can be gauged. In this case the mental health 
minimum dataset (MHMDS) which includes data about the treatment of people with mental 
illness in inpatient care, outpatient care and community treatment services. 
  
Secondly as explained earlier, the ratio also depends on the quality and completeness of 
data linkage between HES records. The quality and completeness of these linkages can be 
checked against two sources, namely previously published data from the UHCE (Gill 2004) 
and published information from the NHS Information Centre and HESonline. The data 
linkage methods between HES-HES records share many similarities with HES-death record 
linkage, thus any discrepancies in the data linkage of HES records would also be expected to 
affect HES-death linkage. 
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Table 6-1 - Number of discharges in England between 1999 and 2006, and number of 




Main discharge diagnosis of BIPOLAR DISORDER 









Number of males  
(% of all discharges) 
Median  age at 
discharge 
(M/F) 
1999 12,369 9,312 3,527 
(37.9) 
42/ 48 
2000 12,285 9,217 3,492 
(37.9) 
42/ 48 
2001 12,803 9,384 3,608 
(38.4) 
43/ 48 
2002 13,153 9,612 3,747 
(39.0) 
43/ 48 
2003 12,757 9,723 3,767 
(38.7) 
44/ 48 
2004 13,221 10,102 3,993 
(39.5) 
43/ 48 
2005 12,375 9,284 3,644 
(39.3) 
44/ 48 
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Table 6-2 - Number of discharges in England between 1999 and 2006, and number of 




Main discharge diagnosis of SCHIZOPHRENIA 









Number of males  
(% of all discharges) 
Median  age at 
discharge 
(M/F) 
1999 35,348 27,133 15,784 
(58.2) 
34/ 44 
2000 33,793 25,785 14,883 
(57.7) 
34/ 44 
2001 34,478 25,870 15,204 
(58.8) 
35/ 44 
2002 34,105 25,524 15,290 
(59.9) 
35/ 44 
2003 33,665 25,856 15,580 
(60.3) 
35/ 44 
2004 35,540 27,425 16,428 
(59.9) 
35/ 44 
2005 33,833 25,709 15,421 
(60.0) 
36/ 44 
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Geographic variations in the number of discharges and trend in admissions for bipolar 
disorder and schizophrenia 
The regional patterns of discharge for these two conditions in 2006 showed that London had 
the highest number of discharges for both conditions; 1,978 discharges with a main 
diagnosis of bipolar disorder for 1,526 people; and 7,155 discharges with a main diagnosis of 
schizophrenia for 5,646. The North East region had the lowest number of discharges for both 
conditions; 832 discharges with a main diagnosis of bipolar disorder for 667 people; and 
1,647 discharges with a main diagnosis of schizophrenia for 1,297 people (see Table 6-3 and 
Table 6-4). 
 
Plotting the trend in discharges for people with both conditions showed that the number of 
discharges had fallen for both bipolar disorder and schizophrenia in England between 1999 
and 2006, with a relatively steeper decline for discharges with schizophrenia. The slope of 
the line of best fit suggests that there were 286.8 fewer discharges with a main diagnosis of 
schizophrenia per year compared with bipolar disorder which saw a modest reduction of 24.5 
discharges per year over the study period, although the direct comparison of discharge 
trends in these two conditions is difficult as the slope of the line of best fit does not take into 
account the differences in the population size, the total number of discharges, the age/ sex 
compositions of discharges cohorts with the two conditions and the change in these factors 
over time. 
 
Given the above provisos about the use of the lines of best fit to compare different samples, 
some general points will be made about the variation of discharge trends across the country. 
Table 6-3 and Table 6-4 show that most regions saw a decline in discharges over the study 
period, with the South West region seeing the greatest decrease in the number of discharges 
with a main diagnosis of bipolar disorder with 46 less discharges per year and the North 
West had the greatest decrease in the number of discharges with a main diagnosis of 
schizophrenia with 161 less discharges per year. In contrast, London saw substantial 
increases in discharges for both conditions over the study period. For bipolar disorder 
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London saw an increase of 59 discharges per year and, for schizophrenia, London saw an 
increase of 178 discharges per year. 
 
Table 6-3 and Table 6-4 also shows that the ratio of HES records to people for each 
Regional Office varied between 1.2 to1.5 for both conditions, with no substantial variation 
between each area. This compares to a ratio of 1.3 for the UK as a whole.  
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Table 6-3 - Number of discharges (and number of people discharged), with a main diagnosis of BIPOLAR DISORDER, by Regional Office 
area and slope of the trend in the number of discharges 
 
 
Number of discharges (and number of people discharged), with a main diagnosis of BIPOLAR DISORDER 
 
Regional Office area (RO) 1999 2000 2001 2002 2003 2004 2005 2006 
Slope of best 
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Table 6-4 - Number of discharges (and number of people discharged), with a main diagnosis of SCHIZOPHRENIA, by Regional Office area 
and slope of the trend in the number of discharges 
 
 
Number of discharges (and number of people discharged), with a main diagnosis of SCHIZOPHRENIA 
 
Regional Office area (RO) 1999 2000 2001 2002 2003 2004 2005 2006 
Slope of best 
fit line for 
discharges 
(R2) 
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Death 365 days following discharge with a diagnosis of bipolar disorder or schizophrenia 
 
Turning to mortality outcomes, approximately 1% of all discharges with a main diagnosis of 
bipolar disorder and schizophrenia were followed by mortality within one year over the 
course of the study. The proportion of deaths from natural and unnatural causes remained 
fairly consistent with about three in four of the deaths in each of the two cohorts due to 
natural causes (see Table 6-5 and Table 6-6).  
 
    81 
Table 6-5 - Number of deaths from all-causes and unnatural causes in people 




Main discharge diagnosis of BIPOLAR DISORDER 
(International Classification of Diseases revision 10 code F31) 
 
Year of discharge 
Deaths from all causes within 365 
days of inpatient discharge 
Unnatural deaths within 365 days of 
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Table 6-6 - Number of deaths from all-causes and unnatural causes in people 




Main discharge diagnosis of SCHIZOPHRENIA 
(International Classification of Diseases revision 10 codes F20 to F29) 
 
Year of discharge 
Deaths from all causes within 365 
days of inpatient discharge 
Unnatural deaths within 365 days of 
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SMRs from all-causes  
 
After taking account of the mortality rate in the general population over the same period of 
time, age and sex-standardised mortality ratios showed that mortality in the psychiatric 
cohorts was about double the population average. All-cause SMRs were 1.9 in people 
discharged with a main diagnosis of bipolar disorder in 2006, and 2.2 in people discharged 
with a main diagnosis of schizophrenia. 
 
All-cause age-truncated and sex specific SMRs 
For both sexes, SMRs were higher in younger than in older people (see Table 6-7). For 
example, in people discharged in 2006.  
• Aged under 45 years, SMRs were 3.4 (95% CI: 1.7 to 5.1) for people with a main 
diagnosis of bipolar disorder and 6.2 (95% CI: 4.9 to 7.5) for people with a main 
diagnosis of schizophrenia. 
• Aged 45 to 64 years, SMRs were 2.6 (95% CI: 1.8 to 3.4) for people with a main 
diagnosis of bipolar disorder and 3.9 (95% CI: 3.1 to 4.6) for people with a main 
diagnosis of schizophrenia. 
• Aged 65 to 84 years , SMRs were 1.8 (95% CI: 1.4 to 2.2) for people with a main 
diagnosis of bipolar disorder and 2.0 (95% CI: 1.7 to 2.3) for people with a main 
diagnosis of schizophrenia. 
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Table 6-7 - All-cause post-discharge SMRs following hospital discharge in 2006 
 
 
All-cause SMRs 365-days following hospital discharge in 2006, for 
both sexes 
 
Main diagnosis on 
discharge 
All ages < 45 yrs 45-64 yrs 65-84 yrs 
BIPOLAR 
DISORDER 1.9 3.4 2.6 1.8 
SCHIZOPHRENIA 2.2 6.2 3.9 2.0 
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There was no significant gender difference in mortality for people discharged with a main 
diagnosis of bipolar disorder. For example, the SMRs for men discharged with a main 
diagnosis of bipolar disorder in 2006 was 2.3 (95% CI: 1.8 to 2.9) compared with 1.8 (95% 
CI: 1.4 to 2.2) for women. 
 
Men discharged with a main diagnosis of schizophrenia had a significantly higher SMR within 
the first year than women, as shown from the fact that the confidence intervals for the SMRs 
in both sexes did not overlap, although formal significance testing was not undertaken. For 
example the SMRs for men discharged with a main diagnosis of schizophrenia in 2006 was 
3.2 (95% CI: 2.8 to 3.6) compared with 1.8 (95% CI: 1.5 to 2.1) for women.  
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Trend in SMR from all-causes 
 
 As shown in Table 6-8 and Figure 6-1, SMRs for people with a main diagnosis of bipolar 
disorder increased from 1.3 (95% CI: 1.1 to 1.6) in people discharged in 1999 to 1.9 (95% CI: 
1.6 to 2.2) in people discharged in 2006. The Poisson test of trend, between 1999 and 2006, 
was at borderline statistical significance (P=0.1). For people with a main diagnosis of 
schizophrenia, SMRs increased from 1.6 (95% CI: 1.5 to 1.8) in people discharged in 1999 to 
2.2 (95% CI: 2.0 to 2.4) in people discharged in 2006, and the Poisson test of trend over this 
period was strongly significant (P<0.001).  
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Table 6-8 – Trend in all-cause post-discharge SMRs between 1999-2006 for BIPOLAR 
DISORDER AND SCHIZOPHRENIA, both sexes, all ages 
 
 
All-cause SMRs 365-days following hospital discharge  
 
Year of discharge Main diagnosis of  
BIPOLAR DISORDER 
Main diagnosis of  
SCHIZOPHRENIA 
1999 1.3 1.6 
2000 1.4 1.9 
2001 1.5 1.7 
2002 1.7 1.8 
2003 1.8 2.2 
2004 1.8 2.1 
2005 1.8 2.3 
2006 1.9 2.2 
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Figure 6-1 - Trend in all-cause SMRs 365-days following discharge for all people 
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Trend in all-cause age-truncated SMRs 
 
The trend in SMRs varied by age and sex. Whilst the SMRs were higher for younger than 
older populations there was no significant trend in SMRs for people under 45 years of age 
discharged with either diagnosis during the course of the study. In contrast, there was a 
noticeable upward trend for people aged 65 to 84 years discharged with either diagnosis 
during the course of the study.  
 
For people with a main diagnosis of bipolar disorder aged under 45 years, the SMR 
decreased from 4.0 (95% CI: 2.0 to 6.0) in people discharged in 1999 to 3.4 (95% CI: 1.7 to 
5.1) in people discharged in 2006. The Poisson test of trend, between 1999 and 2006, was 
not significant (P=1.0).  
 
For people with a main diagnosis of bipolar disorder aged 45-64 years, the SMR increased 
from 1.7 (95% CI: 1.1 to 2.3) in people discharged in 1999 to 2.6 (95% CI: 1.8 to 3.4) in 
people discharged in 2006. The Poisson test of trend, between 1999 and 2006, was again 
not significant (P=0.8). 
 
For people with a main diagnosis of bipolar disorder aged 65 to 84 years the SMR increased 
from 1.1 (95% CI: 0.9 to 1.4) in people discharged in 1999 to 1.8 (95% CI: 1.4 to 2.2) in 
people discharged in 2006. The Poisson test of trend, between 1999 and 2006, was not 
significant (P=0.2).  
 
See Table 6-9. 
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Table 6-9 – Trend in all-cause post-discharge SMRs for BIPOLAR DISORDER between 
1999-2006, both sexes, by age 
 
 
All-cause SMRs 365-days following hospital discharge with a main 
diagnosis of BIPOLAR DISORDER 
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For people with a main diagnosis of schizophrenia aged under 45 years the SMR decreased 
from 6.9 (95% CI: 5.5 to 8.2) in people discharged in 1999 to 6.2 (95% CI: 4.9 to 7.5) in 
people discharged in 2006. The Poisson test of trend, between 1999 and 2006, was not 
significant (P=1.0). 
 
For people with a main diagnosis of schizophrenia aged 45 to 64 years the SMR increased 
from 3.4 (95% CI: 2.8 to 4.0) in people discharged in 1999 to 3.9 (95% CI: 3.1 to 4.6) in 
people discharged in 2006. The Poisson test of trend, between 1999 and 2006, was not 
significant (P=1.0). 
 
For people with a main diagnosis of schizophrenia aged 65 to 84 years the SMR increased 
from 1.3 (95% CI: 1.1 to 1.5) in people discharged in 1999 to 2.0 (95% CI: 1.7 to 2.3) in 
people discharged in 2006. The Poisson test of trend, between 1999 and 2006, was 
borderline statistically significant (P=0.05). 
 
See Table 6-10. 
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Table 6-10 - Trend in all-cause post-discharge SMRs for SCHIZOPHRENIA between 
1999-2006, both sexes, by age 
 
 
All-cause SMRs 365-days following hospital discharge with a main 
diagnosis of SCHIZOPHRENIA 
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Trend in all-cause sex-specific SMRs 
 
The SMRs for men were higher than women for both mental disorder cohorts, and there was 
no evidence of a narrowing of the gender differences in mortality during the study. 
 
As outlined above, for bipolar disorder, there was no significant gender difference in mortality 
over the course of the study, with men who were discharged with a main diagnosis of bipolar 
disorder in 1999 having an SMR of 1.7 (95% CI: 1.2 to 2.1) which increased to 2.3 (95% CI: 
1.8 to 2.9) in 2006, for which the Poisson test of trend, between 1999 and 2006, was not 
significant (P=0.9).  
 
In comparison, for women discharged with a main diagnosis of bipolar disorder, the SMR 
was 1.4 (95% CI: 1.1 to 1.7) in women discharged in 1999 and had reached the same level 
as men at 1.8 (95% CI: 1.4 to 2.2) in people discharged in 2006, for which the Poisson test of 
trend, between 1999 and 2006, was not significant (P=0.4).  
 
See Table 6-11. 
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Table 6-11 - Trend in all-cause post-discharge SMRs for BIPOLAR DISORDER between 
1999-2006, all ages, by sex 
 
 
All-cause SMRs 365-days following hospital discharge with a main 
diagnosis of BIPOLAR DISORDER, by sex 
 
Year of discharge MALE FEMALE 
1999 1.7 1.4 
2000 1.8 1.5 
2001 1.9 1.6 
2002 2.1 1.8 
2003 2.1 1.9 
2004 2.3 1.6 
2005 2.0 1.9 
2006 2.3 1.8 
p-value for trend 0.9 0.4 
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For men discharged with a main diagnosis of schizophrenia in 1999, the SMR was 2.3 (95% 
CI: 2.0 to 2.6) and increased to 3.2 (95% CI: 2.8 to 3.6) in men discharged in 2006. The 
Poisson test of trend, between 1999 and 2006, was statistically significant (P=0.04).  
 
For women, the SMR increased from 1.6 (95% CI: 1.4 to 1.8) in women discharged in 1999 
to 1.8 (95% CI: 1.5 to 2.1) in people discharged in 2006. The Poisson test of trend, between 
1999 and 2006, was not significant (P=0.8).  
 
See Table 6-12.  
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Table 6-12 - Trend in all-cause post-discharge SMRs for SCHIZOPHRENIA between 
1999-2006, all ages, by sex 
 
 
All-cause SMRs 365-days following hospital discharge with a main 
diagnosis of SCHIZOPHRENIA, by sex 
 
Year of discharge MALE FEMALE 
1999 2.3 1.6 
2000 2.6 1.9 
2001 2.5 1.7 
2002 2.5 1.7 
2003 2.9 2.0 
2004 3.0 1.8 
2005 3.3 1.9 
2006 3.2 1.8 
p-value for trend 0.04 0.8 
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SMRs for unnatural and natural causes 
 
SMRs were highest for unnatural causes of death compared with natural causes. For 
example SMRs for unnatural death in people discharged with a main diagnosis of bipolar 
disorder in 2006 was 12.6 compared with 1.4 for natural deaths. Equally large differences in 
SMRs for unnatural and natural causes of death were seen in people discharged with a 
diagnosis of schizophrenia, (see Table 6-13). 
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Table 6-13 - SMRs for unnatural and natural causes of death 365-days following 
hospital discharge in 2006, both sexes 
 
 
SMRs for UNNATURAL causes 
 
Main diagnosis on 
discharge 
All ages < 45 yrs 45-64 yrs 65-84 yrs 
BIPOLAR 
DISORDER 12.6 13.8 15.4 10.5 




SMRs for NATURAL causes 
 
Main diagnosis on 
discharge 
All ages < 45 yrs 45-64 yrs 65-84 yrs 
BIPOLAR 
DISORDER 1.4 0.3 1.8 1.6 
SCHIZOPHRENIA 1.7 2.7 3.2 1.8 
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Trend in SMRs for unnatural causes 
 
Trend analysis showed that there was no evidence of a narrowing mortality gap for unnatural 
causes. In people of all ages discharged with a main diagnosis of bipolar disorder, SMRs for 
unnatural causes were 9.3 (95% CI: 6.0 to 12.7) in 1999 and 12.6 (95% CI: 8.6 to 16.6) in 
2006.  The Poisson test of trend, between 1999 and 2006 was not significant, P=0.8 (see 
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SMRs for unnatural causes 365-days following hospital discharge 
with a main diagnosis of BIPOLAR DISORDER 
 
Year of discharge All ages < 45 yrs 45-64 yrs 65-84 yrs 
1999 9.3 10.6 10.6 6.5 
2000 11.0 9.4 17.6 9.5 
2001 12.3 14.1 18.7 6.6 
2002 11.9 11.2 21.2 4.2 
2003 13.9 17.2 13.0 15.1 
2004 15.6 22.3 18.9 7.1 
2005 14.2 11.5 27.5 7.5 
2006 12.6 13.8 15.4 10.5 
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The corresponding SMRs for people of all ages discharged with a main diagnosis of 
schizophrenia-associated was 11.6 (95% CI: 9.5 to 13.7) for people discharged in 1999 and 
11.6 (95% CI: 9.3 to 13.9) in people discharged in 2006. The Poisson test of trend, between 
1999 and 2006, was not significant (P=1.0). Numbers in individual age groups were small but 
there was no evidence of a narrowing of the gap in any age stratum (see Table 6-15). 
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SMRs for unnatural causes 365-days following hospital discharge 
with a main diagnosis of SCHIZOPHRENIA 
 
Year of discharge All ages < 45 yrs 45-64 yrs 65-84 yrs 
1999 11.6 15.2 16.0 3.9 
2000 12.3 16.7 12.2 8.7 
2001 11.6 15.0 16.6 7.3 
2002 9.8 13.0 10.0 7.9 
2003 11.9 14.8 15.2 9.9 
2004 13.6 17.9 18.1 4.8 
2005 13.8 19.3 13.1 8.2 
2006 11.6 15.2 14.3 6.5 
p-value for trend 1.0 1.0 1.0 1.0 
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Trend in SMRs for natural causes  
 
For natural causes, the mortality gap widened indicating that the increase in all-cause SMRs 
described earlier was accounted for principally by increases in natural causes of death. For 
people discharged with a main diagnosis of bipolar disorder of all ages, the SMRs was 1.2 
(95% CI: 1.0 to 1.4) and 1.6 (95% CI: 1.3 to 1.9). Poisson test of trend, between 1999 and 
2006, was not significant (P=0.3).  
 
See Table 6-16. 
 




SMRs for natural causes 365-days following hospital discharge with a 
main diagnosis of BIPOLAR DISORDER 
 
Year of discharge All ages < 45 yrs 45-64 yrs 65-84 yrs 
1999 1.1 1.0 1.3 1.1 
2000 1.1 1.4 1.5 1.1 
2001 1.1 1.3 1.3 1.2 
2002 1.4 2.0 1.7 1.5 
2003 1.4 0.7 2.0 1.4 
2004 1.2 2.3 1.8 1.3 
2005 1.4 1.8 1.2 1.6 
2006 1.4 0.3 1.8 1.6 
p-value for trend 0.3 1.0 1.0 0.3 
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The corresponding SMRs for people of all ages discharged with a main diagnosis of 
schizophrenia was 1.3 (95% CI: 1.2 to 1.4) in people discharged in 1999 and 1.8 (95% CI: 
1.6 to 2.0) in people discharged in 2006. Poisson test of trend, between 1999 and 2006, was 
highly significant (P=0.0001).  
 
See Table 6-17. 
 




SMRs for natural causes 365-days following hospital discharge with a 
main diagnosis of SCHIZOPHRENIA 
 
Year of discharge All ages < 45 yrs 45-64 yrs 65-84 yrs 
1999 1.2 2.3 2.7 1.3 
2000 1.5 2.6 3.0 1.6 
2001 1.3 2.2 2.7 1.6 
2002 1.5 2.9 2.9 1.5 
2003 1.8 2.9 3.7 1.8 
2004 1.6 2.7 2.8 1.7 
2005 1.8 4.6 2.9 1.8 
2006 1.7 2.7 3.2 1.8 
p-value for trend 0.0001 0.9 1.0 0.1 
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SMRs for specific causes of death 
 
Table 6-18 shows that deaths from accidents and from suicide/ undetermined intent in these 
populations exhibit the greatest disparity compared with general population rates. For 
example SMRs for accidental death in people discharged in 2006 were 6.6 and 6.3 for 
people discharged with a main diagnosis of bipolar disorder and schizophrenia respectively. 
For suicide and undetermined deaths the SMRs were higher at 19.8 and 20.9 for people with 
a main discharge diagnosis of bipolar disorder and schizophrenia respectively. 
 
Table 6-18 - Specific cause post-discharge SMRs following hospital discharge in 2006, 




SMRs for specific causes 365-days following hospital discharge in 2006 
 




























Y34, ICD9: E950-E959, 
E980-E989) 
BIPOLAR 
DISORDER 2.5 0.6 5.8 6.6 19.8 
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Trend in SMRs for specific causes of death 
 
The trend analysis showed that whilst accidental deaths and suicide had the highest SMRs, 
the majority of the observed increase in the all-cause SMRs was accounted for by increases 
in mortality from cardiovascular and respiratory diseases.  
 
For example, in people discharged with a main diagnosis of bipolar disorder the SMRs for 
circulatory disease increased from 1.6 (95% CI: 1.2 - 2.0) in 1999 to 2.5 (95% CI: 1.9 - 3.1) in 
2006 (Poisson test of trend, between 1999 and 2006: P=0.2), whilst the SMRs for respiratory 
disease increased from 3.0 (95% CI: 2.1 - 3.8) in 1999 to 5.8 (95% CI: 4.3 - 7.3) in 2006 
(Poisson test of trend, between 1999 and 2006: P=0.004).  
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Suicide and  
undetermined intent 
 
(ICD10: X60-X84, Y10-Y34, 
ICD9: E950-E959, E980-E989) 
1999 1.6 0.4 3.0 6.8 13.5 
2000 1.4 0.7 2.5 5.2 21.2 
2001 1.6 0.5 3.7 4.7 24.8 
2002 1.8 0.8 5.7 4.9 20.2 
2003 1.8 0.9 5.0 4.0 27.7 
2004 1.8 0.5 4.9 4.8 32.1 
2005 2.1 0.6 4.6 5.0 29.5 
2006 2.5 0.6 5.8 6.6 19.8 
p-value 
for trend 0.2 1.0 0.004 1.0 0.7 
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For people discharged with a main diagnosis of schizophrenia, the SMR for circulatory 
disease rose from 1.6 (95% CI: 1.4 - 1.9) in 1999 to 2.5 (95% CI: 2.1 - 2.9) in 2006 (Poisson 
test of trend, between 1999 and 2006: P=0.0005), whilst the SMR for respiratory disease 
increased from 3.1 (95% CI: 2.6 - 3.6) in 1999 to 4.7 (95% CI: 3.8 - 5.6) in 2006 (Poisson test 
of trend, between 1999 and 2006: P=<0.0001).  
 
See Table 6-20. 
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Suicide and  
undetermined intent 
 
(ICD10: X60-X84, Y10-Y34, 
ICD9: E950-E959, E980-E989) 
1999 1.6 0.8 3.1 6.5 19.5 
2000 2.0 1.0 3.5 7.5 19.6 
2001 1.6 0.9 4.0 5.8 21.8 
2002 1.9 1.0 4.4 4.2 17.8 
2003 2.5 1.1 5.3 5.3 23.3 
2004 2.2 1.1 5.6 6.8 24.7 
2005 2.4 1.1 6.0 8.3 24.0 
2006 2.5 1.3 4.7 6.3 20.9 
p-value 
for trend 0.0005 0.4 <0.0001 1.0 1.0 
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Geographical variations in SMRs 
 
In order to compare mortality across different Regional Office (RO) areas in the UK, indirectly 
standardised mortality ratios were calculated for each RO area by applying the national 
mortality rates in the general population of England to the population with SMI in each RO 
area in five-year age bands. This allowed the comparison of how many deaths would be 
expected in each RO area if the population with SMI had the same mortality rate as the 
general population in England, against the observed number of deaths amongst people with 
SMI in each area.  
 
Table 6-21 shows that after indirectly standardising the mortality rates found in each RO 
area, there was a sizable though not statistically significant geographical variation in mortality 
for people recently discharged with a diagnosis of either condition. The region with the 
greatest mortality gap for people discharged with a main diagnosis of bipolar disorder in 2006 
was the East of England, with an SMR of 2.5 whilst the West Midlands and the North West 
both had the lowest post-discharge mortality gap with an SMR of 1.3. For people discharged 
with a main diagnosis of schizophrenia, the East of England also had the highest post-
discharge mortality gap in 2006 with an SMR of 2.9 and the North East region having the 
lowest risk with an SMR of 1.8.  
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All-cause SMRs following hospital discharge in 2006 
(95% confidence interval) 
 
Regional Office  Main diagnosis of  
BIPOLAR DISORDER 





(0.6 - 2.7) 
 
1.8  




(0.6 - 1.9) 
 
2.4 





(1.1 - 2.9) 
 
1.9 




(0.7 - 2.7) 
 
2.0  




(0.5 - 2.1) 
 
2.2  
(1.5 - 2.9) 
East of England 
 
2.5  
(1.4 - 3.5) 
 
2.9  




(1.0 – 2.6) 
 
2 




(1.6 - 3.3) 
 
2.2 




(1.0 – 3.6) 
 
2.0  
(1.3 - 2.6) 
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Geographical variations of trends in SMRs 
 
All the regions showed an increase in SMRs for people discharged with a main diagnosis of 
schizophrenia during the study period, with the East of England region seeing a noticeable 
though non-significant increase in SMR from 1.6 (95% CI: 1.1 to 2.1) in 1999 to 2.9 (95% CI: 
2.0 to 3.7) in 2006. This was reflected in the non-significant Poisson tests for trend. There 
was no obvious pattern of geographical variation in trend for people discharged with a 
diagnosis of bipolar disorder.  
 
See Table 6-22 and Table 6-23. 
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Table 6-22 - All-cause post-discharge SMRs for BIPOLAR DISORDER, both sexes combined, by Government Regional Office area and year 
 
 
All-cause SMRs 365-days following hospital discharge with a main diagnosis of BIPOLAR DISORDER 
(95% confidence interval) 





(0.4 - 2.1) 
 
3.1  
(1.5 - 4.7) 
 
1.0 
(0.2 - 1.7) 
 
1.3 
(0.3 - 2.3) 
 
1.6 
(0.6 - 2.6) 
 
0.9 
(0.2 – 1.6) 
 
1.6 
(0.5 - 2.8) 
 
1.7 





(0.9 - 2.1) 
 
1.6 
(1.0 - 2.3) 
 
1.7 
(1.0 - 2.4) 
 
1.6 
(1.0 - 2.3) 
 
1.3  
(0.8 - 1.9) 
 
1.8  
(1.1 – 2.6) 
 
1.6 
(0.8 - 2.3) 
 
1.3  






(0.6 – 2.0) 
 
1.1 
(0.5 - 1.8) 
 
1.7 
(0.9 - 2.4) 
 
1.7 
(0.9 - 2.5) 
 
2.2  
(1.3 - 3.2) 
 
2.8  
(1.8 – 3.9) 
 
1.3 
(0.6 - 2.1) 
 
2.0  





(0.3 - 1.7) 
 
1.5 
(0.7 - 2.3) 
 
1.9 
(0.9 - 2.9) 
 
2.1 
(1.1 - 3.1) 
 
1.4  
(0.6 - 2.2) 
 
1.3  
(0.5 - 2.0) 
 
1.8  
(0.8 - 2.9) 
 
1.7  





(1.1 - 2.9) 
 
1.1 
(0.5 - 1.7) 
 
1.9 
(1.0 - 2.7) 
 
1.5 
(0.7 - 2.3) 
 
2.4 
(1.4 - 3.4) 
 
2.6 
(1.5 - 3.8) 
 
2.2  
(1.1 - 3.2) 
 
1.3  
(0.5 - 2.1) 
1.0 
East of England 
 
1.7 
(0.9 - 2.5) 
 
1.3 
(0.6 - 2.1) 
 
1.7 
(0.8 - 2.5) 
 
2.2 
(1.2 - 3.1) 
 
1.6 
(0.8 - 2.4) 
 
1.1 
(0.4 - 1.8) 
 
2.6  
(1.6 - 3.7) 
 
2.5  





(0.4 - 1.5) 
 
1.4 
(0.7 - 2.1) 
 
1.1 
(0.5 - 1.7) 
 
1.1 
(0.5 - 1.7) 
 
1.9 
(1.1 - 2.6) 
 
1.9  
(1.2 - 2.6) 
 
2.1 
(1.3 - 2.9) 
 
1.8  





(0.7 - 1.9) 
 
1.1 
(0.6 - 1.7) 
 
1.4 
(0.8 – 2.0) 
 
2.2  
(1.4 - 2.9) 
 
1.8  
(1.1 - 2.5) 
 
1.9  
(1.2 - 2.6) 
 
1.6 
(0.9 - 2.2) 
 
2.4 









(1.0 - 2.7) 
 
1.8 
(0.9 - 2.7) 
 
1.9 
(1.0 – 2.9) 
 
2.3 
(1.2 - 3.3) 
 
1.1  
(0.4 - 1.8) 
 
1.8 
(1.0 - 2.7) 
 
2.3 
(1.0 – 3.6) 
1.0 
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Table 6-23 - All-cause post-discharge SMRs for SCHIZOPHRENIA, both sexes combined, by Government Regional Office area and year 
 
 
All-cause SMRs 365-days following hospital discharge with a main diagnosis of SCHIZOPHRENIA 
(95% confidence interval) 





(0.6 - 1.7) 
 
1.9 
(1.2 - 2.6) 
 
1.4 
(0.8 - 1.9) 
 
2.4  
(1.4 - 3.4) 
 
2.4  
(1.6 - 3.3) 
 
2.2 
(1.4 – 3.0) 
 
2.7 
(1.7 - 3.7) 
 
1.8  





(1.4 - 2.3) 
 
1.7 
(1.3 - 2.2) 
 
1.5 
(1.1 - 1.9) 
 
1.6 
(1.2 - 2.1) 
 
2.3  
(1.8 - 2.8) 
 
2.2 
(1.7 - 2.7) 
 
2.1  
(1.6 - 2.7) 
 
2.4 






(1.3 - 2.3) 
 
2.7 
(2.0 - 3.4) 
 
1.7 
(1.2 - 2.2) 
 
1.9 
(1.3 - 2.5) 
 
2.9 
(2.2 - 3.6) 
 
2.3 
(1.6 – 3.0) 
 
2.3  
(1.6 – 3.0) 
 
1.9 





(1.1 - 2.3) 
 
2.2 
(1.6 - 2.9) 
 
2.6 
(1.8 - 3.3) 
 
1.8 
(1.2 - 2.4) 
 
2.1 
(1.3 - 2.8) 
 
1.7 
(1.0 - 2.3) 
 
2.7 
(1.8 - 3.5) 
 
2.0  





(1.2 - 2.3) 
 
2.3  
(1.6 – 3.0) 
 
2.0 
(1.4 - 2.6) 
 
1.8  
(1.2 - 2.4) 
 
1.9 
(1.3 - 2.5) 
 
2.5 
(1.8 - 3.3) 
 
2.3 
(1.5 – 3.0) 
 
2.2  
(1.5 - 2.9) 
1.0 
East of England 
 
1.6 
(1.1 - 2.1) 
 
2.4 
(1.7 – 3.0) 
 
1.9  
(1.2 - 2.6) 
 
1.6 
(1.0 - 2.1) 
 
2.0  
(1.3 - 2.7) 
 
1.8 
(1.2 - 2.5) 
 
2.1  
(1.4 - 2.8) 
 
2.9  





(1.4 - 2.3) 
 
1.5 
(1.0 - 1.9) 
 
1.6 
(1.2 – 2.0) 
 
2.0  
(1.5 - 2.5) 
 
1.9 
(1.5 - 2.4) 
 
1.9 
(1.5 - 2.4) 
 
2.5  
(1.9 - 3.0) 
 
2.0 





(1.2 - 2.0) 
 
1.7  
(1.3 - 2.1) 
 
1.9  
(1.4 - 2.4) 
 
2.0 
(1.5 - 2.5) 
 
2.3 
(1.8 - 2.9) 
 
2.6  
(2.0 - 3.1) 
 
2.5 
(1.9 - 3.0) 
 
2.2 









(1.4 - 2.4) 
 
1.6 
(1.1 - 2.0) 
 
1.6 
(1.1 - 2.1) 
 
1.9 
(1.3 - 2.4) 
 
2.0 
(1.4 - 2.7) 
 
1.5 
(1.0 - 2.1) 
 
2.0  
(1.3 - 2.6) 
1.0 
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Absolute all-cause mortality rates 
 
As mentioned previously, the widening mortality gap indicated by relative measure of 
mortality rates, in this case the SMRs, could represent an absolute rise in mortality rates in 
the psychiatric populations, or a fall in mortality rates in the general population in conjunction 
with a smaller fall in mortality rates in the psychiatric population. Accordingly, all-cause post-
discharge deaths rates were calculated and plotted separately against national mortality 
rates over the same period, to allow the comparison of trends in the absolute difference in 
mortality rates between the groups.  
 
The absolute mortality rates for people discharged from hospital with a main diagnosis 
bipolar disorder and schizophrenia were 15.9 per 1,000 and 14.6 per 1,000 respectively. 
Table 6-24 shows that the absolute mortality rate increased with increasing age. 
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Table 6-24 - All-cause absolute mortality rate per 1,000 population 365-days following 
hospital discharge in 2006 
 
 
All-cause absolute mortality rate per 1,000 population 365-days following 
hospital discharge in 2006 
(95% confidence interval) 
 
Main diagnosis on 




(15.6 - 16.3) 
3.9 
(3.8 – 4.0) 
12.3 
(11.9 - 12.7) 
53.4 
(50.7 - 56.0) 
SCHIZOPHRENIA 14.6 (14.5 - 14.8) 
5.7 
(5.6 - 5.8) 
17.4 
(17.0 - 17.9) 
64.4 
(61.7 - 67.0) 
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Trend in absolute all-cause absolute mortality rates 
 
Table 6-25 and Table 6-26, and Figure 6-2 to Figure 6-9, summarise the trend in crude and 
age-specific absolute mortality rates for people discharged with a diagnosis of schizophrenia 
or bipolar disorder during the course of this study. Whilst the absolute mortality rates in the 
general population declined over time, absolute rates in the populations with SMI did not. 
When compared with the absolute mortality rate for the general population, the mortality gap 
remained fairly stable for adults under 65; however for people discharged with a main 
diagnosis of bipolar disorder or schizophrenia between the ages of 65 and 84 years, the 
mortality gap widened during the study period. 
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Table 6-25 - All-cause post-discharge absolute mortality rate for BIPOLAR DISORDER, 
both sexes combined 
 
 
All-cause absolute mortality rate per 1,000 population 365-days following 
hospital discharge with a main diagnosis of BIPOLAR DISORDER 
(95% confidence interval) 
 
Year of discharge All ages < 45 yrs 45-64 yrs 65-84 yrs 
1999 
18.3 
(17.9 - 18.8) 
3.8 
(3.7 - 3.9) 
9.4 
(9.1 - 9.7) 
42.3  
(40.2 - 44.4) 
2000 
14.2 
(13.9 - 14.5) 
3.7 
(3.6 - 3.8) 
12.4  
(12 - 12.8) 
44.7  
(42.5 - 47) 
2001 
15.5  
(15.2 - 15.8) 
5.0 
(4.9 - 5.1) 
11.4  
(11.0 - 11.8) 
45.1 
(42.83 - 47.3) 
2002 
17.2 
(16.8 - 17.5) 
4.5 
(4.3 - 4.6) 
13.9 
(13.5 - 14.4) 
54.8 
(52.0 - 57.5) 
2003 
18.2 
(17.8 - 18.6) 
5.1  
(5.0 - 5.3) 
13.0 
(12.6 - 13.4) 
55.3 
(52.6 - 58.0) 
2004 
16.3 
(15.9 - 16.6) 
7.4  
(7.2 - 7.6) 
13.1 
(12.7 - 13.5) 
43.4 
(41.4 - 45.5) 
2005 
15.4 
(15.1 - 15.7) 
4.1 
(3.9 - 4.2) 
12.5  
(12.0 - 12.9) 
51.8 
(49.3 - 54.3) 
2006 
15.9  
(15.6 - 16.3) 
3.9 
(3.8 – 4.0) 
12.3  
(11.9 - 12.7) 
53.4 
(50.7 - 56.0) 
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Table 6-26 - All-cause post-discharge absolute mortality rate for SCHIZOPHRENIA, 
both sexes combined 
 
 
All-cause absolute mortality rate per 1,000 population 365-days following 
hospital discharge with a main diagnosis of SCHIZOPHRENIA 
(95% confidence interval) 
 
Year of discharge All ages < 45 yrs 45-64 yrs 65-84 yrs 
1999 
19.2 
(18.9 - 19.4) 
5.8  
(5.7 - 5.9) 
17.9 
(17.5 - 18.4) 
51.6  
(49.7 - 53.5) 
2000 
15.7 
(15.6 - 15.9) 
6.2 
(6.1 - 6.3) 
17.8 
(17.4 - 18.3) 
64.1 
(61.7 - 66.5) 
2001 
15.8  
(15.6 - 16.0) 
5.6 
(5.5 - 5.7) 
17.0 
(16.6 - 17.4) 
61.0  
(58.6 - 63.3) 
2002 
15.0 
(14.9 - 15.2) 
5.3 
(5.2 - 5.3) 
16.5 
(16.1 - 16.9) 
57.4  
(55.1 - 59.6) 
2003 
18.0 
(17.8 - 18.2) 
5.7 
(5.6 - 5.8) 
20.8  
(20.3 - 21.3) 
70.2 
(67.4 - 72.9) 
2004 
16.6 
(16.4 - 16.8) 
6.1 
(6.1 - 6.2) 
16.8 
(16.4 - 17.2) 
61.5  
(59.2 - 63.8) 
2005 
15.1  
(14.9 - 15.3) 
7.2 
(7.1 - 7.3) 
15.9 
(15.5 - 16.2) 
61.3  
(58.9 - 63.7) 
2006 
14.6 
(14.5 - 14.8) 
5.7 
(5.6 - 5.8) 
17.4 
(17.0 - 17.9) 
64.4  
(61.7 - 67.0) 
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Figure 6-2 - All cause post-discharge absolute mortality rate within 365-days from 
discharge, per 1,000 people discharged, with a main diagnosis of BIPOLAR 
DISORDER, all ages 
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Figure 6-3 - All cause post-discharge absolute mortality rate within 365-days from 







    122 
Figure 6-4 - All cause post-discharge absolute mortality rate within 365-days from 
discharge, per 1,000 people discharged, with a main diagnosis of BIPOLAR 
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Figure 6-5 - All cause post-discharge absolute mortality rate within 365-days from 
discharge, per 1,000 people discharged, with a main diagnosis of SCHIZOPHRENIA, in 
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Figure 6-6 - All cause post-discharge absolute mortality rate within 365-days from 
discharge, per 1,000 people discharged, with a main diagnosis of BIPOLAR 
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Figure 6-7 - All cause post-discharge absolute mortality rate within 365-days from 
discharge, per 1,000 people discharged, with a main diagnosis of SCHIZOPHRENIA, in 
those aged 45-64 years 
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Figure 6-8 - All cause post-discharge absolute mortality rate within 365-days from 
discharge, per 1,000 people discharged, with a main diagnosis of BIPOLAR 
DISORDER, in those aged 65-84 years 
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Figure 6-9 - All cause post-discharge absolute mortality rate within 365-days from 
discharge, per 1,000 people discharged, with a main diagnosis of SCHIZOPHRENIA, in 
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Summary of findings from chapter 6 
 
The findings from this chapter showed that  
1. Inpatient care for people with bipolar disorder and schizophrenia is becoming 
increasingly uncommon 
• In 1999 there were 12,369 and 35,348 discharges from inpatient care for bipolar 
disorder and schizophrenia respectively. This decreased steadily by 3.9% and 
10.9% for both conditions respectively between 1999 and 2006. 
2. Deaths following discharge are rare but still important outcomes 
• The number of deaths within one year following discharge has remained stable 
since 1999, with approximately 1% of all discharges with a main diagnosis of 
bipolar disorder or schizophrenia resulting in death after one year. 
• A large component of mortality in people with a main diagnosis of bipolar disorder 
is due to deaths from circulatory and respiratory diseases. 
3. Mortality excess for people with bipolar disorder and schizophrenia following 
discharge has changed over the last decade 
• After taking into account mortality in the general population over the same time 
period the mortality gap for both bipolar disorder and schizophrenia increased 
between 1999 to 2006 
• Age, sex and geographical region are also important in the determining the trend 
of the mortality gap 
• An examination of trends in absolute mortality rates showed that the observed 
trends in the mortality gap for people with these conditions was a result of a 
failure to benefit from the decrease in deaths experienced by the general 
population, and in certain groups such as people over the age of 65 years the 
mortality excess was a result of an absolute increase in the mortality risk in these 
populations 
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1. What is the contribution of potentially avoidable deaths to the mortality excess 
experienced by people with main diagnosis of bipolar disorder and schizophrenia? 
2. To what extent are causes of excess deaths potentially avoidable in people with bipolar 
disorder and schizophrenia and therefore what would be the impact on the mortality 




The mechanisms underlying mortality in people with SMI including bipolar disorder and 
schizophrenia are likely to be complex, however it has been suggested that a proportion of 
the excess mortality in these populations could be avoided either through the provision of 
better medical and psychiatric care, or from the provision of better preventative services for 
people with SMI (Wildgust and Beary 2010; Wildgust, Hodgson et al. 2010). Studies in 
Europe have found that people with SMI have up to three times the risk of avoidable deaths 
as the general population of similar age and sex (Brown, Inskip et al. 2000; Rasanen, Hakko 
et al. 2005; Amaddeo, Barbui et al. 2007); however, no recent studies of avoidable deaths in 
populations with SMI have been undertaken in the UK. Findings from the previous chapter 
show that adverse mortality outcome is still an important consideration in people with bipolar 
disorder and schizophrenia, and may be even more so as mortality has been increasing in 
these cohorts over the last decade, especially amongst people recently discharged from 
inpatient care. This lends further weight to the need to investigate the contribution of 
potentially avoidable deaths to the excess mortality seen (Wildgust and Beary 2010; 
Wildgust, Hodgson et al. 2010). 
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In this chapter the concept of ‘avoidable mortality’ will be introduced. This was originally 
proposed by Rutstein and colleagues in 1976, and later adopted by Walter Holland and 
others, to quantify the extent to which potentially avoidable causes of death contribute to the 
mortality excess experienced by people with bipolar disorder and schizophrenia (Rutstein, 
Berenberg et al. 1976; Holland, Paul et al. 1988; Holland 1993; Nolte and McKee 2004; 
Page, Tobias et al. 2006; Wheller, Baker et al. 2006; Wheller, Baker et al. 2007). The aim will 
be to adapt this concept of ‘avoidable death’ to answer the question of what scope is there 
currently to reduce the mortality gap in these populations through the implementation of 
public health interventions or through the provision of better medical care.  
 
Rutstein’s original paper explained the concept and definition of avoidable deaths by stating 
that there is ‘a proportion of deaths from particular conditions, at certain ages, that should not 
occur in the presence of timely and effective health care or other appropriate interventions, 
including public health interventions’ (Rutstein, Berenberg et al. 1976; Rutstein, Berenberg et 
al. 1980). The deaths from specific causes and the age cut-offs for which they could be 
applied were decided by clinical consensus. Since its publication, the concept has been 
applied to look at the quality of healthcare and public health services in a number of 
countries and specific populations, including people with severe mental illness (Holland 
1993; Nolte and McKee 2003; Nolte and McKee 2004; Page, Tobias et al. 2006). Recently 
Wheller and colleagues updated the list of specific causes that were considered avoidable to 
incorporate understanding of the latest evidence on the effectiveness of medical care and 
public health intervention. Wheller identified the following categories of avoidable deaths 
(Wheller, Baker et al. 2007); 
 
• Deaths which could be ameliorated through the efforts of health care services were 
termed ‘amenable’.  
• Deaths which could be ameliorated by broader public health interventions, for example 
accident prevention, were termed ‘preventable’.  
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• Deaths which be ameliorated through the efforts of health care services or through 
broader public health interventions were considered ‘avoidable’ deaths (Note that some 
deaths classified as ‘avoidable’ were considered as both ‘amenable’ and ‘preventable’, 
thus the number of ‘avoidable’ deaths is not equivalent to the sum of ‘amenable’ and 
‘preventable’ deaths.) 
 
Wheller subsequently scrutinised mortality statistics in the UK and found that avoidable 
deaths accounted for 24% of all deaths between 1993-2005, with those that could be 
amenable to medical treatments accounting for 13.5% of all deaths, and those that could be 
prevented by public health interventions making up 17.8% (Wheller, Baker et al. 2007). 
However they did not examine avoidable mortality in sub-populations at high risk of death 
such as people with SMI. 
 
In this chapter the definitions of avoidable deaths posited by Wheller will be used to quantify 
the level of ‘avoidable’ deaths in a cohort of people with a main diagnosis of bipolar disorder 
or schizophrenia in England in the first year following hospital discharge, often recognised as 
the period of highest risk for death (Goldacre, Seagroatt et al. 1993). Specifically the 
question of whether the mortality excess in people with bipolar disorder and schizophrenia 
would be reduced or eliminated if deaths in these patients from causes that should be 
preventable and/or amenable to treatment were reduced to their levels in the general 




Study inclusion criteria 
In order to examine the research questions posed in this chapter, all records of discharges 
from inpatient care in England between 1st January 2006 and 31st December 2007 with 
either bipolar affective disorder (ICD10 code F31), or schizophrenia (ICD10 codes F20-F29) 
as the main diagnosis on the discharge record were extracted from the 13 year file. 
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The first record in each study period with the diagnosis of interest was selected. Follow-up 
time was counted from the time of discharge from this first admission in the study period. 
Follow-up was ceased for the following reasons; 1) The patient died, 2) The patient was 
readmitted as an inpatient for any reason.  
 
Thus for a patient who was admitted multiple times during the study period, only the first 
admission with the diagnosis of interest would be counted, other readmissions in the study 
period would not be counted. 
 
Outcomes 
Follow-up for 365 days after discharge, all done by record linkage within the dataset, was to 
31st December 2008. The primary outcome for this chapter was mortality in people with 
bipolar disorder or schizophrenia compared with the general population, subdividing their 
excess mortality into deaths from avoidable causes and other deaths. Avoidable causes of 
death are selected from a list of diagnostic codes which are shown, with age ranges where 
relevant, in Appendix 5 (Wheller, Baker et al. 2007; 2011). 
 
Deaths from suicide and undetermined intent (ICD10 codes - X60 to X84, Y10 to Y34) were 
considered avoidable if they were recorded anywhere on the death certificate, as these 
causes of death are rarely recorded as the underlying cause of death (Goldacre, Seagroatt et 
al. 1993; Hawton and Heeringen 2002; Goldacre, Duncan et al. 2006), and thus enumeration 
of these deaths where they are listed as the underlying cause only would substantially under-
estimate the contribution of deaths from suicide and  undetermined intent. Deaths from other 
specific causes shown in the appendix were included if they were the coded as the 
underlying cause of death. Deaths that were not classified as ‘avoidable’, as determined by 
their cause, were termed ‘unavoidable’. 
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Whilst the definition of avoidable deaths has been used to categorise specific causes of 
death previously in the general population within the UK (Wheller, Baker et al. 2007), and 
also for populations at high risk of death, such as people with SMI in other countries 
(Amaddeo, Barbui et al. 2007) as explained above, a number of points must be taken into 
account when considering the use of these categories for examining deaths in people with 
SMI. Firstly, the specific causes of death selected by a consensus of clinicians as avoidable 
was done so in the context of identifying diseases in the general population that would be 
amenable to current healthcare and public health interventions. Thus this categorisation is 
based on assumptions about the provision and access to care, and the ability to benefit from 
care. These assumptions can be tested against other studies that have compared the 
access, and ability to benefit from care for people with SMI and other groups, for example 
Lawrence and others have found that people with SMI have less access to acute cardiac 
care than the general population with equivalent physical ill-health (Lawrence and Kisely 
2010). These results would suggest that the same list of conditions considered avoidable in 
the general population may not apply to people with SMI. 
 
Secondly, quantifying avoidable deaths using routinely collected data is dependent on the 
accurate recording of specific causes of deaths which is known to be imprecisely recorded 
(Smith Sehdev and Hutchins 2001; Flaxman, Vahdatpour et al. 2011), thus this method of 
enumeration can only give an indication of the extent of avoidable deaths and should be 
verified with further studies that are able to confirm the cause of death, such as autopsy 
studies. 
 
Lastly investigating specific causes of deaths in people with SMI may result in a differential 
measurement bias if the clinician recording the specific causes of death is not blinded to the 
person’s diagnosis of SMI. I have discussed this in detail in chapter 9. 
 
Analysis 
Proportion and relative risk of avoidable death 
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In order to quantify the contribution of avoidable causes of death in people recently 
discharged with a main diagnosis of bipolar disorder and schizophrenia, the absolute 
contribution of these deaths as a proportion of total deaths is presented. The SMRs for 
avoidable death, or the relative rate of death from avoidable causes which takes into account 
the rate of avoidable deaths in the general population of the same age is also presented and 
allows conclusions to be made about whether the rate of avoidable deaths are more or less 
than expected. The standard definition of avoidable causes of death takes an upper age 
threshold of 74 years as the maximum age at which deaths are assumed to be avoidable 
(Wheller, Baker et al. 2007; 2011), thus avoidable cause SMRs are presented specifically for 
people under the age of 75 years.  
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Figure 7-1 - Calculation of hypothetical SMRs showing the all-cause SMRs that would 
have prevailed if excess avoidable deaths were reduced 
Observed total number of deaths 
Expected total number of deaths 
= All-cause SMR 
A. Calculation of the hypothetical SMR showing the effect of a reduction in 
excess deaths from amenable causes 
Observed total number of deaths minus  
excess deaths from amenable causes 
Expected total number of deaths 
= Hypothetical all-cause SMR 
Where: Excess deaths from amenable 
causes 
= observed – expected number of 
amenable deaths 
B. Calculation of the hypothetical SMR showing the effect of a reduction in 
excess deaths from amenable causes and suicide 
Observed total number of deaths minus excess 
deaths from amenable causes and suicides  
Expected total number of deaths 
= Hypothetical all-cause 
SMR 
Where: Excess deaths from amenable 
causes and suicide 
= observed – expected number of 
amenable deaths and suicides 
C. Calculation of the hypothetical SMR showing the effect of a reduction in 
excess deaths from all avoidable causes 
Observed total number of deaths minus  
excess deaths from all avoidable causes                   
Expected total number of deaths 
= Hypothetical all-cause SMR 
Where: Excess deaths from avoidable 
causes 
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Hypothetical SMRs 
In order to analyse the possible effects on the previously observed mortality excess of a 
reduction in avoidable deaths in these populations, a series of hypothetical SMRs were 
calculated: these were the SMRs that would have prevailed if avoidable deaths were reduced 
to their levels in the general population. A brief explanation of the calculations undertaken is 
given below and in Figure 7-1. Comparable calculations have been undertaken to estimate 
the upper limits of human longevity (Olshansky 1992). 
 
First, mortality from all-causes after hospital discharge was calculated as age and sex 
standardised mortality ratios, comparing mortality in people with schizophrenia, or bipolar 
disorder, with mortality in the general population of England. Standardisation was performed 
using the conventional indirect method, in five-year age groups, using the age- and sex-
specific mortality rates of England in the same time periods as the standard. These age- and 
sex-specific rates were applied to the age and sex structure of each of the discharge cohorts 
with schizophrenia or bipolar disorder to calculate an ‘expected’ number of deaths. The 
observed number was compared with the expected number to calculate the SMRs (Hoang, 
Stewart et al. 2011); 95% confidence intervals for the SMRs were calculated as described 
elsewhere (Higham, Flowers et al. 2005). 
 
Next, the number of excess amenable deaths was calculated by subtracting the observed 
number of amenable deaths from the expected number. All-cause SMRs were then re-
calculated with the amenable component set to the level found in the general population. 
This first set of hypothetical SMRs shows what the all-cause SMR would have been if these 
cohorts had the same mortality rate from amenable causes as the general population, and 
allows one to examine the effect of a reduction in amenable deaths to the level in the general 
population. 
 
As suicide and deaths from undetermined intent are an important contributor to excess 
deaths in people with severe mental illness, a second set of hypothetical SMRs was 
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calculated, in the same way, by subtracting both excess amenable deaths and excess 
deaths from suicide or undetermined intent.  This second set of hypothetical SMRs shows 
what the all-cause SMR would have been if the risk of death from amenable causes and 
suicide in these cohorts had been the same as the general population. It allows the effect of 
a reduction in amenable deaths and suicide to be examined. 
 
A final set of hypothetical SMRs were calculated by subtracting all excess avoidable causes 
of death. This last set of hypothetical SMRs shows what the all-cause SMR would have been 
if the risk of death in these cohorts from all avoidable causes had been the same as the 
general population. It allows one to examine the effect of a reduction in all avoidable deaths 
to the level in the general population. 
 
In order to study whether the effect of reducing avoidable deaths would be more pronounced 
if it was targeted at all adults, adults of working age or young adults, the analysis was 
repeated, calculating age-truncated SMRs, for people aged under 65 years (all adults),  
under 45 years (working age adults) and  under 25 years (younger adults),with age-sex 
standardisation, as above, using five year age groups within each truncated broader age 
group.  
 
This analysis allows the differential effect of a reduction in avoidable deaths at different ages 
to be examined.  The separate risks for males and females were also calculated, to examine 




Number of discharges with a main diagnosis of bipolar disorder and schizophrenia aged 
under 75 years  
There were 20,690 discharges with a main diagnosis of bipolar disorder (for 14,017 people) 
and 54,883 discharges with a main diagnosis of schizophrenia (for 37,607 people) in 
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England between 1st January 2006 and 31st December 2007. Table 7-1 summarises 
demographic characteristics of the cohorts.  
 
Table 7-1 also shows that there were approximately 1.5 HES records per person where the 
main diagnosis was bipolar disorder or schizophrenia over the study period, namely two 
years, which is slightly higher than the ratio of 1.3 HES records per person shown in the last 
chapter. This is the probably due to the fact that the figures in Table 6-1 and Table 6-2 quote 
the ratio of HES records where the main diagnosis was bipolar disorder or schizophrenia 
counted over one year divided by the number of people in that year as opposed to Table 7-1 
which counts the same ratio over two years. 
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Table 7-1 - Number of discharges and number of people aged under 75 years, 
discharged with a main diagnosis of BIPOLAR DISORDER or SCHIZOPHRENIA, and 
their demographic characteristics, between 2006-07, in England 
 
 
Main diagnosis on discharge 
 
BIPOLAR DISORDER SCHIZOPHRENIA  
Number of discharges between 1st Jan 
2006- 31st Dec 2007 
 
20,690 54,883 
Number of people discharged between 1st 










Number of deaths that are amenable  






Number of deaths that are  preventable**  





Number of deaths that are avoidable**  








*Consultation on definitions of avoidable mortality (2011) 
** Deaths from suicide and undetermined intent (ICD10 codes - X60 to X84, Y10 to Y34) 
were included in this group 
*** Note that many conditions classified as ‘avoidable’ are classified as both ‘amenable’ and 
‘preventable’, thus the first two categories do not sum to the last 
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All-cause mortality rate and proportion of deaths from avoidable causes in people with 
bipolar disorder and schizophrenia 
 
Within 365 days of discharge, there were 169 deaths for people under 75 years who had 
recently been discharged with a main diagnosis of bipolar disorder and 480 deaths amongst 
people recently discharged with a main diagnosis of schizophrenia (see Table 7-1). 
Avoidable deaths comprised 59·2% of all deaths for people recently discharged with a main 
diagnosis of bipolar disorder. Amenable deaths accounted for 30·2%, whilst preventable 
deaths accounted for 49·1% of all deaths (many causes on the list are regarded as both 
amenable and preventable). The SMR for avoidable deaths under 75 years was 3.8 (95% CI: 
3.2–4.4).  
 
For people under 75 years recently discharged with a main diagnosis of schizophrenia, 
avoidable deaths comprised 60·2% of all deaths. Deaths potentially amenable to medical 
care accounted for 30·2% of deaths, whilst deaths from conditions that are potentially 
preventable through public health interventions accounted for 50·6% of all deaths (see Table 
7-1).  The SMR for avoidable deaths under 75 in people with schizophrenia was 5.4 (95% CI: 
4.9–5.9), which is similar to previously published results on avoidable mortality in England 
and other countries in Europe (Brown, Inskip et al. 2000; Rasanen, Hakko et al. 2005; 
Amaddeo, Barbui et al. 2007). ‘Unavoidable’ deaths, namely those deaths that remained 
after discounting ‘avoidable’ deaths, were distributed rather generally across major disease 




    141 
Table 7-2 - Underlying causes of death within 365 days after discharge in people with a 
principal diagnosis of BIPOLAR DISORDER or SCHIZOPHRENIA, and the percentage 




Number of deaths 
that were 
unavoidable 
(% of all deaths) 
Total number 
of deaths 
Number of deaths 
that were 
unavoidable 
(% of all deaths) 
Underlying cause of 




headings and code 
ranges) 
 
BIPOLAR DISORDER SCHIZOPHRENIA 
Deaths from all-
causes 
169 69 (40.8%) 480 
191 
(39.8%) 
Deaths from certain 
infectious and 
parasitic diseases 
(ICD10 codes - A00-
B99) 
 




codes - C00-D48) 
 
 
21 13 (61·9%) 48 
23 
(47·9%) 
Diseases of the 
circulatory system 
(ICD10 codes – I00-
I99) 
 
41 13 (31·7%) 125 
49 
(39·2%) 
Diseases of the 
respiratory system 
(ICD10 codes – J00-
J99) 
 
25 0 (0%) 86 
25 
(29·1%) 
Diseases of the 
digestive system 
(ICD10 codes - K00-
K93) 
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Standardised Mortality Ratios  
 
The all-cause SMRs for people discharged between 1st Jan 2006 and 31st Dec 2007 with a 
main diagnosis of bipolar disorder or schizophrenia under the age of 75 were, respectively, 
2·6 (95% Cl: 2·2–3·0) and 4·23 (95% CI: 3·9-4·6).  
 
Table 7-3, Figure 7-2 and Figure 7-3 show that equalising amenable deaths for people with a 
main diagnosis of bipolar disorder resulted in the all-cause SMRs falling from 2·6 to 2·2 (95% 
CI: 1·8– 2·6). For people with a main diagnosis of schizophrenia the all-cause SMRs fell from 
4·2 to 3·3 (95% CI: 3·0-3·7) in this way.  
 
Additionally equalising mortality from suicide gave a further reduction in the all-cause SMRs 
to 1·7 (95% CI: 1·4-2·0) for people with a main diagnosis of bipolar disorder and to 2·4 (95% 
CI: 2·2-2·7) for people with a main diagnosis of schizophrenia.  
 
Finally, equalising amenable deaths, suicides and all other preventable deaths did not 
eliminate the mortality gap, the all-cause SMRs remaining at 1·7 (95% CI: 1·4-2.0) for people 
with a main diagnosis of bipolar disorder and 2·4 (95% CI: 2·1-2·7) for people with a main 
diagnosis of schizophrenia.  
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Table 7-3 - Hypothetical SMRs for people aged under 75 years and discharged with a 
main diagnosis of BIPOLAR DISORDER or SCHIZOPHRENIA, applying death rates 
from amenable causes, suicide and preventable causes at the levels in the general 
population 
 
BOTH SEXES, aged under 75 years 
SMR within 365 days after discharge 
(95% CI) 
Category Main diagnosis on 
discharge of  
BIPOLAR DISORDER 






(2·2 - 3·0) 
4·2 
 
(3·9 – 4·6) 
All-causes minus excess amenable deaths* 
2·2 
 
(1·8 – 2·6) 
3·3 
 
(3 – 3·7) 
All-causes minus excess amenable deaths* and 
suicides or deaths from undetermined intent 
1·7 
 
(1·4 – 2.0) 
2·4 
 
(2·2 – 2·7) 
All-causes minus excess amenable deaths*, suicides 








(2·1 – 2·7) 
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Figure 7-2 - Hypothetical SMRs for people aged under 75 years and discharged with a 
main diagnosis of BIPOLAR DISORDER, applying death rates from amenable causes, 










All-cause SMRs within 
365 days after 
discharge with a main 














(95% CI: 2·2 - 3·0) 
2.2 
 
(95% CI: 1·8 – 2·6) 
1.7 
 
(95% CI: 1·4 – 2.0) 
1.7 
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Figure 7-3 - Hypothetical SMRs for people aged under 75 years and discharged with a 
main diagnosis of SCHIZOPHRENIA, applying death rates from amenable causes, 











All-cause SMRs within 
365 days after 















(95% CI: 3·9 – 4·6) 
3·3 
 
(95% CI: 3 – 3·7) 
2·4 
 
(95% CI: 2·2 – 2·7) 
2·4 
 
(95% CI: 2·1 – 2·7) 
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As shown previously and also in Table 7-4 shows differences between men and women in 
the mortality gap with the general population, especially for people with a main diagnosis of 
schizophrenia. Sex-specific SMRs were higher in men than women especially with a main 
diagnosis of schizophrenia; reducing deaths from avoidable causes had a marginally greater 
impact on men than women. For example the SMR for men with a main diagnosis of 
schizophrenia decreased from 4·6 (95% CI: 4.1 – 5.1) to 2·5 (95% CI: 2·1 – 2·9) if all 
avoidable causes of death were reduced, compared with a reduction from 3.7 (95% CI: 3.1 – 
4·2) in women to 2·2 (95% CI: 1.7 – 2·6). There was no difference between men and women 
when reducing avoidable causes in people with a main diagnosis of bipolar disorder. 
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Table 7-4 - Hypothetical SMRs for people aged under 75 years discharged with a main 
diagnosis of BIPOLAR DISORDER or SCHIZOPHRENIA, applying death rates from 
amenable causes, suicide and preventable causes at the levels in the general 
population, by sex 
 
A.  MALES, aged under 75 years 
SMR within 365 days after discharge 
(95% CI) 
Category Main diagnosis on 
discharge of 
BIPOLAR DISORDER 





(2·1 - 3·3) 
4·6 
(4.1 – 5.1) 
All-causes minus excess amenable deaths* 
2·3 
(1·8 – 2·9) 
3·5 
(3·1 – 4) 
All-causes minus excess amenable deaths* and 
suicides or deaths from undetermined intent 
1·8 
(1·3 – 2·3) 
2·5 
(2·1 – 2·9) 
All-causes minus excess amenable deaths*, suicides 
or deaths from undetermined intent, and preventable 
deaths* 
1·7 
(1·2 – 2.1) 
2·5 
(2·1 – 2·9) 
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B. FEMALES, aged under 75 years 
SMR within 365 days after discharge 
(95% CI) 
Category Main diagnosis on 
discharge of  
BIPOLAR DISORDER 





(2·3 - 3·4) 
3.7 
(3.1 – 4·2) 
All-causes minus excess amenable deaths* 
2·3 
(1·8 – 2·8) 
3.0 
(2.5 – 3·5) 
All-causes minus excess amenable deaths* and 
suicides or deaths from undetermined intent 
1·8 
(1·3 – 2·3) 
2·4 
(1.9 – 2·8) 
All-causes minus excess amenable deaths*, suicides 
or deaths from undetermined intent, and preventable 
deaths* 
1·8 
(1·3 – 2.3) 
2·2 
(1.7 – 2·6) 
*(Wheller, Baker et al. 2007) 
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Further age-truncated analysis suggests that reducing avoidable deaths in people <45 years 
would have the greatest age-specific effect on reducing excess mortality. Table 7-5 shows 
that people with a main diagnosis of bipolar disorder <45 years would experience a reduction 
of SMR from 3.7 (95% CI: 2·3–5.1) to 1·6 (95% CI: 0.7–2.5), whilst people with a main 
diagnosis of schizophrenia <45 years would experience a reduction of SMR from 7·1 (95% 
CI: 6.0–8.2) to 3·3 (95% CI: 2·6 – 4.1) if all avoidable causes of death were reduced to the 
same level as the general population. 
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Table 7-5 - Hypothetical SMRs for people aged under 65, under 45 and under 25 
discharged with a main diagnosis of BIPOLAR DISORDER or SCHIZOPHRENIA, 
applying death rates from amenable causes, suicide and preventable causes at the 
levels in the general population 
 
A. Both sexes, aged UNDER 65 YEARS 
SMR within 365 days after discharge 
(95% CI) 
Category Main diagnosis on 
discharge of  
BIPOLAR DISORDER 





(2·4 - 3·5) 
5.2 
(4.7 – 5.8) 
All-causes minus excess amenable deaths* 
2·7 
(2.2 – 3.3) 
4.3 
(3.8 – 4.8) 
All-causes minus excess amenable deaths* and 
suicides or deaths from undetermined intent 
1·9 
(1·4 – 2·3) 
2·9 
(2·5 – 3.3) 
All-causes minus excess amenable deaths*, suicides 
or deaths from undetermined intent, and preventable 
deaths* 
1·8 
(1·4 – 2.3) 
2·8 
(2·4 – 3.2) 
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B. Both sexes, aged UNDER 45 YEARS 
SMR within 365 days after discharge 
(95% CI) 
Category Main diagnosis on 
discharge of  
BIPOLAR DISORDER 





(2·3 – 5.1) 
7·1 
(6.0 – 8.2) 
All-causes minus excess amenable deaths* 
3.6 
(2.2 – 5.0) 
6.7 
(5.6 – 7.8) 
All-causes minus excess amenable deaths* and 
suicides or deaths from undetermined intent 
1·7 
(0.8 – 2·7) 
3.5 
(2·7 – 4.3) 
All-causes minus excess amenable deaths*, suicides 
or deaths from undetermined intent, and preventable 
deaths* 
1·6 
(0.7 – 2.5) 
3·3 
(2·6 – 4.1) 
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C. Both sexes, aged UNDER 25 YEARS 
SMR within 365 days after discharge 
(95% CI) 
Category Main diagnosis on 
discharge of  
BIPOLAR DISORDER 





(0 - 4·0) 
5.3 
(3·2 – 7.4) 
All-causes minus excess amenable deaths* 
1.9 
(0 - 4·0) 
4.9 
(2.9 – 6.9) 
All-causes minus excess amenable deaths* and 
suicides or deaths from undetermined intent 
1·4 
(0 – 3.3) 
2·5 
(1.0 – 4.0) 
All-causes minus excess amenable deaths*, suicides 
or deaths from undetermined intent, and preventable 
deaths* 
1·3 
(0 – 3.1) 
2·2 
(0.8 – 3.5) 




    153 
Summary of findings from chapter 7 
 
The findings from this chapter showed that  
1. Avoidable deaths are a substantial contributor to overall mortality in people discharged 
with a main diagnosis of bipolar disorder and schizophrenia 
• Avoidable causes accounted for 59·2% of all deaths in people recently discharged 
with a main diagnosis of bipolar disorder, and 60·2% of all deaths in people with a 
main diagnosis of schizophrenia  
2. Potentially avoidable causes of death are an important contributor to the mortality excess 
seen in these conditions 
• The SMR for avoidable deaths in people under 75 years recently discharged with 
a main diagnosis of bipolar disorder was 3.8 (95% CI: 3.2–4.4), and for people 
with a main diagnosis of schizophrenia it was 5.4 (95% CI: 4.9–5.9) 
3. Unavoidable causes of death were distributed across a broad range of disease groups 
4. Current approaches including health care interventions and public health policies to 
reduce mortality would be expected to reduce the overall mortality excess in SMI by 
about 50% in people under the age of 75 years, but not entirely eliminate this well known 
disparity. In fact reducing avoidable deaths in people with SMI <45 years would have the 
greatest age-specific effect on reducing excess mortality. 
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Does comorbid illness with bipolar disorder and schizophrenia in people with another main 




In the previous chapters an excess risk of mortality was found, including death from 
avoidable causes, in people with a recent main diagnosis of bipolar disorder and 
schizophrenia on discharge, and the mortality gap was found to have been increasing over 
the last decade. However, the results may have underestimated the true extent of the 
mortality gap as a result of these conditions as, up to now in this thesis, only the mortality 
gap for people who have been discharged from hospital with a main diagnosis of bipolar 
disorder or schizophrenia has been considered. Previous research found that mortality risk 
extends to people who are affected primarily by a physical illness, and have a severe mental 
illness as a comorbid condition. Most evidence relates to adverse outcomes in people who 
present with cardiovascular disease or diabetes, and have comorbid SMI. (Lawrence, 
Holman et al. 2000; Lesperance, Frasure-Smith et al. 2000; Jaffe, Krumholz et al. 2006; 
Lawrence and Kisely 2010; Lawrence, Kisely et al. 2010). For example Osborn and 
colleagues used information from the UK General Practice Research Database (GPRD) to  
show that there is a high risk of cardiovascular and stroke deaths in people with SMI not 
explained by the presence of common risk factors including anti-psychotic drug use, smoking 
or social deprivation (Osborn, Levy et al. 2007). There may be a number of reasons for these 
findings including; 
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- people with SMI may present with more severe physical illness disease as a result of 
late presentation (Lawrence, Holman et al. 2000; Kessler, Chiu et al. 2005; Callahan 
and Khizar 2010) 
- people with SMI may have difficulty accessing physical healthcare services and 
difficulty with compliance with ongoing medical care (Ussher, Stanbury et al. 2007; 
Kisely, Campbell et al. 2009; Lawrence and Kisely 2010; Mitchell and Lord 2010) 
- ongoing treatments for mental illness, such as the adverse effects of anti-psychotics 
may complicate the management of physical illness (Barak, Baruch et al. 2007; 
Laursen, Munk-Olsen et al. 2009; Blasco-Fontecilla, Baca-Garcia et al. 2010) 
 
Other studies have found the opposite result with people with comorbid SMI having lower 
mortality, especially in the short-term (Abrams, Vaughan-Sarrazin et al. 2008; Abrams, 
Vaughan-Sarrazin et al. 2009; Abrams, Vaughan-Sarrazin et al. 2010). A number of 
explanations have been put forward for this including; 
- medical record coding may be more likely to include a psychiatric comorbidity in 
patients with less complicated hospital courses of illness 
- providers may be more vigilant or be more likely to intervene in patients with physical 
illness and psychiatric comorbidities 
- people with physical illness and psychiatric comorbidities may experience lower 
utilization of invasive diagnostic or potentially harmful therapeutic procedures 
 
Given the previous evidence of an increasing mortality gap for people with a main diagnosis 
of bipolar disorder and schizophrenia in England, and the evidence from other countries of 
the importance of comorbid SMI on mortality, but the lack of previous research in the UK, I 
will aim to explore the question of whether having a co-existing diagnosis of bipolar disorder 
or schizophrenia in people admitted with a main diagnosis of cardiovascular disease or 
diabetes puts people at greater risk of death.  
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Method 
 
Study inclusion criteria 
In order to examine the research questions posed in this chapter, all records of inpatient care 
in England between 1st January 2007 and 31st December 2007 with a main diagnosis of 
either cardiovascular disease (ICD10 codes I00–I99), or diabetes (ICD10 codes E10-E14), 
were extracted. 
 
Within these inpatient cohorts, people with comorbid bipolar disorder (ICD10 code F31) or 
schizophrenia (ICD10 codes F20–F29) were identified by searching for the diagnosis 
anywhere else on the same hospital record. However data from the NHS Information Centre 
(NHS IC) suggests that the accuracy of secondary diagnostic coding, i.e. codes other than 
the main diagnosis is approximately 75% for a variety of diagnosis (Spencer 2011). 
Additionally this technique to identify comorbid SMI has been criticised by Abrams and 
colleagues who suggest that it may selectively miss people with more severe comorbid 
mental disorders, and under-estimate the association between psychiatric comorbidity and 
mortality (Abrams, Vaughan-Sarrazin et al. 2008), thus the hospital records were searched to 
identify people who may also have been admitted for inpatient care with a main diagnosis of 
bipolar disorder or schizophrenia within the past year. This served as a second method of 
defining the study group. 
 
Again the counting method included the first record in each study period with the diagnoses 
of interest. Follow-up time was counted from the time of discharge from this first admission in 
the study period. Follow-up was ceased for the following reasons; 1) The patient died, 2) The 
patient was readmitted as an inpatient for any reason.  
 
Thus for a patient who was admitted multiple times during the study period, then only the first 
admission with the diagnoses of interest would be counted, other readmissions in the study 
period would not be counted. 
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Outcomes recorded and analysis plan 
The primary outcome for this chapter was mortality from all-causes within 365 days after 
admission. First, a description of patient characteristics and unadjusted post-admission 
mortality rates is presented in people with and without a comorbid diagnosis of bipolar 
disorder or schizophrenia as defined above. Second, the mortality risk was compared using 
survival analysis to calculate the hazard ratio controlling for age and sex differences between 
the two groups. Survival curves were plotted for people with and without comorbid SMI to 




Characteristics of people admitted with a main diagnosis of cardiovascular disease in 2007 
There were 717,556 admissions for 542,848 people with a main diagnosis of cardiovascular 
disease between 1st January and 31st December 2007 in England. Their demographic profile 
is shown in Table 8-1. 
 
Table 8-1 shows that there were approximately 1.3 HES records per person where the main 
diagnosis was cardiovascular disease over one year, which is similar to than the ratio of 1.3 
HES records per person shown in chapter 6 for SMI over the same period. 
    158 
Table 8-1 - Characteristics of people admitted with a main diagnosis of cardiovascular 
disease (CVD) in 2007 
 All admitted with a main diagnosis of CVD 
(ICD10 codes I00 to I99) 
 
 
















Average length of stay (males/ females) 
 
8.1/ 10 
Number of deaths within 365 days of admission 54,687 
Unadjusted death rates per 1,000 admissions (95% CI) 
100.7 
(99.9 – 101.6) 
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Characteristics of people admitted with a main diagnosis of cardiovascular disease and 
comorbid SMI 
Of people admitted with a main diagnosis of cardiovascular disease, 0.07-0.1% had 
comorbid bipolar disorder according to whether the diagnosis of bipolar disorder was noted 
as a secondary diagnosis on the same hospital record or if the diagnosis of bipolar disorder 
was recorded as the main diagnosis within the past year (see Table 8-2 and Table 8-3). 
Comorbid schizophrenia was present in 0.2 - 0.3% of the cohort, using the same inclusion 
criteria (see Table 8-4 and Table 8-5). Although all people with a main diagnosis of 
schizophrenia have been included in these proportions, the figures of hospital comorbidity 
are slightly less than the annual prevalence of schizophrenia of 0.5% recorded in a US 
sample (Wu, Shi et al. 2006) but similar to prevalence recorded in non-Maori populations in 
New Zealand (Kake, Arnold et al. 2008). 
 
People with comorbid bipolar disorder or schizophrenia were slightly younger than those 
without comorbid SMI, and people with comorbid bipolar disorder were more likely to be 
female. The average length of stay for people with comorbid SMI depended on how the 
comorbid sample was selected. People who had a diagnosis of schizophrenia or bipolar 
disorder as a secondary diagnosis on their hospital record had longer average length of 
stays than people with no comorbid SMI (see Table 8-2 to Table 8-5).  
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Table 8-2 - Characteristics of people admitted with a main diagnosis of CVD in 2007 
and comorbid bipolar disorder defined as secondary diagnosis of BIPOLAR 
DISORDER on the same hospital record 
 Main diagnosis of CVD and 
comorbid bipolar disorder No comorbid bipolar disorder 
 














Average age at discharge 
(males/ females) 
 
62.2/ 65.4 74.6/ 79 
Average length of stay 
(males/ females) 
 
12.2/ 11.6 7.9/ 9.7 
Number of deaths within 
365 days of admission 
 
47 54,640 
Unadjusted death rates 




(47.4 – 84.1) 
100.8 
(100.0 – 101.6) 
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Table 8-3 - Characteristics of people admitted with a main diagnosis of CVD in 2007 
and comorbid bipolar disorder defined by recent discharge with main diagnosis of 
BIPOLAR DISORDER in the past year 
 Main diagnosis of CVD and 
comorbid bipolar disorder No comorbid bipolar disorder 
 














Average age at discharge 
(males/ females) 
 
61.5/ 65.3 74.6/ 79 
Average length of stay 
(males/ females) 
 
6.8/ 8.6 7.9/ 9.7 
Number of deaths within 
365 days of admission 
 
32 54,655 
Unadjusted death rates 




(52.0 – 104.3) 
100.8 
(99.9 – 101.6) 
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Table 8-4 - Characteristics of people admitted with a main diagnosis of CVD in 2007 
and comorbid schizophrenia defined as secondary diagnosis of SCHIZOPHRENIA on 
the same hospital record 
 Main diagnosis of CVD and 
comorbid schizophrenia No comorbid schizophrenia 
 














Average age at discharge 
(males/ females) 
 
59.2/ 70.5 76.6/ 79 
Average length of stay 
(males/ females) 
 
13.4/ 16.1 7.9/ 9.6 
Number of deaths within 
365 days of admission 
 
188 54,499 
Unadjusted death rates 




(101.4 – 135.0) 
100.7 
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Table 8-5 - Characteristics of people admitted with a main diagnosis of CVD in 2007 
and comorbid schizophrenia defined by recent discharge with main diagnosis of 
SCHIZOPHRENIA in the past year 
 Main diagnosis of CVD and 
comorbid schizophrenia No comorbid schizophrenia 
 














Average age at discharge 
(males/ females) 
 
58.3/ 68.7 76.6/ 79 
Average length of stay 
(males/ females) 
 
8.7/ 12.1 7.9/ 9.7 
Number of deaths within 
365 days of admission 
 
104 54,583 
Unadjusted death rates 




(100.8 – 148.2) 
100.7 
(99.9 – 101.6) 
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Characteristics of people admitted with a main diagnosis of diabetes in 2007 
There were 40,249 admissions for 31,332 people with a main diagnosis of diabetes between 
1st January and 31st December 2007 in England. The ratio of 1.3 HES records per person 
where the main diagnosis was diabetes over one year is similar to than the ratio of 1.3 HES 
records per person shown in chapter 6 for SMI over the same time period. The demographic 
profile of the group is shown in Table 8-6. 
 
Table 8-6 - Characteristics of people admitted with a main diagnosis of diabetes (DM) 
in 2007 
 All admitted with a main diagnosis of DM 
(ICD10 codes E10 to E14) 
 
 
















Average length of stay (males/ females) 
 
7.6/ 7.3 
Number of deaths within 365 days of admission 
 1,171 
Unadjusted death rates per 1,000 admissions (95% CI) 
37.4 
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Characteristics of people admitted with a main diagnosis of diabetes mellitus and comorbid 
SMI 
Comorbidity with bipolar disorder and schizophrenia was slightly more common in people 
with a main diagnosis of diabetes mellitus. For example, of people admitted with a main 
diagnosis of diabetes mellitus, 0.2 - 0.3% had comorbid bipolar disorder depending on 
whether the diagnosis of bipolar disorder was noted as a secondary diagnosis on the same 
hospital record or if the diagnosis of bipolar disorder was recorded as the main diagnosis 
within the past year (see Table 8-7 and Table 8-8). Using the same criteria, 0.4 - 0.8% of 
people with diabetes had comorbid schizophrenia, (see Table 8-9 and Table 8-10). 
 
The overall demographic characteristics of people with comorbid bipolar disorder or 
schizophrenia and a main diagnosis of diabetes did not vary substantial from people without 
comorbid SMI (see Table 8-7 to Table 8-10). 
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Table 8-7 - Characteristics of people admitted with a main diagnosis of DM in 2007 and 
comorbid bipolar disorder defined as secondary diagnosis of BIPOLAR DISORDER on 
the same hospital record 
 
Main diagnosis of DM and 
comorbid bipolar disorder No comorbid bipolar disorder 
 














Average age at discharge 
(males/ females) 
 
54.3/ 57.2 52.5/ 52.3 
Average length of stay 
(males/ females) 
 
8.8/ 8.9 7.5/ 7.5 
Number of deaths within 
365 days of admission 
 
3 1,168 
Unadjusted death rates 




(8.8 – 93.8) 
37.4 
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Table 8-8 - Characteristics of people admitted with a main diagnosis of DM in 2007 and 
comorbid bipolar disorder defined by recent discharge with main diagnosis of 
BIPOLAR DISORDER in the past year 
 Main diagnosis of DM and 
comorbid bipolar disorder No comorbid bipolar disorder 
 














Average age at discharge 
(males/ females) 
 
56.5/ 56.6 52.5/ 52.3 
Average length of stay 
(males/ females) 
 
14.6/ 7.3 7.5/ 7.5 
Number of deaths within 
365 days of admission 
 
4 1,167 
Unadjusted death rates 




(21.5 – 163.5) 
37.3 
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Table 8-9 - Characteristics of people admitted with a main diagnosis of DM in 2007 and 
comorbid schizophrenia defined as secondary diagnosis of SCHIZOPHRENIA on the 
same hospital record 
 
Main diagnosis of DM and 
comorbid schizophrenia No comorbid schizophrenia 
 














Average age at discharge 
(males/ females) 
 
47/ 58.5 52.6/ 52.3 
Average length of stay 
(males/ females) 
 
8.9/ 11.6 7.5/ 7.5 
Number of deaths within 
365 days of admission 
 
6 1,165 
Unadjusted death rates 




(10.3 – 52.9) 
37.5 
(35.4 – 39.7) 
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Table 8-10 - Characteristics of people admitted with a main diagnosis of DM in 2007 
and comorbid schizophrenia defined by recent discharge with main diagnosis of 
SCHIZOPHRENIA in the past year 
 
Main diagnosis of DM and 
comorbid schizophrenia No comorbid schizophrenia 
 














Average age at discharge 
(males/ females) 
 
48.5/ 53.6 52.5/ 52.3 
Average length of stay 
(males/ females) 
 
6/ 7.7 7.5/ 7.5 
Number of deaths within 
365 days of admission 
 
7 1,164 
Unadjusted death rates 




(22.8 – 103.3) 
37.3 
(35.2 – 39.5) 
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Unadjusted post-admission mortality rates 
For all people with a main diagnosis of CVD, the mortality rate in the first 365 days after 
admission was 100.7 per 1,000 people admitted (95% CI: 99.9 – 101.6), see 
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Table 8-1. For people with comorbid bipolar disorder the mortality rate was lower than people 
without comorbidity at between 63.7 and 74.8 per 1,000 depending on the method chosen to 
select comorbid cases, see Table 8-2 and Table 8-3. On the other hand, for people with 
comorbid schizophrenia, the mortality rate was higher than people without comorbidity, see 
Table 8-4 and Table 8-5.  
 
For all those with a main diagnosis of diabetes, the mortality rate in the first 365 days after 
admission was 37.4 per 1,000 people admitted (95% CI: 35.3 – 39.6), see Table 8-1. The 
mortality rate for people with the comorbid SMI was highly dependent on the method chosen 
to select comorbid cases, see Table 8-7 to Table 8-10.  
 
Similar to findings shown by Abrams et al (2008), the unadjusted mortality rate for comorbid 
SMI was generally higher when comorbid cases were defined as having been discharged 
within the last year with a diagnosis of bipolar disorder or schizophrenia, than when 
comorbidity was defined as having a secondary diagnosis of bipolar disorder or 
schizophrenia on the same record (Abrams, Vaughan-Sarrazin et al. 2008). 
 
Hazard rates adjusted for age and sex 
From survival analyses summarized in Table 8-11, Table 8-12, and Figure 8-1 to Figure 8-8, 
after taking into account age and sex differences, comorbidity with bipolar disorder or 
schizophrenia was associated with higher mortality in people with a main diagnosis of CVD 
or DM, although only two results were statistically significant at the 5% level, and the findings 
were much less clear for people with a diagnosis of diabetes. For example, for people with a 
diagnosis of CVD and comorbid schizophrenia, the adjusted hazard ratio varied between 1.5 
and 1.1 depending on the criteria used to select comorbid mental illness. In contrast, for 
people with a diagnosis of CVD and comorbid bipolar disorder, the adjusted hazard ratio 
varied between 0.9 and 1.5.  
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For people with a diagnosis of DM and comorbid schizophrenia, the adjusted hazard ratio 
varied between 1.7 and 1.4 depending on the criteria used to select comorbid mental illness. 
For people with a diagnosis of DM and comorbid bipolar disorder, the adjusted hazard ratio 
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Table 8-11 - Hazard ratios comparing the mortality risk in people with a main diagnosis 
of CVD with and without comorbid SMI, adjusted for age and sex 
  
Adjusted hazard ratio 
 
 
Comorbidity defined as a 
secondary diagnosis of SMI 
recorded on the same hospital 
record 
Comorbidity defined by recent 
discharge with a main diagnosis of 





(p = <.0001) 
0.9 






(p = 0.1) 
1.5 
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Table 8-12 - Hazard ratios comparing the mortality risk in people with a main diagnosis 
of DM with and without comorbid SMI, adjusted for age and sex 
  
Adjusted hazard ratio 
 
 Comorbidity defined as a 
secondary diagnosis of SMI 
recorded on the same hospital 
record 
Comorbidity defined by recent 
discharge with a main diagnosis of 





(p = 0.4) 
0.8 






(p = 0.1) 
1.7 
(p = 0.2) 
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Figure 8-1 - Survival curves comparing admitted with a main diagnosis of CVD in 2007 and comorbid BIPOLAR DISORDER defined as 
secondary diagnosis of bipolar disorder on the same hospital record, adjusted for age and sex 
 
____ 
With comorbid bipolar disorder defined as secondary diagnosis of bipolar disorder on the same 
hospital record 
____ No comorbidity 
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Figure 8-2 - Survival curves comparing admitted with a main diagnosis of CVD in 2007 and comorbid BIPOLAR DISORDER defined by 
recent discharge with main diagnosis of bipolar disorder in the past year, adjusted for age and sex 
 
____ 
With comorbid bipolar disorder defined by recent discharge with main diagnosis of bipolar disorder in 
the past year 
____ No comorbidity 
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Figure 8-3 - Survival curves comparing admitted with a main diagnosis of CVD in 2007 and comorbid SCHIZOPHRENIA defined as 
secondary diagnosis of schizophrenia on the same hospital record, adjusted for age and sex 
 
____ 
With comorbid schizophrenia defined as secondary diagnosis of schizophrenia on the same hospital 
record 
____ No comorbidity 
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Figure 8-4 - Survival curves comparing admitted with a main diagnosis of CVD in 2007 and comorbid SCHIZOPHRENIA defined by recent 
discharge with main diagnosis of schizophrenia in the past year, adjusted for age and sex 
 
____ 
With comorbid schizophrenia defined by recent discharge with main diagnosis of schizophrenia in the 
past year 
____ No comorbidity 
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Figure 8-5 - Survival curves comparing admitted with a main diagnosis of DM in 2007 and comorbid BIPOLAR DISORDER defined as 
secondary diagnosis of bipolar disorder on the same hospital record, adjusted for age and sex 
 
____ 
With comorbid bipolar disorder defined as secondary diagnosis of bipolar disorder on the same 
hospital record 
____ No comorbidity 
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Figure 8-6 - Survival curves comparing admitted with a main diagnosis of DM in 2007 and comorbid BIPOLAR DISORDER defined by recent 
discharge with main diagnosis of bipolar disorder in the past year, adjusted for age and sex 
 
____ 
With comorbid bipolar disorder defined by recent discharge with main diagnosis of bipolar disorder in 
the past year 
____ No comorbidity 
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Figure 8-7 - Survival curves comparing admitted with a main diagnosis of DM in 2007 and comorbid SCHIZOPHRENIA defined as 
secondary diagnosis of schizophrenia on the same hospital record, adjusted for age and sex 
 
____ 
With comorbid schizophrenia defined as secondary diagnosis of schizophrenia on the same hospital 
record 
____ No comorbidity 
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Figure 8-8 - Survival curves comparing admitted with a main diagnosis of DM in 2007 and comorbid SCHIZOPHRENIA defined by recent 
discharge with main diagnosis of schizophrenia in the past year, adjusted for age and sex 
 
____ 
With comorbid schizophrenia defined by recent discharge with main diagnosis of schizophrenia in the 
past year 
____ No comorbidity 
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Summary of findings from chapter 8 
 
The findings from this chapter showed that  
1. Comorbidity with bipolar disorder or schizophrenia affects less than 1% of all admissions 
to inpatient care for CVD or diabetes. The exact level of comorbidity depends on the 
definition used.  
2. Comorbidity with bipolar disorder or schizophrenia in people discharged with a primary 
diagnosis of cardiovascular disease or diabetes, has an important influence on mortality, 
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Chapter 9 – Summary and Discussion 
 
Key findings 
In chapter 5 the following research questions were posed  
1. Has the excess in all-cause mortality for people with bipolar disorder and schizophrenia 
increased or decreased over the last decade in England? 
2. Is the mortality excess of the same magnitude for people with bipolar disorder and 
schizophrenia in England? 
3. Is the trend in mortality consistent for people with bipolar disorder and schizophrenia of 
different ages and genders in England? 
4. Is mortality for people with bipolar disorder and schizophrenia geographically consistent 
across England? 
5. Does comorbid illness with bipolar disorder and schizophrenia in people with another 
main diagnosis, namely cardiovascular disease or diabetes, result in excess mortality? 
6. To what extent are causes of excess deaths potentially avoidable in people with bipolar 
disorder and schizophrenia and therefore what would be the impact on the mortality 
excess of equalising those causes in England? 
 
In this thesis the following details about the recent epidemiology of mortality in people with 
bipolar disorder and schizophrenia in England are presented to answer these questions. 
 
The findings from chapter 6 confirm that the risk of death for people recently discharged from 
inpatient psychiatric care in England with a diagnosis of schizophrenia or bipolar disorder 
remains significantly higher than that of the general population. This excess all-cause 
mortality was observed for both discharge diagnoses although age- and sex-adjusted 
analyses indicated a greater magnitude of risk for schizophrenia, as indicated by a higher all-
cause SMR. The results of specific-cause mortality analysis show that there was a greater 
excess of deaths from unnatural causes, such as accidents and suicides than natural 
causes, such as deaths from cardiovascular and respiratory diseases as evidenced by 
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greater specific cause SMRs in these populations. However, natural causes of death are 
much more numerous than unnatural causes, and hence the toll of mortality attributable to 
natural causes is the greater of the two overall. The results also show that age and gender 
are important determinants of the mortality gap, with young men who have a diagnosis of 
schizophrenia most at risk of death in the first year after discharge. Gender differences in the 
mortality gap for bipolar disorder were not evident. The mortality gaps described were not 
consistent across the country, with wide though non-significant geographical variation in the 
mortality gap observed. The underlying reasons for this variation are not explored in this 
thesis, but are likely to be multiple and complex given the many influences on mortality 
explained earlier. 
 
The trend analysis shows that the mortality gap for people with bipolar disorder and 
schizophrenia had increased over the time period covered by the study.  
 
Further investigation of the components of the increase in all-cause mortality excess over the 
study period showed that the trend had not been similar for both sexes, or different age 
groups, or for unnatural/ natural causes of death. Findings summarised in chapter 6 indicated 
that the mortality rate in some groups, especially people discharged with bipolar disorder or 
schizophrenia between the ages of 65 – 84 years is increasing, contrary to the overall 
mortality rate in both the general population and other people with the same condition. The 
results also showed that the increase in mortality was greater for men than for women with 
schizophrenia, resulting in a widening of the gender difference in the mortality gap over the 
course of the last decade. Trends in specific cause mortality suggested that the majority of 
the increase in the mortality gap was accounted for by deaths from natural causes, especially 
cardiovascular and respiratory diseases. The mortality gap due to unnatural causes such as 
suicide and accidental deaths on the other hand had remained reasonably stable over the 
years analysed.  
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Findings summarised in chapter 7 indicate that ‘avoidable’ causes of death are an important 
cause of death in people with bipolar disorder and schizophrenia and also a substantial 
contributor to the mortality gap seen in these populations.  In cases under the age of 75 
years, almost two thirds of all deaths within the first 365 days after discharge from inpatient 
care were found to be possibly avoidable. However calculation of hypothetical SMRs 
indicated that avoidable causes of death were not wholly responsible for the mortality gap in 
these populations, although interventions to reduce deaths from avoidable causes could 
reduce the mortality gap between these case groups and the general population appreciably, 
especially in people aged 45 years or below. In people with schizophrenia, reducing 
avoidable causes of death may also slightly narrow the gender difference in mortality.  As 
mentioned, the hypothetical SMRs also indicate that reducing excess deaths classified as 
avoidable did not eliminate the mortality gap between these case groups and the general 
population. Even after discounting excess deaths from all causes classified as avoidable, 
people with schizophrenia under the age of 75 were still twice as likely to die as the general 
population in the first year after their discharge from hospital. This residual mortality was 
accounted for by unavoidable deaths across a broad range of disease groups. 
 
Lastly, findings summarised in chapter 8 indicated that comorbidity with bipolar disorder or 
schizophrenia in people discharged with a primary diagnosis of cardiovascular disease or 
diabetes, had an important influence on mortality, although after adjustment for age and sex 
differences the results were not statistically conclusive. Comorbid illness with bipolar disorder 
and schizophrenia is an important consideration in characterising the epidemiology of 
mortality for cardiovascular disease or diabetes. However, more work needs to be done to 
accurately define comorbidity and identify people with comorbid disorders, as well as 
assessing the mortality amongst people who are admitted with a wider range of physical 
conditions and comorbid SMI to assess the totality of mortality risk from these severe mental 
disorders as comorbidity. 
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Methodological considerations, and strengths and weakness of this thesis (including 
the role of chance, bias, and confounding, and issues of causality) 
The results in this thesis currently provide the most comprehensive and up to date estimates 
of the mortality gap for people with bipolar disorder and schizophrenia in England over the 
last decade. However the findings must be considered in the light of a number of 
methodological limitations of observational research designs, namely the role of chance or 
random error, the effects of bias or systematic error, as well as the role of confounding 
(Mann 2003; Zaccai 2004; Rothman, Greenland et al. 2008; Healy and Devane 2011).  
 
Random error comes into play when the results of a study are governed by the laws of 
probability or chance, such as when the measure of effect in a study estimates the true 
population effect from a sample (Last 2006). As explained in chapter 4 the dataset used for 
this study contains a complete enumeration of all patients admitted to NHS care in England 
and, through linkage to national mortality data, a total national measure of mortality risk has 
been calculated in these vulnerable groups without the need to extrapolate from sample 
estimates. Thus the observed results are not derived from a sampling process and a role of 
chance is not applicable to these national data. These characteristics of the studies in this 
thesis aid the precision of the mortality estimates and generalisability of the findings 
compared with previous studies in the UK which have been limited to case registers within 
individual mental health trusts (Brown, Kim et al. 2010; Chang, Hayes et al. 2010) or within 
general practice registers (Osborn, Levy et al. 2007). However one should bear in mind that 
the measures calculated in this thesis relate to the mortality gap in the first year following 
hospital discharge over this time period only, and are not necessarily the same as the 
mortality risk experienced by people with bipolar disorder or schizophrenia outside these 
narrow parameters, notably people who have not recently been admitted for hospital care, 
and people who have been discharged for greater than one year.  
 
Bias, namely the effect of systematic errors on the results from this study are possible for a 
number of reasons (Tversky and Kahneman 1974; Aschengrau and Seage 2003). First, as 
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explained earlier the selection of cases only who have been admitted for inpatient care and 
recently discharged in the last year is likely to have resulted in the systematic inclusion of a 
cohort of people with the most severe mental disorder given the fact that an increasing 
proportion of treatment for people with mild and moderate mental disorder now takes place 
outside the hospital setting (Bijl, de Graaf et al. 2003; Thompson, Shaw et al. 2004; Kessler, 
Demler et al. 2005).  
 
In chapter 5, I mentioned how the extent to which the study populations in this thesis 
represents all people with bipolar disorder and schizophrenia could be gauged by comparing 
with information from other datasets such as the MHMDS and the QOF SMI register. Thus it 
is advisable that the conclusions from this thesis are limited to those who have been recently 
discharged with SMI and not to other population groups with SMI. However the degree to 
which selection bias has affected the results may also be quantified by comparing the results 
from this thesis with other studies that have selected cases from a community sample. For 
example, Joukamaa and colleagues found an SMR for CVD in a community sample of 
people from Finland in 2001 with a diagnosis of schizophrenia of between 1.6 and 2.9 for 
women and men respectively. Whilst David Lawrence and colleagues found an SMR for CVD 
of between 0.9 and 1.7 for women and men respectively from a community sample of people 
from Australia in 2003. This compares with an SMR for CVD of 2.5 found in this thesis in 
people recently discharged with schizophrenia in England in 2006 (Joukamaa, Heliovaara et 
al. 2001; Lawrence, Holman et al. 2003; Osborn, Levy et al. 2007). Amaddeo and colleagues 
directly compared mortality from a cohort of people with SMI who had attended outpatients 
only (SMR=1.3) and inpatients (SMR=2.2) as well over the course of their study in 1980-90s 
and found a substantial difference in the SMRs (Amaddeo, Bisoffi et al. 1995). 
 
Second, reliance on routinely collected records has a number of advantages and 
disadvantages for epidemiological research which are well known (Glover 2003; Mann 2003; 
Rothman, Greenland et al. 2008; Perera, Soremekun et al. 2009), and listed in Table 9-1. An 
important limitation of routinely collected hospital records that could be a source of bias is the 
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completeness and accuracy of diagnostic codes used to identify people with a main or 
comorbid diagnosis of bipolar disorder or schizophrenia. The extent of measurement bias 
due to the miscoding of the diagnosis could be assessed by comparing accuracy of hospital 
records with the recording of cases using gold standard diagnostic tools, although the extent 
of bias due to the incompleteness of data is harder to quantify. A recent systematic review of 
hospital diagnostic coding accuracy by Burns and colleagues in England suggested that the 
main diagnosis is over 80% accurate for a range of conditions compared with gold-standard 
diagnosis, although the accuracy of bipolar disorder and schizophrenia diagnoses were not 
specifically tested (Burns, Rigby et al. 2011). According to a recent report by the Audit 
Commission in the UK, the secondary diagnosis is approximately 70% accurate across a 
range of conditions (Spencer 2011). However any measurement error due to the poor 
ascertainment of cases or miscoding of hospital records is likely to result in non-differential 
information bias, unrelated to the outcome as the data was collected before death. This is 
likely to result in no change in the mortality risk compared with the general population, or an 
under-estimate of the true result due to cases of bipolar disorder or schizophrenia being 
missed from the study. 
 
With regards to the study of trends in psychiatric epidemiology, routinely collected data also 
has the disadvantage that it may be influenced by trends and fashions in the recording of 
certain symptoms and diagnosis (Paris 2004; Baca-Garcia, Perez-Rodriguez et al. 2007), as 
well as changes to diagnostic classification criteria. During this study the clinical coding of 
national hospital records was consistent using ICD10, however the coding of deaths changed 
from ICD9 to ICD10 between 1999-2000. Changes in diagnostic fashions are harder to 
identify. These changes may limit the comparisons of different cohorts over time, however 
the nature of these measurement biases are difficult to predict, although they may be 
estimated by using different range of codes to select cohorts of people with bipolar disorder 
and schizophrenia, and specific causes of death. 
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The measurement of outcomes in this thesis may also be influenced by bias. All-cause 
mortality is likely to be complete and accurate given the statutory requirement to record all 
deaths in the UK. However specific cause mortality including the enumeration of avoidable 
causes of death are likely to be influenced by the recording practices of clinicians (Nielsen, 
Bjornsson et al. 1991; Maudsley and Williams 1993). For example previous evidence has 
shown that psychiatric conditions are rarely mentioned as the primary cause of death and 
more often mentioned elsewhere on the death certificate if at all (Goldacre, Duncan et al. 
2006). In fact it is estimated that only 5% of deaths in people with a diagnosis of 
schizophrenia are recorded as having such on their death certificate in the UK (Brown, Kim 
et al. 2010). However, the analyses in, and conclusions in, this thesis do not depend on the 
accurate identification of the mental illnesses on death certificates. A specific issue in the 
study of mortality in people with mental illness is the possibility that death in a person with a 
previous diagnosis of mental illness or recent contact with mental health services may be 
scrutinised more thoroughly than other deaths (Robinson, Meehan et al. 2002; Swinson, 
Ashim et al. 2007). This may include the need for a coroner’s investigations and may result in 
a delay in the recording of deaths and differential recording of some mortality outcomes in 
these groups, such as suicide resulting in higher specific-cause mortality for these groups 
compared with the general population. 
 
The quality and completeness of routinely collected records, may also affect the precision of 
data linkage, causing differential bias in trend studies. As mentioned in chapter 5, whilst 
changes in the recording of diagnosis, and variables used for data linkage may not affect 
studies done over a short period of time, studies done over longer periods of time may be 
affected by changes in the recording of diagnosis and the quality of data linkage in routinely 
collected linked databases. Data from the NHS Information Centre and HESOnline, showing 
an improvement in the recording of valid NHS numbers on HES records over the last decade 
from 83.2% in 2000-01 to 96.8% in 2008-09 (2009) suggests that it may have been easier to 
identify records belonging to the same person later in the file than earlier on. Thus the quality 
of data linkage over the course of the 13 year file may have increased as suggested by the 
    191 
ratio of HES records to people in the 13 year file of approximately 3.6 HES records per 
person compared with an earlier 5 year file which had a ratio of approximately 2.3 HES and 
death records per person (Gill 2004). This may result in more linked death records being 
identified towards the end of the datafile than at the start, and may cause an inflation of all 
post-discharge mortality rates. Equally, if more records were assigned to each person, 
namely more readmissions were identified then the counting methods used in this thesis, 
namely counting only the first admission in a study period and ceasing follow-up when there 
is a readmission for any diagnosis or death, (described more fully in chapter 6) would be 
expected to decrease the number of deaths included and deflate all post-discharge mortality 
rates. The degree and direction of bias in mortality trends caused by these two competing 
factors is difficult to predict. 
 
A third potential source of bias is from the use of definitions of natural/ unnatural mortality, 
and avoidable/ unavoidable deaths to group together specific causes of death. I have 
discussed the pros and cons of using definitions of avoidable mortality in populations with 
SMI in chapter 7. Essentially enumeration of specific causes of death is dependent on the 
accurate recording of specific causes of deaths which is known to be imprecisely recorded 
(Smith Sehdev and Hutchins 2001; Flaxman, Vahdatpour et al. 2011). This is likely to cause 
a non-differential bias, however, if a definition of specific cause mortality includes only those 
deaths that are better recorded in people with SMI, then specific cause mortality would be 
systematically over-estimated in this group. This may occur for example with the recording of 
unnatural deaths in people with SMI, especially if the clinician completing the death 
certificate is not blinded to the diagnosis of the patient. This would cause a differential bias 
and a falsely higher mortality rate in those with SMI. 
 
Bias as a result of the use of categories to classify specific causes of death cannot be 
absolutely excluded, however it is difficult to predict in which direction the biases will operate 
on the morality risk estimates. 
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Lastly, the use of persons rather than person-time as the denominator in my analysis to 
calculate mortality rates and SMRs may have resulted in measurement bias as individuals in 
the study group would have been at risk for different lengths of time, i.e. the study population 
was dynamic. The calculation of mortality rates use in this study involves counting the total 
number of individuals in the population at the start of the study. This is then used as the 
denominator for calculation of mortality rates. Person-years analysis involves calculating the 
exact time each individual spends in the study before developing the outcome of interest and 
using person-time as the denominator (Rothman, Greenland et al. 2008). For the calculation 
of SMRs, the use of person rather than person-years as the denominator in the calculation of 
mortality rates assumes that on balance each individual in the study population spends the 
same amount of time in the study. This is more likely to cause bias when the study 
population is not in a steady state, namely the number of people entering the population is 
not balanced by the number exiting the population in any period of time within levels of age, 
sex and other determinants of risk (Rothman, Greenland et al. 2008). In the calculation of 
SMRs the use of person denominator may cause bias when the period of risk for the study 
population is systematically different from the period of risk in the comparison population 
used to calculate the SMRs. For example if people with SMI had spent less time in the study 
group before they died as opposed to the time recorded in the general population, then the 
use of person as opposed to person-years as the denominator may have adversely inflated 
the mortality rate in the study population with SMI, thus artificially inflating the SMRs.  
 
Residual confounding, or the distortion of the estimated effect of an exposure on an outcome 
caused by the presence of an extraneous factor associated with both the exposure and the 
outcome (Last 2006) is possible given the complex relationship between severe mental 
illness and mortality shown in Figure 1-1, and. the limitation of routine health records used in 
this thesis. Important confounders, and explanatory variables to be considered in the 
analysis, including drug and alcohol use, socio-economic status, smoking status, dietary 
consumption, and physical exercise as well as the severity of the physical illness are not 
recorded. 
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Delay between collection and publication, 
especially for mental health research where there 
is often a lengthy delay with deaths needing to be 
referred to the coroner 
 
Often standard variables are available across the 
country 
Equivalent data not always available for all 
countries 
 
Low cost to obtain and use for research purposes Data may not be collected in a uniform way 
across the entire population, thus causing 
measurement bias 
 
Linkage to other datasets can enlarge the number 
of variables within the research dataset, 
compared to the administrative dataset, and allow 
many more research questions to be addressed 
including physical health in those with mental 
illness, which may not be answered with 
information from psychiatric registers used on 
their own 
 
Data is not primarily collected for research 
purpose thus data quality, including reliability of 
diagnoses, and missing data may result in 
potential selection and measurement biases. 
Information on important co-variates is often 
missing or of variable quality 
 
Modern encryption methods have improved data 
security 
Where there are small numbers of cases, it may 
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 Reconsideration of the key findings in relation to the background literature 
 
1. What do the findings tell us about the recent epidemiology of mortality in people 
discharged from inpatient care with bipolar disorder and schizophrenia? 
 
People with bipolar disorder and schizophrenia are known to be at high risk of death. Similar 
to the findings in this thesis, previous studies have shown that people with schizophrenia 
have a slightly higher risk of death, and that age (Laursen, Munk-Olsen et al. 2007; 
Chwastiak and Tek 2009; Tiihonen, Lonnqvist et al. 2009; Lawrence, Kisely et al. 2010) , sex 
(Hoye, Jacobsen et al. 2011), and geographical location (Kiviniemi, Suvisaari et al. 2010) are 
important determinants of mortality. However this is the first time that data for the whole of 
England has been used to quantify the mortality gap from all causes in all people discharged 
from inpatient care with a diagnosis of bipolar disorder and schizophrenia (see 
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Table 2-1). This is also the first time that mortality risk has been explored by geographical 
location in England. Taking into account the methodological considerations mentioned 
above, the large size of the studies included in this thesis aids the generalisability of the 
findings. 
 
Specific causes of death in people with a diagnosis of SMI have been described before, 
especially the higher risk of death from unnatural causes including accidents and suicide 
(Goldacre, Seagroatt et al. 1993; Harris and Barraclough 1997; Hall, O'Brien et al. 1998; 
Hiroeh, Appleby et al. 2001; 2002; 2002; Gau and Cheng 2004; Dutta, Boydell et al. 2007; 
Simon, Hunkeler et al. 2007), as well as some natural causes such as cardiovascular and 
respiratory disease (Goldacre, Seagroatt et al. 1993; Harris and Barraclough 1997; Hall, 
O'Brien et al. 1998; 1999; Hiroeh, Appleby et al. 2001; Osby, Brandt et al. 2001; 2002; 2002; 
Gau and Cheng 2004; Goff, Cather et al. 2005; Tsai, Lee et al. 2005; 2008; Hiroeh, Kapur et 
al. 2008; Roshanaei-Moghaddam and Katon 2009; Chang, Hayes et al. 2011). These 
findings are also replicated in this thesis, showing that age and sex are important 
determinants of death from specific causes as well as all causes. 
 
The findings that a majority of the mortality gap is a result of avoidable causes of death 
amongst people with bipolar disorder and schizophrenia is similar to recent findings by 
Amaddeo in Italy (Amaddeo, Barbui et al. 2007) and Rasanen in Finland (Rasanen, Hakko et 
al. 2005), however they are the first in England using data collected in the past decade. 
Brown and colleagues had previously reported an SMR for avoidable causes of 4.7 in people 
with a diagnosis of schizophrenia followed up between 1981-95. In this thesis, a similar SMR 
of 5.4 was found for people under the age of 75 discharged with a diagnosis of schizophrenia 
in 2006-07. This finding suggests that there may have been an increase in avoidable causes 
of death in the past decade, although the findings are difficult to compare directly as the 
definitions of avoidable deaths and the age groups used in the two studies are slightly 
different. 
 
    197 
2. What do the findings tell us about the recent trends in mortality amongst people 
discharged from inpatient care with bipolar disorder and schizophrenia over the last decade? 
 
Mortality trend analysis confirmed that the mortality gap for people recently discharged with a 
main diagnosis of bipolar disorder and schizophrenia compared with the general population, 
has not narrowed in the past decade in England.  
 
However trends in mortality are inherently difficult to study especially using routinely 
collected data because in addition to the methodological issues associated with studying SMI 
mentioned above, there are also difficulties associated with consistently collecting repeated 
diagnostic and outcomes measures, as well as important covariates and confounders over 
long periods of time (Miller 2011). For example as mentioned above the consistent collection 
of NHS number is important in determining the quality and consistency of data linkage and 
minimising bias. 
 
In addition one needs to be careful about the interpretation of trends as they can be 
confounded by unmeasured variables such as changes in admission threshold for inpatient 
care over the study period. For example if mortality is related to the severity of mental illness 
the findings of increasing SMRs over time in this thesis may be confounded by a change in 
admission thresholds that results in more severely disturbed people being admitted over 
time. This would increase the mortality gap measured in the inpatient population, compared 
with the mortality gap measured in the total population with SMI as a whole. To some extent 
this could have been addressed by taking account of differences in disease severity in SMR 
analysis and taking account of changes in admission thresholds in trend analyses 
(Thompson, Shaw et al. 2004). However stratified analysis by disease severity was not 
possible as information on severity is not collected within the dataset used in this thesis and 
other studies have suggested that there is not a direct relationship between the severity of 
mental illness as measured by symptomatology and risk of death (Hayes, Chang et al. 2012).  
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Residual confounding from severity of illness cannot be excluded entirely and the finding of 
reductions in discharges over the period covered by this thesis suggests that there may have 
been some concentration of mortality risk in these hospitalised cohorts which could account 
for the widening mortality gap. Any subsequent research should aim to control for disease 
severity and take account of changing patterns of admission over time, for example by 
including data from the MHMDS which includes information on inpatient, outpatient and 
community treatment services. 
 
Bearing in mind the methodological considerations and need for caution in interpreting these 
results, then the observed upward trend in mortality is similar to trends in a number of other 
countries (Saha, Chant et al. 2007) although again caution must be taken in comparing these 
studies directly as they are similarly subject to biases, residual confounding, and other 
problems of measuring mortality trends.  However, Saha and colleagues undertook a 
systematic review and meta-analysis of 37 mortality studies in people with schizophrenia 
from 25 countries, including the UK between 1980 and 2006, and found that the all-cause 
SMR was 2.6 during this period (Saha, Chant et al. 2007), which is similar to findings in this 
thesis of an SMR of 2.2 for people discharged with schizophrenia in 2006. This is compared 
with two meta-analysis conducted by Brown and colleagues using 18 studies from 8 
countries, between 1969 and 1996 and by Harris and Barraclough examining data from 20 
studies conducted between 1973 and 1995 which both showed an all-cause SMR of 1.5 
(Brown 1997; Harris and Barraclough 1998), suggesting that there has been a widening of 
the mortality gap over the last decades. In contrast to Saha, the findings from this thesis 
showed that in England the mortality gap has widened over the past decade in specific age 
groups, especially people over the age of 65 years and for specific conditions such as deaths 
from cardiovascular and respiratory disease rather than across the board for people with 
bipolar disorder and schizophrenia. 
 
A more recent large cohort study of 66,881 people with schizophrenia from Finland between 
1996 and 2006 by Jari Tiihonen and colleagues however suggests that there has been no 
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widening of the mortality gap over time in Finland, although this study was based on a 
community sample, rather than an admitted sample of people (Tiihonen, Lonnqvist et al. 
2009). 
 
The finding of a widening mortality gap in a number of countries worldwide suggests that 
there may be common factors underlying the trends in mortality that are not restricted to one 
country.  
 
One potential explanation for the findings is the increasing use of second-generation anti-
psychotic medications, which has been seen over the past decade in many countries 
(Santamaria, Perez et al. 2002; Aparasu, Bhatara et al. 2005; Caceres, Penas-Lledo et al. 
2008; Ilyas and Moncrieff 2012) and particularly prescribing of these medications to the 
elderly in the UK (Fossey, Ballard et al. 2006; Banerjee 2009). Evidence of adverse effects of 
these medications has been suggested (Cheng-Shannon, McGough et al. 2004; Lee, Gill et 
al. 2004; Najjar, Welch et al. 2004; Aparasu and Bhatara 2005; Rapoport, Mamdani et al. 
2005; Citrome 2007; Chahine, Acar et al. 2010; Leon, Gerretsen et al. 2010) especially 
amongst the elderly who may be more susceptible to risk effects from these drugs (Citrome 
2007; Leon, Gerretsen et al. 2010) which may explain some of the mortality trends seen. 
However the adverse effects of second-generation anti-psychotic medications has been 
contested (Jones, Barnes et al. 2006; Lewis, Davies et al. 2006) and the hypothesis relating 
to their effects on mortality trends must be answered in future research using information on 
prescribing trends for populations with SMI. This information is available from community 
datasets such as the GPRD or from some psychiatric case registers such as that held by the 
South London and Maudsley NHS Trust. 
 
Another possible explanation is a change in the management practices for people with SMI 
with the use of less aggressive drug treatments, more emphasis on psychosocial 
management, and the use of medication free periods to minimise the occurrence of adverse 
effects from anti-psychotics, and increase compliance with treatment (Calton and Spandler 
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2009). In recent years, early intervention services have attempted to identify people with a 
first episode of psychosis as early as possible, reducing the duration of untreated psychosis 
and changing the timing of delivery of interventions (Tiffin and Glover 2007; Francey, Nelson 
et al. 2010). However some have questioned whether short periods, medication free, in early 
the stages of an episode of schizophrenia can result in demonstrable long-term on morbidity 
and mortality (Carpenter 1997). Again this hypothesis cannot be directly tested in this thesis 
and further work should be done to test this using other data sources. 
 
As discussed earlier, trends in deinstitutionalisation of psychiatric care and changing hospital 
admission patterns during the study period could also influence the type of people admitted 
for inpatient care, resulting in the mortality trends seen.   
 
Lastly the mortality trends may be a result of a more general changes in health service policy 
and delivery over the last decade, including a move to the provision of healthcare services in 
the community and primary care could also explain the findings, especially in the context of 
socially isolated, disabled service users who may have difficulty accessing healthcare 
services (Foundation 2010; Meltzer, Bebbington et al. 2013). For example Patterson and 
others have demonstrated that self-reported loneliness is a risk factor for all-cause mortality, 
mortality from ischemic disease and mortality from other cardiovascular diseases, 
independent of other risk factors (Patterson and Veenstra 2010; Luo, Hawkley et al. 2012). 
 
The mortality trend has not been of consistent magnitude for all countries (Saha, Chant et al. 
2007) which would suggest that local factors are also important in determining the trend in 
mortality. For example geographical differences in anti-psychotic prescribing have been 
described (Masand, Arora et al. 2001; Owen, Feng et al. 2001; Hayhurst, Brown et al. 2003). 
Other local factors include geographical differences in healthcare provision (Philo 1997; 
Bindman, Glover et al. 2000; Philo 2005; Edlund, Belin et al. 2006), differential access to 
physical and mental healthcare (Lawrence and Kisely 2010), differences in treatment 
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practices including follow-up care, and differences in the prevalence of comorbid alcohol/ 
substance abuse (Luty 2002; Edlund, Belin et al. 2006). 
 
Bradford-Hill’s criteria for causation (Hill 1965) can be used to assess the possible causative 
factors shown in Figure 1-1 involved in the mortality trends. These criteria provide a logical 
structure for investigating and defining causality in epidemiological studies (Ward 2009), and 
Swaen had offered a method to quantify the weight of evidence for a causal association 
(Swaen and van Amelsvoort 2009), see Table 9-2.  
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Table 9-2 - Bradford Hill criteria 
 
Strength of association – i.e. the stronger the statistical association, the greater likelihood of 
causal effect 
 
Consistency – i.e. when results are replicated in studies in different settings using different 
methods 
 
Specificity – i.e. when a single putative cause produces a specific effect 
 
Temporal relationship – i.e. where exposure always precedes the outcome. 
 
Biological gradient – i.e. where an increasing amount of exposure increases the risk. 
 
Plausibility – i.e. where the association agrees with currently accepted understanding of 
pathological processes 
 
Coherence – i.e. the association is compatible with existing theory and knowledge 
 
Experiment – i.e. the condition can be altered (prevented or ameliorated) by an appropriate 
experimental regimen 
 
Analogy – i.e. the extent to which other possible explanations have been taken into account 
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3. What do the findings tell us about the impact of comorbidity with SMI on mortality? 
 
The finding that comorbidity with SMI in people admitted primarily with cardiovascular 
disease or diabetes results in increased mortality has been shown previously by other 
researchers including Lesperance and others who found increased mortality in people with 
CVD and depression (Lesperance, Frasure-Smith et al. 2000; Blumenthal, Lett et al. 2003), 
although this is the first time it has been shown for people with comorbid bipolar disorder and 
schizophrenia in England over the last decade. However the findings are at odds with the 
lower mortality found by Abrams and colleagues amongst people with CVD and comorbid 
SMI more generally (Abrams, Vaughan-Sarrazin et al. 2008; Abrams, Vaughan-Sarrazin et 
al. 2009; Abrams, Vaughan-Sarrazin et al. 2010). These differences may be explained by the 
different techniques used to select comorbid psychiatric disorder, which has a considerable 
impact on the estimate of mortality risk as shown in this thesis and previously by Abram and 
colleagues (Abrams, Vaughan-Sarrazin et al. 2008). It may also be explained by the residual 
differences in socio-economic status, smoking, dietary consumption, and physical exercise 
as well as the severity of the physical illness between those with and without SMI that were 
not accounted for in the analysis and may have affected the risk of death. 
 
Further research on mortality in people with co-,morbid bipolar disorder or schizophrenia, 
especially controlling for the factors mentioned above, may reveal whether comorbidity is an 
important contributor to mortality from these conditions. It may also reveal whether the same 
pathophysiological mechanisms involved in causing mortality in people with a main diagnosis 
of bipolar disorder or schizophrenia would be involved in mortality in people with comorbid 
bipolar disorder or schizophrenia, as little research has been conducted on this subject thus 
far. 
 
4. What do the findings tell us about the possible impact of interventions to reduce mortality, 
especially those deaths that are considered avoidable? 
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 The use of hypothetical SMRs allow us to quantify the scope for public health and health 
services interventions to reduce the mortality gap between people with SMI and the general 
population. As mentioned above, a similar technique has been used in the field of 
demography to quantify the maximum extent of longevity of human life using estimates of the 
extent of ‘exogenous’, i.e. deaths as a result of external or modifiable causes, and 
‘endogenous’, i.e. deaths as a result of internal or non-modifiable causes (Olshansky 1992). 
However this is the first time that this technique has been used to estimate the contribution of 
‘avoidable’ deaths, namely those that are ‘amenable’ to high quality medical services and 
those that are ‘preventable’ through public health interventions (Wheller, Baker et al. 2007). It 
is also the first time these estimates have been undertaken in populations at high risk of 
death in England, namely people with SMI. The findings suggest that current medical and 
public health technologies could have a large effect on reducing the mortality gap, 
decreasing this gap by almost two-thirds, which is an important message for health care 
policy makers. However the findings also suggest that the effect of unavoidable deaths 
across a broad range of disease groups still requires further research.   
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Implications 
 
Areas for further research 
 
The results in thesis reinforce the need for further research in this area in the UK, as the 
mortality gap has not decreased and is increasing in some groups such as those over the 
age of 65. Further research is needed to investigate the contribution of possible important 
explanatory variables such as anti-psychotic medications, drug and alcohol use, smoking, 
dietary consumption, physical exercise and access to healthcare services on the mortality 
trend over the past decade. Future studies should also aim to collect information on 
important confounders such as social and economic deprivation, and illness severity, to allow 
their effects to be quantified and appropriately controlled. Detailed sub-studies need to be 
undertaken on those groups with particularly high risk of death, including older people (>65 
years old) with SMI who appear to have experienced the most substantial increases in 
excess mortality over the studied period, as well as people with respiratory and 
cardiovascular disease whose deaths appear to form the majority of the excess. 
 
There is also a need to investigate the burden the death from unavoidable causes, in order to 
better characterise these deaths and offer remedial solutions. This work may need to go 
hand-in-hand with refining current definitions for avoidable mortality for populations with SMI, 
as the definitions used in this thesis are applicable to the general population which has a 
different mortality experience from these sub-groups. An example is the use of ICD10 codes 
U00 to U99 (codes for special purposes) which are recorded widely on the death certificates 
of patients with a previous admission for SMI but which are not considered ‘avoidable’. 
Codes U00 to U99 are new to ICD10 4th edition, which is reserved for the provisional 
assignment of new diseases of uncertain aetiology (WHO website). 
 
Last, there is a need to further study the effects of comorbidity with bipolar disorder and 
schizophrenia in people with other physical and mental illnesses, as the preliminary analysis 
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in this thesis and other research has shown that it may be an important contributor to 
mortality. However as mentioned earlier, a number of important unresolved questions 
remain, including how to define comorbidity SMI validly and reliably using routinely collected 
records, whether the pathophysiological mechanisms underlying mortality in people with 
comorbid SMI are the same as people with SMI as a main diagnosis, and whether the recent 
epidemiology of comorbid SMI mirrors the epidemiology of SMI as a main diagnosis in 
England. 
 
Clinical and policy implications 
 
These results have particular clinical and policy relevance in the context of the 
implementation of the new national mental health strategy in England which states that ‘more 
people with mental health problems will have good physical health’ as one of its objectives, 
specifically stating the objective that ‘fewer people with mental health problems will die 
prematurely’ (2010).  
 
The results from this thesis strongly point to the need for continued action to target risk 
factors particularly to lower the risk for these people in the first year following discharge from 
hospital (Goldacre, Seagroatt et al. 1993) for both natural and unnatural causes of death, 
including known risk factors for circulatory and respiratory disease the main causes of natural 
deaths seen in this thesis which have been increasing in populations with bipolar disorder 
and schizophrenia over the last decade. 
 
The findings indicate that current medical and public health technologies to tackle avoidable 
causes of mortality could have a large effect in reducing the mortality gap, at least in the first 
year after discharge, and have an impact on the gender inequalities in mortality. Thus a 
logical policy approach would be ensure that people with bipolar disorder and schizophrenia 
have the access to the best possible medical and public health interventions (2009). This 
would include promoting good access to general medical, including primary care for people 
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with SMI and concurrent physical health problems to allow early detection, treatment and 
good follow-up care.  
 
Secondly, it would involve providing better access to public health and healthy living services 
for people with SMI, helping them to make healthy lifestyle choices, including encouraging 
people with SMI to stop smoking, reduce their alcohol intake, eat healthily and increase the 
amount of physical exercise they undertake to reduce the risk factors for premature deaths. 
 
Challenge for primary care 
 
Given that the majority of psychiatric and general medical management of people with SMI is 
undertaken outside of the hospital setting, a reduction of the mortality gap would require a 
substantial amount of input from General Practitioners (GPs), Community Psychiatric Nurses 
(CPNs), district nurses, practice nurses and other community nurses. This recommendation 
must also be viewed in the context of the forthcoming reorganisation of the National Health 
Service in England, including the lead role taken by GP commissioning, and the focus on an 
outcomes-driven National Health Service (2010).  
 
As mentioned earlier good clinical management of bipolar disorder and schizophrenia 
revolves around early diagnosis, the prompt treatment of acute psychiatric episodes, re-
integration into the community, and the prevention of further acute psychiatric events and 
complications including physical ill-health (Katona and Robertson 2000; Belmaker 2004; 
Picchioni and Murray 2007; Gelder, Andreasen et al. 2009; Van Os and Kapur 2009).  
 
Effective primary care services are essential for these functions and for tackling the 
underlying reasons for physical illness and mortality in these populations, such as high levels 
of smoking, substance abuse, unhealthy diets and physical inactivity.  
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Well trained and observant primary care practitioners could help spot and minimise the 
impact from the metabolic side effects of anti-psychotic medications (De Hert, Schreurs et al. 
2009).  
 
Well engaged social workers, CPNs and community advocates including elected officials 
could help address the issue of stigma and discrimination for people with severe mental 
illness and tackle difficulties with accessing appropriate medical and psychiatric treatments, 
including preventative health measures (Lawrence and Kisely 2010). 
 
Challenge for secondary care 
 
In a recent editorial Brian Millar suggested that inpatient psychiatric hospital admission can 
provide a critical window to identify patients at risk of physical illness and ensure that they 
are offered appropriate physical health care during admission and follow-up after discharge 
(Miller 2011). This requires better education of psychiatrists on risk factors for physical 
illness, better integration and communication between mental and physical healthcare 
services; and primary and secondary care (2009). This includes ensuring optimal 
management of anti-psychotic medications for people with SMI (2009). 
 
Challenge for public health 
 
Apart from the need to engage people with SMI in current public health and health promotion 
interventions, including programmes aimed at reducing deliberate self-harm and suicide 
(1999; 2002; 2002), smoking (2008; 2008; 2009; Banham and Gilbody 2010; Tsoi, Porwal et 
al. 2010; 2011), alcoholism, and drug misuse (2007; 2007), and other lifestyles associated 
with increased mortality (2004; 2011), there is the need for specific research into physical 
illness in those with SMI, especially methods for early detection of life-threatening illness, 
and health promotion interventions that work in the most vulnerable, high-risk populations. 
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Abstract
Objective To investigate whether the mortality gap has reduced in recent
years between people with schizophrenia or bipolar disorder and the
general population.
Design Record linkage study.
Setting English hospital episode statistics and death registration data
for patients discharged 1999-2006.
Participants People discharged from inpatient care with a diagnosis of
schizophrenia or bipolar disorder, followed for a year after discharge.
Main outcome measures Age standardised mortality ratios at each
time, comparing the mortality in people with schizophrenia or bipolar
disorder with mortality in the general population. Poisson test of trend
was used to investigate trend in ratios over time.
Results By 2006 standardised mortality ratios in the psychiatric cohorts
were about double the population average. The mortality gap widened
over time. For people discharged with schizophrenia, the ratio was 1.6
(95% confidence interval 1.5 to 1.8) in 1999 and 2.2 (2.0 to 2.4) in 2006
(P<0.001 for trend). For bipolar disorder, the ratios were 1.3 (1.1 to 1.6)
in 1999 and 1.9 (1.6 to 2.2) in 2006 (P=0.06 for trend). Ratios were
higher for unnatural than for natural causes. About three quarters of all
deaths, however, were certified as natural, and increases in ratios for
natural causes, especially circulatory disease and respiratory diseases,
were the main components of the increase in all cause mortality.
Conclusions The total burden of premature deaths from natural causes
in people with schizophrenia or bipolar disorder is substantial. There is
a need for better understanding of the reasons for the persistent and
increasing gap in mortality between discharged psychiatric patients and
the general population, and for continued action to target risk factors for
both natural and unnatural causes of death in people with serious mental
illness.
Introduction
Schizophrenia has been described as a life shortening condition,1
and many studies have shown that people with schizophrenia
or bipolar disorder have higher mortality rates than the general
population, both as a result of natural2-10 and unnatural causes,2-6
including suicide. Over the past decade several strategies have
been implemented in England andWales aimed at reducing the
mortality gap between people with serious mental illness and
the general population, including those to address deliberate
self harm and to reduce suicide,7-9 to decrease smoking,10-12
alcoholism, and drug misuse,13 14 and to deal with other lifestyles
associated with increased mortality.15 16 Recent studies have
suggested that the rate of suicide has been stabilising among
people with mental disorders as a whole17-21; however, trends in
mortality for people with schizophrenia or bipolar disorder
remain poorly characterised, particularly the relative
contributions of natural and unnatural causes. The United
Kingdom government’s recent mental health strategy states that
“more people with mental health problems will have good
physical health” as one of its objectives, specifically stating that
“fewer people with mental health problems will die
prematurely.”22 It is therefore timely to review the level of and
trends in these recognised inequalities.
We investigated trends in mortality between 1999 and 2006
during the year after discharge from hospital for people with
schizophrenia or bipolar disorder as the principal diagnosis at
discharge. We compared mortality in these populations with
mortality in the general population of equivalent age in England
to determine whether the “mortality gap” between people with
these mental disorders and the general population has narrowed
in recent years and to describe the relative contributions from
natural and unnatural causes of death.
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Data sources and population included in this
study
Our data for analysis came from a linked dataset of English
national hospital episode statistics and data from death
certification built by the team that developed and manages the
Oxford record linkage study. The hospital episode statistics
component of the dataset includes statistical abstracts of records
of all inpatient episodes undertaken in National Health Service
(NHS) trusts in England, including acute hospitals and mental
health trusts. Information about deaths came from death
certificates held by the Office for National Statistics. This
information included the date of death and the causes of death,
which were coded by the Office for National Statistics using
the ninth and 10th revisions of the international classification
of diseases (ICD-9 and ICD-10).
We extracted all records of discharges from inpatient care in
England from 1 January 1999 to 31 December 2006 with either
schizophrenia (ICD-10 codes F20-29) or bipolar affective
disorder (ICD-10 code F31) as the principal diagnosis on the
discharge record.
Our primary outcome was mortality within 365 days after
psychiatric inpatient care as defined above.We also investigated
deaths from unnatural and natural causes. Unnatural deaths were
defined on the basis of ICD-10 codes V01-Y98 or ICD-9 codes
E800-999 recorded anywhere on the death certificate; the
remaining deaths were classified as natural. To allow more
detailed interpretation of deaths under these broad categories
we have also presented data for deaths from the following
specific causes where there were sufficient deaths to provide a
stable estimate of risk of mortality—namely, deaths from
cardiovascular disease (ICD-10 codes I00-99, ICD-9 codes
390-459), respiratory disease (ICD-10 codes J00-99, ICD-9
codes 460-519), cancer (ICD-10 codes C00-D48, ICD-9 codes
140-239), accidents (ICD-10 codes V01-X59, ICD-9 codes
E800-929), and suicide/deaths from undetermined intent
(ICD-10 codes X60-89 and Y10-34, ICD-9 codes E950-959
and E980-989).
Analysis
We calculated mortality after hospital discharge as age and sex
standardised mortality ratios, comparing mortality in people
with schizophrenia or bipolar disorder with mortality in the
general population of England. Standardisation was done by
using the indirect method, in five year age groups, with the age
and sex specific mortality rates of England in the same time
periods as the standard. These age and sex specific rates were
applied to the age and sex structure of each of the discharge
cohorts with schizophrenia or bipolar disorder to calculate an
“expected” number of deaths. The observed number was
comparedwith the expected number to calculate the standardised
mortality ratios. Its confidence intervals were calculated as
described elsewhere.23 We further compared the mortality rates
in three broad age groups: <45, 45-64, and 65-84 (with age
standardisation, as above, using five year age groups within
each truncated broader age group). We excluded analysis of
those aged over 85 because of small numbers.
We used the Poisson test of trend to investigate whether there
was a significant trend in standardised mortality ratios over
time.24
Results
Trends in discharges with schizophrenia and
bipolar disorder
For this study we included 100 851 discharges from hospital
for bipolar disorder and 272 248 discharges for schizophrenia
in England for 1999-2006. Tables 1⇓ and 2⇓ show the basic
demographic characteristics of the populations. Over the course
of the study, the total number of discharges for bipolar disorder
decreased by 3.9% from 12 369 to 11 888 (table 1) and the total
number of discharges for schizophrenia decreased by 10.9%
from 35 348 to 31 486 (table 2). About three in four of the deaths
in each of the two cohorts were from natural causes.
Standardised mortality ratios for
schizophrenia and bipolar disorder
Age and sex standardised mortality ratios in the psychiatric
cohorts were about double the population average. For example,
in the 2006 cohort the ratio was 2.2 in the population discharged
with schizophrenia and 1.9 in the population discharged with
bipolar disorder. Standardised mortality ratios were higher in
younger than in older people: in those aged under 45 discharged
in 2006, the ratios were 6.2 (95% confidence interval 4.9 to 7.5)
for schizophrenia and 3.4 (1.7 to 5.1) for bipolar disorder
compared with 2.0 (1.7 to 2.3) and 1.8 (1.4 to 2.2), respectively,
in people aged 65-84 (tables 3⇓ and 4⇓). Men with a discharge
diagnosis of schizophrenia had a significantly higher risk of
death within the first year than women. For example, in the
2006 cohort the standardised mortality ratio for men was 3.2
(2.8 to 3.6) and 1.8 (1.5 to 2.1) for women (table 4⇓). There
was no significant sex difference in mortality risk for those
discharged with a diagnosis of bipolar disorder (table 3⇓).
Trends in mortality ratios
As shown in table 4⇓ and figure 1⇓, standardisedmortality ratios
for people with schizophrenia increased from 1.6 (1.5 to 1.8)
in people discharged in 1999 to 2.2 (2.0 to 2.4) in people
discharged in 2006. The Poisson test for trend confirmed that
the trend in risk of mortality was significant (P<0.001). For
people with bipolar disorder, standardised mortality ratios
increased from 1.3 (1.1 to 1.6) in people discharged in 1999 to
1.9 (1.6 to 2.2) in people discharged in 2006 (table 3⇓). The
Poisson test of trend had results of borderline significance
(P=0.06). Figures 2 and 3⇓⇓ summarise the data for the people
with bipolar disorder or schizophrenia and the general population
expressed as rates (to give absolute values). While the mortality
rates in the general population tended to decline over time, those
in the populations with mental disorders did not. Compared
with the mortality rate for the general population, the mortality
gap remained fairly stable for adults aged under 65; for those
aged 65-84, however, the mortality gap widened during the
study period.
Standardised mortality ratios for
unnatural/natural causes and specific causes
For unnatural causes, the standardised mortality ratios showed
no evidence of a narrowing mortality gap. In people with
schizophrenia they were 11.6 (9.5 to 13.7) in the 1999 cohort
and 11.6 (9.3 to 13.9) in the 2006 cohort. The corresponding
figures for bipolar disorder were 9.3 (6.0 to 12.7) and 12.6 (8.6
to 16.6). Numbers in individual age groups were small, but there
was no evidence of a narrowing of the gap in any age group
(table 5⇓).
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For natural causes, the mortality gap widened (table 6⇓). For
people with schizophrenia, the standardised mortality ratio was
1.2 (1.1 to 1.4) in the 1999 cohort and 1.7 (1.5 to 1.9) in the
2006 cohort. The corresponding figures for bipolar disorder
were 1.1 (0.9 to 1.3) and 1.4 (1.2 to 1.7). Table 7⇓ shows that
deaths from cardiovascular disease and respiratory diseases
accounted for most of this increase. From 1999 to 2006, in those
with schizophrenia, the standardised mortality ratios for
circulatory disease rose from 1.6 (1.4 to 1.9) to 2.5 (2.1 to 2.9),
while the risk of death from respiratory disease increased from
3.1 (2.6 to 3.6) to 4.7 (3.8 to 5.6). The figures for those
discharged with bipolar disorder rose from 1.6 (1.2 to 2.0) to
2.5 (1.9 to 3.1) for circulatory disease and from 3.0 (2.1 to 3.8)
to 5.8 (4.3 to 7.3) for respiratory disease.
Discussion
Principal findings
The risk of death for people recently discharged from inpatient
psychiatric care in England is significantly higher than that in
the general population. This excess risk was observed for
patients with a diagnosis of schizophrenia and for those with a
diagnosis of bipolar disorder. Our findings of a persistent
mortality gap in England in patients discharged between 1999
and 2006 are similar to results recently published by Tiihonen
et al on all cause mortality in people with schizophrenia over a
similar time period in Finland.25 26 Additionally, our findings
suggest that the differential mortality for people with
schizophrenia has widened in some groups, a result that is
similar to the findings from a systematic review by Saha et al
in 2007.27 Much of the increase in mortality is attributable to
deaths from natural causes, especially circulatory disease and
respiratory disease. Our findings support the recommendation
of Saha et al that “in light of the potential for second-generation
antipsychotic medications to further adversely influence
mortality rates . . . optimizing the general health of people with
schizophrenia warrants urgent attention.”27
Strengths and weaknesses
Strengths of this study include its large size and the fact that it
includes all records of discharges with a diagnosis of
schizophrenia or bipolar disorder in the study period and is
therefore nationally representative. By linkage to national
mortality data we have included comprehensive information on
mortality in these vulnerable groups, especially in the period
after discharge from hospital when the risk of death is greatest.2
In addition, to the best of our knowledge, ours are the first
published findings on trends in mortality over the past decade
for people with bipolar disorder in England, a condition that
shares some clinical and management characteristics with
schizophrenia.28 These study characteristics aid the
generalisability of our findings compared with previous studies
in the UK, which have been limited to case registers within
individual mental health trusts.29 30
To quantify the mortality gap and assess the trend in risk of
mortality for people with schizophrenia or bipolar disorder, we
calculated standardised mortality ratios, which take into account
differences in the age structure of the cases, as well as changes
in the underlying mortality rates of the general population. The
widening gap in standardised mortality ratios alone could
represent an absolute rise in mortality in the psychiatric
population or a fall in mortality in the general population in
conjunction with a smaller fall in mortality in the psychiatric
population. Accordingly, we have presented rates for all causes
of death after discharge compared with national mortality rates
over the same period, which allowed us to compare trends in
the absolute difference in mortality risk between the groups.
Both figures—the standardised mortality ratios and the
rates—show that the risk of mortality after discharge is
substantial and that the gap in risk, whether calculated in relative
or absolute terms, remains substantial. The standardised
mortality ratios for schizophrenia and bipolar disorder towards
the end of this observation period are similar to those recently
reported from the South London and Maudsley Biomedical
Research Centre psychiatric case register for 2007-9, which also
found a similarly pronounced excess in younger patients.29
Potential limitations include the usual caveats concerning the
use of routinely collected data, including information from
hospital records and death certificates, which are not collected
for research purposes.31-34 There are also caveats about the
validity of a dichotomy between “natural” and “unnatural”
categories of death, although the definitions of these categories
from the ICD codes were standard.35 36The case groups consisted
of people who had been recently admitted to hospital with a
principal diagnosis of a mental disorder during the period in
question and cannot be said to represent all people with the
disorders; they are likely to represent a more severely affected
group at a period of higher risk. The severity of the disorders
in the case groups might have changed over the monitoring
period because of changes in admission policy. Keown et al
found little evidence of any significant decrease in admissions
for schizophrenia or bipolar disorder during this period,37 and
our finding of minor reductions in discharges over the
observation period compared with the increases in standardised
mortality ratios suggests that the concentration of mortality risk
in these patients admitted to hospital is unlikely to be the sole
explanation for the widening mortality gap, although residual
confounding with severity of illness cannot be excluded entirely.
Interpretation, unanswered questions, and
need for further work
Schizophrenia and bipolar disorder are known to be associated
with a higher risk of mortality.1 Over the past decade the
contribution of natural causes to excess mortality in people with
severe mental illness has been increasingly recognised,
particularly the impact of coronary heart disease, stroke, and
cancer.38 For example, Osborn and colleagues used information
from the UK General Practice Research Database to follow up
a community sample of people with severe mental illness and
found that these people had a significantly increased risk of
death from coronary heart disease and stroke compared with
controls that was not wholly explained by antipsychotic
medication, smoking, or social deprivation.39
While knowledge about the specific causes of death in severe
mental illness are becoming clearer, the pathogenic mechanisms
that culminate in higher than expected mortality from natural
causes in people with mental disorder are little understood and
likely to be complex.40 41 Mechanisms acting through the direct
effects of symptoms of mental disorder are unlikely to have a
large effect on mortality from natural causes, although they are
likely to influence death from suicide and other unnatural
causes.42 Premature deaths from natural causes are likely to be
influenced by adverse lifestyle and social factors associated
with the presence of mental illness—such as smoking, use of
alcohol and illicit drugs, and exposure to poor housing and social
conditions40 43—or the adverse effects of antipsychotic
medication.44 45 It has been suggested, however, that these factors
do not account for all the excess mortality,39 and there is an
urgent need for more research to understand the contribution of
the six leading global risk factors for mortality identified by
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WHO—namely, hypertension, smoking, raised glucose
concentration, physical inactivity, overweight and obesity, and
high cholesterol concentration—to excess mortality in people
with severe mental illness, including schizophrenia and bipolar
disorder.41
Our results reinforce the need for further research in the UK as
the mortality gap has not decreased and is increasing in some
groups, such as those aged over 65. These results have particular
policy relevance in the context of the implementation of the
new national mental health strategy in England. They strongly
point to the need for continued action to target risk factors for
both natural and unnatural causes of death, including known
risk factors for circulatory and respiratory disease, particularly
to lower the risk for these people in the year after discharge
from hospital. It is encouraging that the government has
recognised and prioritised the importance of preventing
premature mortality in its recently published mental health
strategy.22 A reduction of the gap is also a challenge for the
forthcoming reorganisation of the NHS in England, for general
practitioner commissioning, and for the reorganisation’s
emphasis on an NHS driven by outcomes. The already widening
mortality gap between people with schizophrenia or bipolar
disorder and the general population, however, suggests that
these policies might be challenging aspirations.
Contributors: UH and MG were responsible for the conception and
design of this study. UH analysed the data. All authors were involved
in the interpretation of data, drafting the article, and approval of the final
manuscript. All authors had full access to all of the data (including
statistical reports and tables) in the study and can take responsibility
for the integrity of the data and the accuracy of the data analysis. UH
is guarantor.
Funding: This work was funded in part by the English National Institute
for Health Research. RS is funded by the NIHR Specialist Biomedical
Research Centre for Mental Health at the South London and Maudsley
NHS Foundation Trust and Institute of Psychiatry, King’s College
London. UH is an academic clinical fellow at the Oxford University
Clinical Academic Graduate School and the Oxford School of Public
Health. The work of the authors is independent from the funders of this
research. The funders were not involved in the study design; in the
collection, analysis, and interpretation of data; in the writing of the report;
or in the decision to submit the article for publication.
Competing interests: All authors have completed the ICMJE uniform
disclosure form at www.icmje.org/coi_disclosure.pdf (available on
request from the corresponding author) and declare: no support from
any organisation for the submitted work; no financial relationships with
any organisations that might have an interest in the submitted work in
the previous three years; no other relationships or activities that could
appear to have influenced the submitted work.
Ethical approval: The current work programme of analysis using the
linked datasets held at the unit of health-care epidemiology was
approved by an ethics committee of the NHS central office for research
(reference No 04/Q2006/176).
Data sharing: Hospital Episodes Statistics and mortality data can be
obtained through the NHS Information Centre and the Office for National
Statistics, respectively. More detailed aggregated statistical tables than
those shown in this paper are available from the corresponding author.
1 Allebeck P. Schizophrenia: a life-shortening disease. Schizophr Bull 1989;15:81-9.
2 Goldacre M, V Seagroatt, K Hawton. Suicide after discharge from psychiatric inpatient
care. Lancet 1993;342:283-6.
3 Hall DJ, O’Brien F, Stark C, Pelosi A, Smith H. Thirteen-year follow-up of deliberate
self-harm, using linked data. Br J Psychiatry 1998;172:239-42.
4 Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis.
Br J Psychiatry 1997;170:205-28.
5 Hiroeh U, Appleby L, Mortensen PB, Dunn G. Death by homicide, suicide, and other
unnatural causes in people with mental illness: a population-based study. Lancet
2001;358:2110-2.
6 Gau SSF, Cheng ATA. Mental illness and accidental death: case-control psychological
autopsy study. Br J Psychiatry 2004;185:422-8.
7 National Service Framework for Mental Health; modern standards and service models.
Department of Health, 1999.
8 National Suicide Prevention Strategy for England. Department of Health. 2002.
9 National Framework for the Prevention of Suicide and Deliberate Self-Harm in Scotland.
Scottish Executive, 2002.
10 Moving towards smoke-free in mental health services in Scotland. NHS Health Scotland,
2008.
11 Smoking cessation services in primary care, pharmacies, local authorities and workplaces,
particularly for manual working groups, pregnant women and hard to reach communities.
National Institute for Health and Clinical Excellence, 2008.
12 Health Bill. Department of Health, 2009.
13 Drug misuse: opioid detoxification. National Institute for Health and Clinical Excellence,
2007.
14 Drug misuse: psychosocial interventions. National Institute for Health and Clinical
Excellence, 2007.
15 Choosing health: making healthier life choices. Department of Health, 2004.
16 Public health white paper. Department of Health, 2009.
17 Biddle L, Brock A, Brookes ST, Gunnell D. Suicide rates in young men in England and
Wales in the 21st century: time trend study. BMJ 2008;336:539-42.
18 Deaths 1901-2000: deaths from injury and poisoning: external cause and year of
registration or occurrence. Mortality statistics: injury and poisoning (series DH4 no 26).
Office for National Statistics, 2005.
19 Griffiths C, Wright O, Rooney C. Trends in injury and poisoning mortality using the ICE
on injury statistics matrix, England and Wales, 1979-2004. Health Stat Q 2006;32:5-18.
20 Life expectancy and all age all cause mortality monitoring (overall and health
inequalities)—update to include data for 2007. Department of Health, 2008.
21 Kapur N, Hunt IM, Webb R, Bickley H, Windfuhr K, Shaw J, et al. Suicide in psychiatric
in-patients in England, 1997 to 2003. Psychol Med 2006;36:1485-92.
22 No health without mental health: a cross-government mental health outcomes strategy
for people of all ages. Department of Health, 2010.
23 Higham J, Flowers J, Hall P. Standardisation. Eastern Region Public Health Observatory,
2005.
24 Breslow N, Day N. Statistical methods in cancer research. Vol II: the design and analysis
of cohort studies. International Agency for Research on Cancer, 1987.
25 Chwastiak LA, Tek C. The unchanging mortality gap for people with schizophrenia. Lancet
2009;374:590-2.
26 Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year
follow-up of mortality in patients with schizophrenia: a population-based cohort study
(FIN11 study). Lancet 2009;374:620-7.
27 Saha S, Chant D, McGrath J, A systematic review of mortality in schizophrenia: is the
differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123-31.
28 Gelder M, Andreasen N, Lopez-Ibor J, Geddes J. New Oxford textbook of psychiatry.
Oxford University Press, 2009.
29 Chang CK, Hayes RD, Broadbent M, Fernandes AC, Lee W, Hotopf M, et al. All-cause
mortality among people with serious mental illness (SMI), substance use disorders, and
depressive disorders in southeast London: a cohort study. BMC Psychiatry 2010;10:77.
30 Hassall C, Prior P, Cross KW. A preliminary study of excess mortality using a psychiatric
case register. J Epidemiol Community Health 1988;42:286-9.
31 Byrne N, Regan C, Howard L. Administrative registers in psychiatric research: a systematic
review of validity studies. Acta Psychiatr Scand 2005;112:409-14.
32 Goldacre M, Shiwach R, Yeates D. Estimating incidence and prevalence of treated
psychiatric disorders from routine statistics: the example of schizophrenia in Oxfordshire.
J Epidemiol Community Health 1994;48:318-22.
33 Goldacre MJ, Duncan ME, Griffith M, Cook-Mozaffari P. Psychiatric disorders certified
on death certificates in an English population. Soc Psychiatry Psychiatr Epidemiol
2006;41:409-14.
34 Higgins N, Howard L. Database use in psychiatric research: an international review. Eur
J Psychiatry 2005;19:19-30.
35 Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort
with schizophrenia. Br J Psychiatry 2010;196:116-21.
36 Nordentoft M, Breum L, Nordestgaard AG, Hunding A, Laursen Bjaeldager PA. High
mortality by natural and unnatural causes: a 10 year follow up study of patients admitted
to a poisoning treatment centre after suicide attempts. BMJ 1993;306:1637-41.
37 Keown P, Mercer G, Scott J. Retrospective analysis of hospital episode statistics,
involuntary admissions under the Mental Health Act 1983, and number of psychiatric beds
in England 1996-2006. BMJ 2008;337:a1837.
38 Bushe CJ, Taylor M, Haukka J. Mortality in schizophrenia: a measurable clinical endpoint.
J Psychopharmacol 2010;24:17-25.
39 Osborn DPJ, Levy G, Nazareth I, Petersen I, Islam A, King M. Relative risk of
cardiovascular and cancer mortality in people with severe mental illness from the United
Kingdom’s General Practice Research Database. Arch Gen Psychiatry 2007;64:242-9.
40 Leucht S, Burkard T, Henderson JH, Maj M, Sartorius N. Physical illness and
schizophrenia. Cambridge University Press, 2007.
41 Wildgust HJ, Hodgson R, Beary M. The paradox of premature mortality in schizophrenia:
new research questions. J Psychopharmacol 2010;24:9-15.
42 Dutta R, Murray RM, Allardyce J, Jones PB, Boydell J. Early risk factors for suicide in an
epidemiological first episode psychosis cohort. Schizophr Res 2011;126:11-9.
43 Robson D, Gray R. Serious mental illness and physical health problems: a discussion
paper. Int J Nursing Stud 2007;44:457-66.
44 Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin
Psychiatry 2002;9:5-11.
45 Sicouri S, Antzelevitch C. Sudden cardiac death secondary to antidepressant and
antipsychotic drugs. Expert Opin Drug Saf 2008;7:181-94.
Accepted: 8 August 2011
Cite this as: BMJ 2011;343:d5422
This is an open-access article distributed under the terms of the Creative Commons
Attribution Non-commercial License, which permits use, distribution, and reproduction in
any medium, provided the original work is properly cited, the use is non commercial and
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2011;343:d5422 doi: 10.1136/bmj.d5422 Page 4 of 13
RESEARCH
What is already known on this topic
People with schizophrenia or bipolar disorder have higher mortality rates than the general population, both as a result
of natural and unnatural causes
Recent evidence suggests that the rate of suicide and death from unnatural causes has been stabilising among people
with mental illness in the UK
The English government’s recent mental health strategy has stated clearly that “fewer people with mental health
problems will die prematurely”
What this study adds
The mortality gap between people with schizophrenia or bipolar disorder who have been recently discharged from
hospital and the general population persisted between 1999 and 2006 in England
For some age groups, such as those aged 65-84, the mortality gap has increased
Most of this excess mortality was the result of deaths from natural causes, especially deaths from circulatory and
respiratory diseases
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Tables
Table 1| Characteristics of people discharged with principal diagnosis of bipolar disorder (ICD-10 code F31) in England, 1999-2006




dischargedNo of dischargesYear of discharge







51 (32.3)15843/484010 10213 2212004
43 (27.6)15644/4839928412 3752005
38 (25.7)14844/4841908611 8882006
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Table 2| Characteristics of people discharged with principal diagnosis of schizophrenia (ICD-10, codes F20-29) in England, 1999-2006




dischargedNo of dischargesYear of discharge
From unnatural causes (% of all
deaths)From all causes
114 (27.4)41634/445827 13335 3481999
113 (26.5)42734/445825 78533 7932000
111 (27.2)40835/445925 87034 4782001
86 (22.1)38935/446025 52434 1052002
106 (23.1)45935/446025 85633 6652003
123 (28.7)42935/446027 42535 5402004
112 (27.1)41436/446025 70933 8332005
96 (25.5)37636/446124 20531 4862006
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Table 3| Age and sex standardised all causemortality ratios in year after hospital discharge between 1999 and 2006 with principal diagnosis
of bipolar disorder (ICD-, 10, code F31) by age
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Table 4| Age and sex standardised all causemortality ratios in year after hospital discharge between 1999 and 2006 with principal diagnosis
of schizophrenia (ICD-10, codes F20-29) by age
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Table 5| Age and sex standardised mortality ratios for unnatural causes of death in year after hospital discharge between 1999 and 2006
by age and principal diagnosis
65-84 years45-64 years<45 yearsAll agesYear of discharge
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Table 6| Age and sex standardised mortality ratios for natural causes of death in year after hospital discharge between 1999 and 2006 by
age and principal diagnosis
65-84 years45-64 years<45 yearsAll agesYear of discharge
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Table 7| Age and sex standardisedmortality ratios for death in year after hospital discharge between 1999 and 2006 by principal psychiatric
diagnosis and specific cause of death
Suicide and undetermined intent¶Accidents§Respiratory disease‡Cancer†Circulatory disease*Year of discharge


















*ICD-10: I00-I99; ICD-9: 390-459.
†ICD-10: C00-D48; ICD-9: 140-239.
‡ICD-10: J00-99; ICD-9: 460-519.
§ICD-10: V01-X59; ICD9: E800-E929.
¶ICD-10: X60-X84, Y10-Y34; ICD-9: E950-E959, E980-E989.
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Figures
Fig 1 Trend in standardised 365 day all cause mortality ratio for all people discharged from hospital with principal diagnosis
of bipolar disorder or schizophrenia
Fig 2 All cause mortality rate within 365 days after discharge per 1000 people discharged with principal diagnosis of bipolar
disorder by age
Fig 3 All cause mortality rate within 365 days after discharge per 1000 people discharged with principal diagnosis of
schizophrenia by age
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Avoidable mortality in people with
schizophrenia or bipolar disorder in England
Hoang U, Goldacre MJ, Stewart R. Avoidable mortality in people with
schizophrenia or bipolar disorder in England.
Objective: To quantify the extent of ‘avoidable mortality’ in those with
schizophrenia or bipolar disorder and to quantify the eﬀect a reduction
in these might have on the mortality gap associated with severe mental
illness.
Method: A cohort was studied of people aged <75 years, discharged
from inpatient care with schizophrenia or bipolar disorder in 2006–
2007, and followed up for 365 days. Standardised mortality ratios
(SMRs) were calculated followed by hypothetical SMRs, estimating the
residual mortality gap if ‘avoidable’ causes and suicide in the cohorts
had occurred at the same level as those in the general population.
Results: Avoidable deaths comprised 60.2% and 59.2% of all deaths in
the schizophrenia and bipolar disorder cohorts respectively. All-cause
SMRs were 4.23 (95% CI 3.85–4.60) and 2.60 (2.21–3.00) respectively.
After discounting the excess attributable to avoidable causes and
suicide, the SMRs fell to 2.38 (2.09–2.66) and 1.66 (1.35–1.98)
respectively.
Conclusion: Bringing mortality from avoidable causes and suicide down
to general population levels would reduce the overall mortality excess in
severe mental illness substantially, by about 50%, but would not
eliminate it. Other underlying factors beyond those conventionally
considered as ‘avoidable’ need further research.
U. Hoang1, M. J. Goldacre1,
R. Stewart2
1Unit of Health-Care Epidemiology, Department of Public
Health, University of Oxford, Oxford, UK and 2King’s
College London, Institute of Psychiatry, London, UK
Key words: schizophrenia; bipolar disorder; mortality
Uy Hoang, Unit of Health-Care Epidemiology,
Department of Public Health, University of Oxford, Old
Road Campus, Oxford OX3 7LF, UK.
E-mail: uy.hoang@dphpc.ox.ac.uk
Accepted for publication October 11, 2012
Signiﬁcant outcomes
• There is a substantial ‘mortality gap’ between mortality rates in people with severe mental illness and
the general population.
• If deaths from ‘avoidable causes’ in people with schizophrenia or bipolar disease came down to the
level of deaths from avoidable causes in the general population, the mortality gap would reduce by
about 50% but would not be eliminated.
• We recommend that more research needs to be undertaken to characterise ‘non-avoidable causes’ of
death in these populations to allow practical insights into ways
of increasing life expectancy.
Limitations
• A weakness of our study is the reliance on hospital records to deﬁne our study cohort. People who
have been recently hospitalised for psychiatric care are known to have higher mortality rates than
other people with psychiatric disorders, and so our results may not be applicable to people with
schizophrenia and bipolar disorder who are not hospitalised.
• Our study is restricted to follow-up over the ﬁrst 365 days following discharge, which will have
underestimated the true impact of avoidable deaths over the patients’ lifespan.
• Our study relied on routinely collected data to deﬁne our cohorts and outcomes, which are not pri-
marily collected for research purposes, and we do not have information on the underlying criteria
used to deﬁne the psychiatric illnesses or the causes of death.
1





People with severe mental illness (SMI) are known
to have higher mortality rates than other people
within the general population (1, 2). Recent evi-
dence suggests that this ‘mortality gap’ has wid-
ened over the past decade in England and several
other countries, especially for people with schizo-
phrenia and bipolar disorder, and serves as a call
to action for everyone involved in the care of peo-
ple with severe mental illness (3–6).
Mortality rates for unnatural causes of death,
including suicide, are high in people with SMI, but
these are uncommon and much of the excess mor-
tality associated with SMI is from natural causes
(2, 7). Whilst there is a consensus that the underly-
ing mechanisms resulting in mortality amongst this
group are likely to be complex (2), there is little
quantitative evidence concerning how much of the
excess mortality could be avoided either through
the provision of better medical and psychiatric care
or from the provision of better preventative ser-
vices for those with SMI. The concept of ‘avoid-
able mortality’ originally introduced by Rutstein
et al. and recently updated by other authors oﬀers
a method to quantify the proportions of these
deaths in a population (8–11).
Aims of the study
In this study, we sought to quantify the level of
‘avoidable’ deaths in a cohort of people with
schizophrenia or bipolar disorder in England in
the ﬁrst year following hospital discharge, often
recognised as the period of highest risk for death.
To the best of our knowledge, ours is the ﬁrst
study to present avoidable mortality risk in people
with bipolar disorder.
We speciﬁcally sought to answer the question
whether the mortality excess in people with schizo-
phrenia and bipolar disorder would be reduced or
eliminated if deaths in these patients from causes
that should be preventable and/or amenable to
treatment were reduced to their levels in the
general population’.
Material and methods
Population and data set
A linked data set containing data from English
national Hospital Episode Statistics (HES, data
supplied by the NHS Information Centre) and
death registrations (supplied by the Oﬃce for
National Statistics), linked by the Oxford Record
Linkage Group(12, 13), was analysed for this
study. The hospital component of the data set
includes records of all inpatient admissions, includ-
ing day cases, in NHS acute and psychiatric hospi-
tals in England. This information included the date
of death and the causes of death which were coded,
by the Oﬃce for National Statistics (ONS), using
the International Classiﬁcation of Diseases (ICD)
revision 10.
We extracted all records of discharges from
inpatient care for people less than 75 years on
admission in England between 1 January 2006 and
31 December 2007 with either schizophrenia
(ICD10 codes F20-F29), or bipolar disorder
(ICD10 code F31) as the principal diagnosis on the
discharge record. Follow-up for 365 days after dis-
charge, all performed by record linkage within the
data set, was to 31 December 2008.
Avoidable mortality
The primary outcome for this study was mortal-
ity in people with schizophrenia or bipolar disor-
der compared with the general population,
subdividing their excess mortality into deaths
from avoidable causes and other deaths. Avoid-
able causes of death were deﬁned by a list of
diagnostic codes (10, 14) which are shown, with
age ranges where relevant, in the web appendix.
Deaths that are considered ‘avoidable’ have been
updated by the ONS from Rutstein’s original
deﬁnition in 1976 (8, 15). They include the fol-
lowing categories i) deaths which could be
avoided through the eﬀorts of healthcare services,
termed ‘amenable’ (i.e. focusing on deaths arising
potentially because of less than optimal health-
care provision); ii) deaths which could be avoided
by broader interventions, for example, accident
prevention, termed ‘preventable’ (deaths from
suicide and undetermined intent were included in
this group); iii) deaths which could be amenable
through the eﬀorts of healthcare services or could
be prevented through broader interventions,
termed ‘avoidable’ deaths (14). Some deaths clas-
siﬁed as ‘avoidable’ are considered as both ‘ame-
nable’ and ‘preventable’; thus, the number of
‘avoidable’ deaths is not equivalent to the sum of
‘amenable’ and ‘preventable’ deaths.
In this study, deaths from suicide and undeter-
mined intent (ICD10 codes-X60 to X84, Y10 to
Y34) were considered avoidable if they were
recorded anywhere on the death certiﬁcate; deaths
from the other diagnostic codes shown in the web
appendix were included if they were the coded
underlying cause of death. Deaths that were not
classiﬁed as ‘avoidable’, as determined by their




The standard deﬁnition of avoidable causes of
death takes an upper age threshold of 74 years as
the maximum age at which deaths are assumed to
be avoidable (10, 14). Accordingly, we calculated
the percentage of avoidable deaths in people
<75 years with schizophrenia or bipolar disorder.
To analyse the possible eﬀects of a reduction in
avoidable deaths in these populations, we calcu-
lated a series of hypothetical standardised mortal-
ity ratios (SMRs): these were the SMRs that would
have prevailed if avoidable deaths were reduced to
their levels in the general population. A brief
explanation of the calculations undertaken is given
below and in Fig. 1. Comparable calculations have
been undertaken to estimate the upper limits of
human longevity (16).
First, we calculated mortality from all-causes
after hospital discharge as age and sex standar-
dised mortality ratios, comparing mortality in the
people with schizophrenia or bipolar disorder, with
mortality in the general population of England.
Standardisation was performed using the conven-
tional indirect method, in 5-year age groups, using
the age- and sex-speciﬁc mortality rates of England
in the same time periods as the standard. These
age- and sex-speciﬁc rates were applied to the age
and sex structure of each of the discharge cohorts
with schizophrenia or bipolar disorder to calculate
an ‘expected’ number of deaths. The observed
number was compared with the expected number
to calculate the standardised mortality ratios (4);
95% conﬁdence intervals for the SMRs were calcu-
lated as described elsewhere (17).
Next, we calculated the number of excess ame-
nable deaths by subtracting the observed number
of amenable deaths from the expected number.
All-cause SMRs were then re-calculated as above
with the amenable component set to the level
found in the general population. This ﬁrst set of
hypothetical SMRs shows what the all-cause SMR
would have been if these cohorts had the same
mortality risk from amenable causes as the general
population and allows us to examine the eﬀect of a
reduction in amenable deaths.
As suicide and deaths from undetermined intent
are an important contributor to excess deaths in
those with severe mental illness (18), we calculated
a second set of hypothetical SMRs, in the same
way, by subtracting both excess amenable deaths
and excess deaths from suicide or undetermined
intent. This second set of hypothetical SMRs
shows what the all-cause SMR would have been if
the risk of death from amenable causes and suicide
in these cohorts had been the same as the general
population.
A ﬁnal set of hypothetical SMRs were calculated
by subtracting all excess avoidable causes of death.
This last set of hypothetical SMRs shows what the
all-cause SMR would have been if the risk of death
in these cohorts from all avoidable causes had been
the same as the general population. It allows us to
examine the eﬀect of a reduction in all avoidable
deaths.
We repeated the analysis, calculating age-trun-
cated SMRs, for people aged <65 years, <45 and
<25 years (with age-sex standardisation, as above,
using 5-year age groups within each truncated
broader age group) to allows us to examine the dif-
ferential eﬀect of a reduction in avoidable deaths
at diﬀerent ages. We repeated the analysis for
males and females separately, to examine the dif-
ferential eﬀect of a reduction in avoidable deaths
for each sex separately.
Statistical analyses were performed with the SAS
statistical software package (SAS version 9.3,
2011, Cary, NC).
Role of the funding source
The work of the authors is independent from the
funders of this research. The views in this article
Observed total number of deaths
Expected total number of deaths
= All-cause SMR
A. Calculation of the hypothetical SMR showing the effect of a reduction in 
excess deaths from amenable causes
Observed total number of deaths minus 
excess deaths from amenable causes
Expected total number of deaths
= Hypothetical all-cause SMR 
excluding amenable deaths
Where:
Excess deaths from amenable causes equals observed minus expected 
number of amenable deaths
B. Calculation of the hypothetical SMR showing the effect of a reduction in 
excess deaths from amenable causes, and suicide or undetermined intent
Observed total number of deaths minus excess 
deaths from amenable causes and suicides 
Expected total number of deaths
= Hypothetical all-cause 
SMR excluding amenable 
deaths, and suicides or 
undetermined intent
Where:
Excess deaths from amenable causes (including suicide or undetermined 
intent) equals observed minus expected number of amenable deaths 
(including suicides or undetermined intent)
C. Calculation of the hypothetical SMR showing the effect of a reduction in 
excess deaths from all avoidable causes
Observed total number of deaths minus 
excess deaths from all avoidable causes  
Expected total number of deaths
= Hypothetical all-cause SMR 
excluding all avoidable deaths
Where:
Excess deaths from avoidable causes equals observed minus expected 
number of avoidable deaths
Fig. 1. Calculation of hypothetical SMRs starting from the
actual all-cause SMR and showing the all-cause SMRs that
would have prevailed if excess avoidable deaths were reduced.
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do not necessarily reﬂect those of the funding
body. The funding body had no role in the analysis
or interpretation of the data. The funding body
had no role in the analysis or interpretation of the
data. The authors had full access to the data in the
study, were not paid by any external agency to
write the study, and had ﬁnal responsibility for the
decision to submit for publication.
Results
Number of discharges for schizophrenia and bipolar disorder aged
<75 years
There were 54 883 discharges for schizophrenia
(for 37 607 individuals) and 20 690 discharges for
bipolar disorder (for 14 017 individuals) in Eng-
land between 1 January 2006 and 31 December
2007. Table 1 summarises demographic character-
istics of the cohorts.
All-cause mortality and proportion of deaths from avoidable
causes in people with schizophrenia and bipolar disorder
Within 365 days of discharge, there were 480
deaths amongst people recently discharged with
schizophrenia, and 169 deaths in people recently
discharged with bipolar disorder <75 years
(Table 1). For people recently discharged with a
principal diagnosis of schizophrenia, avoidable
deaths comprised 60.2% of all deaths. Deaths
potentially amenable to medical care accounted
for 30.2% of deaths, whilst deaths from conditions
that are potentially preventable through public
health interventions accounted for 50.6% of all
deaths (many causes on the list are regarded as
both amenable and preventable). For people
recently discharged with a principal diagnosis of
bipolar disorder, avoidable deaths comprised
59.2% of all deaths. Amenable deaths accounted
for 30.2%, whilst preventable deaths accounted for
49.1% of all deaths (see Table 1). ‘Unavoidable’
deaths, namely those deaths that remained after
discounting ‘avoidable’ deaths, were distributed
rather generally across major disease groups, with-
out heavy concentration in any disease category
(see Table 2).
Standardised mortality ratios
The all-cause SMRs for people with schizophrenia
or bipolar disorder <75 years were, respectively,
4.23 (95% conﬁdence interval.85–4.60) and 2.60
(2.21–3.00). Table 3 shows that equalising amena-
ble deaths resulted in the SMR for people with
schizophrenia falling from 4.23 to 3.34 (95% CI:
3.00–3.67). For those with bipolar disorder, the
SMR was reduced from 2.60 to 2.19 (95% CI: 1.83
–2.55) in this way. Additionally, equalising suicide
mortality gave a further reduction in the SMRs to
2.44 (95% CI: 2.15–2.73) for schizophrenia and to
1.70 (95% CI: 1.38–2.02) for bipolar disorder.
Finally, equalising amenable deaths, suicides and
all other preventable deaths did not eliminate the
mortality gap, the SMR remaining at 2.38 (95%
CI: 2.09–2.66) for schizophrenia and 1.66 (95%
CI: 1.35–1.98) for bipolar disorder.
Table 3 also shows diﬀerences between men and
women in the mortality gap with the general popu-
lation. Sex-speciﬁc SMRs were higher in men than
women; reducing deaths from avoidable causes
had a marginally greater impact on men than
Table 1. Number of discharges and number of people aged under 75 years, dis-
charged with a principal diagnosis of schizophrenia or bipolar disorder, and their
demographic characteristics, between 2006–2007, in England
Principal diagnosis on discharge
Schizophrenia Bipolar disorder
Number of discharges between 1st
January 2006–31 December 2007
54 883 20 690
Number of people discharged between
1 January 2006–31 December 2007
37 607 14 017
% male 62 41
Deaths from all causes within 365
days of discharge
480 169
Number of deaths that are
amenable** (% of all deaths)
145 (30.2%) 51 (30.2%)
Number of deaths that are
preventable** (% of all deaths)
243 (50.6%) 83 (49.1%)
Number of deaths that are
avoidable** (% of all deaths)
289 (60.2%) 100 (59.2%)
Consultation on definitions of avoidable mortality (UK ONS, 2011).
**Deaths from suicide and undetermined intent (ICD10 codes – X60 to X84, Y10 to
Y34) were included in this group.
Note that many conditions classified as ‘avoidable’ are classified as both ‘amena-
ble’ and ‘preventable’; thus, the first two categories do not sum to the last (UK
ONS, 2011).
Table 2. Underlying causes of death within 365 days after discharge in people with
a principal diagnosis of schizophrenia or bipolar disorder, and the percentage of
deaths that were from unavoidable causes in each of four disease chapters
Underlying cause of death
365 days after discharge
(ICD10 chapter headings and code ranges)
Number of unavoidable deaths in
each chapter in people with: (% of




(ICD10 codes – C00-D48)
23 (47.9) 13 (61.9)
Diseases of the circulatory
system (ICD10 codes – I00-I99)
49 (39.2) 13 (31.7)
Diseases of the respiratory
system (ICD10 codes – J00-J99)
25 (29.1) 0 (0)
Diseases of the digestive
system (ICD10 codes – K00-K93)
15 (88.2) 7 (87.5)
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women. For example, the SMR for men with
schizophrenia decreased from 4.55 (95% CI: 4.05–
5.05) to 2.48 (95% CI: 2.11–2.85) if avoidable
causes of death were reduced, compared with a
reduction from 3.68 (95% CI: 3.11–4.24) in women
to 2.16 (95% CI: 1.73–2.59. There was no diﬀer-
ence between men and women when reducing
avoidable causes in people with bipolar disorder.
Further age-truncated analysis suggests that
reducing avoidable deaths in people <45 years
would have the greatest eﬀect on reducing excess
mortality. Table 4 shows that people with schizo-
phrenia <45 years would experience a reduction of
SMR from 7.13 (95% CI: 6.02–8.23) to 3.32 (95%
CI: 2.57–4.07), whilst people with bipolar disorder
<45 years would experience a reduction of SMR
from 3.72 (95% CI: 2.32–5.13) to 1.59 (95% CI:
0.67–2.50) if avoidable causes of death were
reduced to the same level as the general population.
Discussion
There is a substantial excess mortality risk in peo-
ple with schizophrenia and bipolar disorder
<75 years, which is slightly greater for schizophre-
nia than for bipolar disorder. Almost two-thirds of
all deaths within the ﬁrst 365 days after discharge
from inpatient care are potentially avoidable as
judged by standard deﬁnitions of avoidable causes
of death. Our ﬁndings suggest that reductions in
these avoidable causes, which include suicide,
could reduce the mortality gap appreciably, espe-
cially in people <45 years. In people with schizo-
phrenia, reducing avoidable causes of death may
also slightly narrow the gender diﬀerence in mor-
tality excess that has been described by previous
researchers (19). However, our hypothetical SMRs
also indicate that reducing excess deaths classiﬁed
Table 3. Hypothetical SMRs for people aged under 75 years discharged with a
principal diagnosis of schizophrenia or bipolar disorder, applying death rates from
amenable causes, suicide and preventable causes at the levels in the general popu-
lation, by sex
Category
SMR within 365 days after discharge
Schizophrenia Bipolar disorder
Both sexes, aged under 75 years
All-causes 4.23 (3.85–4.60) 2.60 (2.21–3.00)
All-causes minus excess
amenable deaths*
3.34 (3.00–3.67) 2.19 (1.83–2.55)
All-causes minus excess
amenable deaths* and
suicides or deaths from
undetermined intent
2.44 (2.15–2.73) 1.70 (1.38–2.02)
All-causes minus excess
amenable deaths*, suicides
or deaths from undetermined
intent, and preventable deaths*
2.38 (2.09–2.66) 1.66 (1.35–1.98)
Males, aged under 75 years
All-causes 4.55 (4.05–5.05) 2.66 (2.07–3.25)
All-causes minus excess
amenable deaths*
3.54 (3.10–3.98) 2.34 (1.78–2.89)
All-causes minus excess
amenable deaths* and suicides
or deaths from undetermined intent
2.50 (2.13–2.87) 1.77 (1.29–2.25)
All-causes minus excess
amenable deaths*, suicides or
deaths from undetermined intent,
and preventable deaths*
2.48 (2.11–2.85) 1.66 (1.20–2.13)
Females, aged under 75 years
All-causes 3.68 (3.11–4.24) 2.88 (2.26–3.43)
All-causes minus excess
amenable deaths*
2.98 (2.47–3.48) 2.29 (1.76–2.81)
All-causes minus excess
amenable deaths* and suicides
or deaths from undetermined intent
2.35 (1.90–2.80) 1.79 (1.33–2.25)
All-causes minus excess
amenable deaths*, suicides or
deaths from undetermined
intent, and preventable deaths*
2.16 (1.73–2.59) 1.80 (1.34–2.27)
*Consultation on definitions of avoidable mortality (UK ONS, 2011).
Table 4. Hypothetical SMRs for people aged under 65, under 45 and under 25 dis-
charged with a principal diagnosis of schizophrenia or bipolar disorder, applying
death rates from amenable causes, suicide and preventable causes at the levels in
the general population
Category
SMR within 365 days after discharge
Schizophrenia Bipolar disorder
Both sexes, aged under 65 years
All-causes 5.21 (4.67–5.75) 2.96 (2.39–3.54)
All-causes minus excess
amenable deaths*
4.33 (3.84–4.82) 2.70 (2.15–3.25)
All-causes minus excess
amenable deaths* and
suicides or deaths from
undetermined intent
2.89 (2.49–3.29) 1.85 (1.40–2.31)
All-causes minus excess
amenable deaths*, suicides
or deaths from undetermined
intent, and preventable deaths*
2.77 (2.38–3.17) 1.81 (1.36–2.26)
Both sexes, aged under 45 years
All-causes 7.13 (6.02–8.23) 3.72 (2.32–5.13)
All-causes minus excess
amenable deaths*
6.71 (5.64–7.78) 3.58 (2.20–4.95)
All-causes minus excess
amenable deaths* and
suicides or deaths from
undetermined intent
3.48 (2.71–4.26) 1.71 (0.76–2.66)
All-causes minus excess
amenable deaths*, suicides
or deaths from undetermined
intent, and preventable deaths*
3.32 (2.57–4.07) 1.59 (0.67–2.50)
Both sexes, aged under 25 years
All-causes 5.29 (3.17–7.41) 1.89 (0–4.02)
All-causes minus excess
amenable deaths*
4.90 (2.87–6.94) 1.89 (0–4.02)
All-causes minus excess
amenable deaths* and
suicides or deaths from
undetermined intent
2.47 (1.02–3.97) 1.41 (0–3.26)
All-causes minus excess
amenable deaths*, suicides
or deaths from undetermined
intent, and preventable deaths*
2.18 (0.82–3.54) 1.32 (0–3.11)
*Consultation on definitions of avoidable mortality (UK ONS, 2011).
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as avoidable does not eliminate the mortality gap
between these case groups and the general popula-
tion. Even after discounting excess deaths from all
avoidable causes, people with schizophrenia, in
their ﬁrst year after their discharge from hospital,
were still twice as likely to die as the general popu-
lation. For people with bipolar disorder, the mor-
tality excess remained one and half times greater
than the general population. For both conditions,
the residual excess mortality was accounted for by
unavoidable deaths across a broad range of disease
groups.
Strengths and weaknesses of our study
The large size of this study, and the fact that it
includes all records of discharges with a diagnosis
of schizophrenia or bipolar disorder in the study
period nationally, is the strength of our study. To
the best of our knowledge, this study is the largest
to date on avoidable causes of death in people with
schizophrenia (20–22) and the only one to examine
avoidable mortality risk in those with bipolar dis-
order (23), a condition which shares many clinical
and management characteristics with schizophre-
nia (24). These study characteristics aid the gener-
alizability of our ﬁndings. We also use the latest
deﬁnitions of avoidable mortality which incorpo-
rate understanding and consensus on the impact of
the latest medical and surgical interventions on
causes of death (10). Finally, our presentation of
hypothetical SMRs allows policy makers to quan-
tify the current eﬀects of avoidable causes of death
and the possible impact of diﬀerent interventions
to reduce these.
A weakness of our study is the reliance on the
accuracy of routinely collected data, which are not
primarily collected for research purposes. Recent
evidence from Burns and colleagues has shown
that the consistent and accurate recording of diag-
nosis across a range of conditions, especially the
primary diagnosis for which reimbursement is cal-
culated, has improved in recent years in hospital
episode statistics in the UK (25), although there
have been no similar recent studies examining the
accuracy of death certiﬁcation. A further weakness
is the fact that we restricted our analysis of avoid-
able deaths to the ﬁrst 365 days following dis-
charge, whereas an appreciable proportion of
avoidable deaths may occur over a longer period,
thereby underestimated in our analysis. However,
a number of studies have found that this is the per-
iod of highest mortality risk in SMI (18) and argu-
ably one where interventions might have particular
impact in reducing the mortality gap (3). Third,
our study only focused on investigating avoidable
mortality risk in people who had been admitted
with a diagnosis of schizophrenia or bipolar disor-
der, and it could be argued that our methods may
have over-estimated the risk from these conditions
as we could not include people who had not been
recently admitted. However, we would argue that
in these speciﬁc groups, the mortality gap has been
shown to be increasing (4–6), and thus, the need
for further research and intervention is most press-
ing (3, 26). Finally, whilst we were able to examine
the eﬀect of age and sex diﬀerences on avoidable
causes of death, we were not able to examine the
impact of some other important determinants of
mortality in our analysis including ethnicity and
duration of mental illness, as information on these
variables are not collected within our data set (2).
Thus, we recommend that any further research on
avoidable causes of death in these populations
should also collect information on these determi-
nants and quantify their eﬀects on avoidable
mortality.
Meaning of the study
Our study indicates that avoidable mortality is an
important component of death in people with
schizophrenia and bipolar disorder who have
recently been discharged from inpatient care, espe-
cially deaths potentially amenable to high-quality
medical care. There are a number of possible
explanations for our ﬁndings including higher risks
of physical illness associated with SMI, reduced
access to care and/or worse care provision (27).
Further explanations include the possibility of pre-
mature discharge from inpatient care with
untreated or partially treated physical illness and/
or challenges with adherence to or less adequate
provision of medical or surgical follow-up result-
ing in greater risk of death from avoidable dis-
eases. Higher risks of incident physical illness
following discharge may be directly related to
underlying mental disorders, may be compounded
by co-existing alcohol or substance abuse or may
be an adverse eﬀect of treatments given. Finally,
higher mortality may be a result of poorer care
when admitted with physical illness (27).
Our hypothetical SMRs show that even with
reductions in all avoidable causes of death (includ-
ing suicide) down to expected levels the mortality
gap was not reduced completely. This may reﬂect a
wider increase in risk of disease associated with
SMI, not just for those diseases for which death is
deemed avoidable. It is also possible that current
deﬁnitions of avoidable causes of death have lower
speciﬁcity in these populations at high risk of mor-
tality. We suggest that further research is needed
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to quantify the sensitivity and speciﬁcity of these
deﬁnitions of avoidable causes of mortality in these
populations by comparing population-based esti-
mates with estimates from studies utilising infor-
mation from clinical case reviews or conﬁdential
inquiries.
Our study indicates that investment to tackle
avoidable causes of mortality, especially those
potentially amenable to medical care and under-
lying socio-economic inequalities could have a
large eﬀect in reducing the mortality gap, at
least in the ﬁrst year after discharge. We wel-
come the current government’s focus on reduc-
ing premature mortality in the UK (28), and
our ﬁndings suggest that their focus on reducing
physical illness in those with mental illness is an
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Appendix 2 - Literature review of mortality studies in those with schizophrenia and bipolar disorder over the past decade 



















      
Systematic review of mortality studies in mental illness 
over the last 30 years, intended to update Harris and 
Barraclough’s original systematic review in 1997(Harris 
and Barraclough 1997; Harris and Barraclough 1998). 
They suggest from their review of the existing evidence 
that the mortality gap is increasing as a result of people 
with mental illness not benefitting from advances in 
healthcare seen in the general population. 
 
(Ilgen, 









3 million people who 
used VA services 
>18 years See summary Found that men with bipolar disorder (HR=2.98) and 
women with substance abuse (HR=6.62) were 
particularly at risk of suicide. 
(Dutta, Murray 









2723 people with first 
episode of psychosis 
16-86 
years 
All-cause SMR for 
1st episode 
psychosis = 1.84 
Found that the case fatality from suicide was 
considerably lower than in previous published research, 
but the risk of suicide persisted even a decade after 1st 
presentation, with mean time to suicide of 5.6 years. 
(Wildgust and 
Beary 2010) 





- - - Literature review that found an increasing number of 
recent studies suggesting people with schizophrenia 
are dying from modifiable causes, however they found 
few prospective studies that looked at interventions to 
lower modifiable risks. 
 
(Bushe, Taylor 
et al. 2010) 
Literature review 101 
references 
included 
2006-10 - - - Review of research from 2006 on mortality in people 
with schizophrenia, especially examining four specific 
questions; whether mortality rates are declining, what 
the causes of death are, the effects of antipsychotic 
treatments on mortality and whether these data inform 
as to how mortality may be reduced in the future. They 
found that the mortality gap with the general population 
increased from the 1970s but may have peaked in the 
mid-1990s. Mortality was dependent upon the age of 
the cohort, length of follow up and type of study. 
Antipsychotic treatments reduced mortality when 
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compared with no treatment and atypical antipsychotics 
did not appear to increase cardiovascular mortality and 











- - - Systematic review of studies that examined medical 
procedures in people with schizophrenia, and a pooled 
analysis of prescribed medication in those with and 
without comorbid mental illness, focusing on those 
which recruited individuals with schizophrenia and 
measured mortality. Six of eight studies examining the 
adequacy of cardiac procedures found lower than 
average provision of medical care and two studies 
found no difference. Meta-analytic pooling of nine 
medication studies showed lower than average rates of 
prescribing for cardiovascular drugs. There were ten 
studies linking poor quality of care and possible effects 
on mortality in specialist settings. In half of the studies 
there was significantly higher mortality in those with 
mental ill health compared with controls, although there 
was inadequate data to confirm a causative link. They 
concluded that the quality of medical treatment 
provided to those with cardiac conditions and comorbid 
schizophrenia is often suboptimal and may be linked 
with avoidable mortality. 
 
(Chang, 







2007-09 31,719 people with SMI >15 years All cause SMR for 
SMI = 2.15 
Found high SMRs for those who accessed services 
between 2007 to 2009, and also suggested that 
mortality differs substantially with age, diagnosis, 
gender and ethnicity. 
 
(Bowers, 









  No relative risks or 
SMRs reported 
Systematic review of suicides in psychiatric inpatients. 
Found that suicide rates and demographic features 
connected to suicides varied substantially between 
articles, suggesting that there are distinct subgroups of 
people committing suicide (e.g., people with depression 
vs. schizophrenia) with differing epidemiological 
characteristics and contributing determinants. They also 
confirmed that early in the admission is a high-risk 
period for suicide, but that the risk of suicide declines 
most slowly for people with schizophrenia. They also 
found that the timing and location of suicides seem to 
be associated with absence of support, supervision, 
and the presence of family conflict 
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(Hunt, 











1,851 absconded from 
an in-patient psychiatric 
ward 
All ages No relative risks or 
SMRs reported 
Found that 469 people died after absconding from the 
ward. Schizophrenia was the most common diagnosis. 
Absconders were proportionally more likely than current 
in-patients on agreed leave to have been legally 
detained for treatment, non-compliant with medication, 
and to have died in the first week of admission 
 
(Brown, Kim 










370 people with 




All cause SMR for 
schizophrenia = 
2.89 
Found a higher rate of all-cause mortality, with 
unnatural deaths concentrated in the first five years of 
follow-up. They also suggested that there was an 
indication that cardiovascular mortality may have 
increased relative to the general population over the 
course of the study 
 
(Baandrup, 









193 people with 
schizophrenia who died 
of natural causes and 
1937 matched controls 
who did not die 
18-53 
years 
See summary Found that the use of anti-psychotics with long half-
lives was associated with increased mortality 
(OR=1.78), but concurrent use of a number of anti-
psychotics did not increase mortality above 
monotherapy (OR=1.48) 
 












No absolute numbers 
quoted 
All ages No relative risks or 
SMRs reported 
Found six-fold difference in mortality rates depending 
on how psychiatric conditions were selected from death 
certificates and the mortality differences between the 
countries increased over the period of the study, except 
for dementia. 
(Nielssen, 










160 people who 
attempted suicide by 
jumping. 
All ages No relative risks or 
SMRs reported 












7591 people with 
schizophrenia 
All ages All-cause SMR for 
schizophrenia = 
4.45 
Found regional differences in mortality, unrelated to 




Meta-analysis 23 trials -   See summary Meta-analysis of 23 phase 2/3 RCTs looking at 
mortality in people with schizophrenia within 30 days 
after starting anti-psychotic treatment. Found no 
significant difference in all-cause mortality between 
treatment group and controls (OR=1.58) 












1686 people with 
schizophrenia +/- 
treated with clozapine. 
20-69 
years 
All-cause SMR for 
people with 
schizophrenia on 
clozapine = 4.7 
Found no evidence to suggest that clozapine increased 












  - Systematic review of studies on bipolar disorder and 
medical mortality. Included studies with people who 
require inpatient psychiatric care, or treatment with 
lithium, or schizoaffective disorder. Found bipolar 
spectrum disorders are associated with increased 













66,881 people with 
schizophrenia taking 
anti-psychotics 
All ages See summary Found that longer cumulative exposure to anti-
psychotics (HR=0.81), especially with clozapine 
(HR=0.74) and second generation anti-psychotics was 









Finland 1966-97 10934 people from a 
birth cohort, 100 with 
schizophrenia 
>16 years OR for suicide in 
people with 
schizophrenia = 2 
Found that suicide accounts for half of all deaths in 
people with schizophrenia, more so in the first 3-years. 
(Reutfors, 










84 people with 
schizophrenia who died 
from suicide and 84 
matched controls who 
did not die 
<65 years See summary Found that higher educational attainment (OR=3), older 
age at onset of symptoms (OR=4.8) and history of 
deliberate self harm (OR=5) were significantly 
associated with subsequent suicide 
(Weinmann, 










   Review of mortality in people with schizophrenia on 
anti-psychotic medications 
(Copeland, 







US 2002-05 241,466 people with 
schizophrenia, DM, or 
schizophrenia + DM 
>50 years See summary Found that those who attended primary care less often 
had worse mortality outcomes regardless of comorbidity 
(OR=3.8) 
(Rantanen, 








23,959 first admissions 
for schizophrenia  
15-65 
years 
See summary Found a reduction in overall 5-year mortality among 
people hospitalized in 1995-1998 (OR=1) compared to 
people hospitalized in 1980-1984 (OR=0.9). 
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(Hawken, 









50 people with 
schizophrenia and 
polydipsia, and 40 
comparators. 













4.6 million people with 
SMI.   
All ages HR for CVD 
mortality in people 
with SMI = 2.9 
Found a negligible excess rates of healthcare contacts 
for heart disease in people with SMI, compared with a 
large increase in risk of mortality from heart disease 
(Kilbourne, 









147,193 people with 
SMI 
All ages See summary Found that people with schizophrenia (HR=1.17) or 
other psychotic disorders (HR=1.3) were more likely to 
die from IHD than those without mental illness. 
(Tran, 













All-cause SMR for 
schizophrenia = 3.6 
Found that cancer was the second most frequent cause 
of mortality, especially lung cancer in men and breast 
cancer in women 
(Chong, Tay 








608 people with 
schizophrenia 








VA hospital  
admission list 
US 2004 31,218 people with 
principal diagnosis of 
CCF or pneumonia 
with/ without psychiatric 
comorbidity. 
All ages See summary Found that the method used to identify psychiatric 
comorbidities in acute medical populations has a strong 
influence on the rates of identification and the 
associations between psychiatric illnesses with hospital 
mortality (OR of death from CVD with psychiatric 
comorbidities  between 0.59 – 1.04,OR of death from 











- - - Literature review of sudden CVD mortality in people 
with schizophrenia 
(McGrath, 










- - All-cause SMR for 
schizophrenia for 
the duration of the 
study = 2.6 
Systematic review of incidence, prevalence and 
mortality in people with schizophrenia. Concluded that 
people with schizophrenia have a 2-3 fold risk of dying, 
and this differential mortality gap has increased over 
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recent decades, SMR 1970s = 1.8, 1980s = 3.0, 1990s 
= 3.2 
 












510 people with 
schizophrenia 
>15 years All-cause SMR for 
schizophrenia = 4 
Found that people with schizophrenia of all age groups 
had a marked increase in mortality and suicide. 
(Tokuda, 









1108 people with 
schizophrenia  
All ages All-cause SMR for 
schizophrenia = 
1,29 
Found that the leading causes of death were suicide, 
malignant lymphoma or leukemia, stroke, and sepsis 
(Honkonen, 












All-cause SMR for 
schizophrenia = 
3.93 
The SMRs for unnatural causes were higher than those 
for natural causes. The highest SMRs for unnatural 
causes of death were found in patients with mood 
disorders and the highest SMRs for natural causes of 
death in people with schizophrenia spectrum disorders 
 
(Hiroeh, Kapur 







Denmark 1973-93 4.1 million people with 
SMI 
>15 years All-cause SMR for 
schizophrenia = 2.1 
(men), 1.9 (women) 
Found the highest cause-specific SMRs for people with 
SMI were for nervous system diseases, gastrointestinal 
diseases, lung diseases, and "all other natural causes"; 







Canada - 527 consecutive 
suicides in people with/ 
without schizophrenia 
All ages See summary Found people with schizophrenia who had committed 
suicide were likely to be younger (mean = 32 years) 
more likely to have attended university (OR=2.12), less 
likely to be married (OR=0.09) and have increased 
levels of impulsive aggressive behaviours, compared to 
people without schizophrenia. 
 
(Tidemalm, 








12,103 people with 
SMI. 
All ages All-cause SMR for 
SMI in 1998-2000 = 
3.3 (men), 2.3 
(women) 
 
Before-after study of the effects of a community mental 
healthcare reform program. Nil effect found on mortality 
(Haukka, 









1611 people with 
schizophrenia 
>16 years See summary Found anti-psychotic use was associated with 
significant reduced mortality from suicide (HR=0.52), 
either alone or in combination with anti-depressants 
(Capasso, Cohort study Minnesota 1950- 319 people with All ages No relative risks or Found that there was no narrowing of mortality gap 










Cohort study  
 
Hospital  






597 people admitted 
with SMI 
>16 years All-cause HR for 
SMI = 3.25 
Found that mortality was mediated by behavioural risk 
factors such as socioeconomic status (OR=2.17), 
history of smoking (OR=4.69) and poor level of physical 
activity (OR=2.24). 
(Kisely, Sadek 








247,344 people with 
SMI 
All ages RR for cancer 
mortality in SMI = 
1.59 
Found an increased cancer mortality, but no evidence 
of increased incidence 
(Saha, Chant 











37 articles from 25 countries over 25 years reviewed to 
identify trends in all-cause mortality for people with 
schizophrenia. They found a consistent increased risk 
of mortality in people with schizophrenia compared with 
the national populations, and also mortality rates have 
increased in recent decades 
 
(Pirkola, 















- See summary Found that suicide risk had decreased during the study 
(RR between 1985-91 & 1995-2001=1.25-1.5), and that 
well-developed community mental-health services are 
associated with lower suicide rates 
(Hunt, Kapur 











222 people who died of 
suicide while in 
psychiatric in-patient 




See summary Previous deliberate self-harm (OR=4.3), recent adverse 
life events (OR=2), and symptoms of depressive illness 
at last contact (OR=2) were associated with increased 
risk of suicide. 
(Dutta, 









1965-99 235 people with first 
diagnosis of bipolar 
disorder. 
All ages SMR from suicide 
for bipolar disorder 
= 9.77 
Found that suicide is significantly increased, but actual 
case fatality was not as high as previously seen in the 
literature. Alcohol abuse (HR=6.7) and deterioration in 
premorbid functioning (HR=5.2) were associated with 










5.5 million with SMI All ages All-cause RR for 
schizophrenia = 
1.7-13.4 (men), 
Found the rate of natural deaths is higher in people with 
schizophrenia than other psychiatric conditions, and 
family history of psychiatric admission was associated 




All cause RR 




with excess mortality 
(Amaddeo, 









6,956 people with SMI >14 years SMR avoidable 
mortality in SMI = 
4.31 
Found high rates of preventable mortality in people with 
SMI compared with general population. 
(Limosin, Loze 








3470 people with 
schizophrenia 
All ages All-cause SMR for 
schizophrenia = 3.7 
(men), 4.5 (women) 
Found that male gender, (HR=2.03), previous suicide 
attempts, history of drug abuse and short duration of 
illness all predicted suicide attempts. 
(Pompili, 
Amador et al. 
2007) 
 
Literature review      Literature review of suicide in people with schizophrenia 
(Fors, Isacson 








255 people with 
schizophrenia and 1275 
matched comparators 




Found high rates of mortality for unnatural causes and 
CVD, especially for those living in urban areas 
(Auquier, 
Lancon et al. 
2007) 
 
Literature review       
(Simon, 









32,360 people with 
bipolar disorder  
All ages See summary Found that the risk of suicide death is significantly 
related to female sex (HR of suicide for men=0.68) and 




Cohort study  
 






16,791 people with 
schizophrenia 




versus not = 0.23 
Found no evidence of increased risk of death in those 
with schizophrenia taking antipsychotics, compared 
with placebo group 
(Barak, 







3111 elderly people 
with SMI 
>65 years No relative risks or 
SMRs reported 
Found no evidence of increased adverse medical 
outcomes including incidence of stroke, CVD and 
mortality in those with SMI on anti-psychotics 










US 2003-05 14,194 with admission 
for acute coronary 
syndrome (ACS) 
All ages HR for all-cause 
mortality in people 
with SMI and ACS, 




Found increased level of SMI in those with ACS, but no 
association between SMI and ACS mortality 
(Osborn, Levy 








46,136 people with SMI 
and 300,426 matched 
comparators 
All ages HR for CVD in 
those with SMI = 
1.1 - 3.2, 
HR for stroke in 
those with SMI = 
1.3 – 2.5 
 
Found high risk of CVD, and stroke deaths in those with 
SMI not explained by the presence of common risk 
factors including anti-psychotic drug use, smoking or 
social deprivation 
(Kapur, Hunt 












No absolute numbers 
given 
>15 years Likelihood ratio for 
suicide rates in 
people with 
schizophrenia 
between 1997-03 = 
19.54 (p<0.001) 
Study tracking trends in in-patient and post-discharge 
suicide. Found a fall in rate of inpatient and post-
discharge suicide 
(Hunt, Kapur 











20,927 people who 
committed suicide who 
had been in contact 
with mental health 
services in last year 
All ages No relative risks or 
SMRs reported 
Found that people with schizophrenia who committed 
suicide were more likely to be young, male, 
unemployed and from ethnic minority. There was a high 
likelihood of violent method of suicide in people with 
schizophrenia. 
(Goldacre, 







England 1979-99 No absolute numbers 
given 
All ages No relative risks or 
SMRs reported 
Study reporting trends in the recording of psychiatric 
diagnosis on the death certificates. Found that mortality 
associated with psychiatric illness is greatly under-
estimated if only the underlying cause is taken into 
account. Also found that the trend in psychiatric 
diseases on the death certificates varies between 
disease over time, with a decline in mortality rates for 
schizophrenia, and an increase for depression and 
dementia on death certificates between 1979 to 1999. 
 
(Healy, Harris 







1279 people admitted 
with psychosis 
All ages No relative risks or 
SMRs reported 
Comparison of suicide rates before and after 
introduction of chlorpromazine in north-west Wales. 
Found that suicide rates per hospital admission were 
twenty times higher between the first and last surveys 













No absolute numbers 
given for people with 
SMI included 
All ages All cause SMR for 
SMI between 1.8-
4.9, YPLL between 
13.5-32.2 
 
Found increase mortality especially from natural causes 
in all states, and widespread variation between states 
(Kurihara, 












All ages All-cause SMR for 
schizophrenia = 
5.98 









Canada - 85 people who died of 
suicide with 
schizophrenia and 
matched controls who 
did not commit suicide 
 
All ages See summary Found that the presence of depressive illness 
(OR=395), moderate to severe psychotic symptoms 
(OR=87) and a family history of suicidal behaviour 








Finland 1978-97 7,217 people with 
mental illness 
>30 years RR of mortality in 
schizophrenia = 
2.84 
Follow-up to study published in 2001. Found that 
mortality in people with schizophrenia was increased 
compared with others in the cohort, and taking into 
account a number of confounding variables. 
Antipsychotics had a graded effect on mortality 
depending on dose 
 
(Copeland, 







US 2001-02 27,798 deaths in former 
attended at VA hospital. 
All ages OR for unforeseen 
deaths = 2.4 
Found that death from unforeseen causes was more 
common in people with schizophrenia 
(Miller, 









20,018 people with SMI >18 years All-cause SMR for 
SMI = 3.2, YPLL = 
32 +/- 12.6 
Found high SMR and YPLL, especially for heart 
disease and suicides 







US 1989-95 567 people with first 
onset psychosis  
15-60 
years 
No relative risks or 
SMRs reported 
Found these people experience similar patterns of 
mortality over the first 10 years after the index 
admission regardless of the underlying diagnosis 
(Ward, Ishak 











>15 years HR for all-cause 
mortality in those 
with good versus 
poor compliance = 
Found that good compliance with atypical antipsychotic 
medications was associated with substantial reductions 
in the risk for all-cause and psychosis-related 
hospitalizations 














60 deceased people 
with bipolar disorder 




See summary Found that antipsychotic treatment prior to the last visit 
(OR=0.87), serum alanine aminotransferase levels 
(OR=1.13), and leukocyte counts (OR=1.58) were all 
associated with the risk of death from natural causes 
(Goff, Cather 
et al. 2005) 
Literature review      Literature review of physical illness in those with SMI 
and clinical guidelines for management of modifiable 
risk factors for mortality 
 
(Rasanen, 













See summary Found that deaths due to avoidable conditions caused 
about 30% of all deaths, SMRs from avoidable deaths 
being 1.9 (males) and 3.2 (females). 











pairs of people with 
schizophrenia who did/ 
did not commit suicide 
All ages See summary Found depressive symptoms (OR=23), and higher 
suicide intensity (OR=2.8) were significant predictors of 
suicide 









19059 people with SMI All ages All-cause SMR for 
SMI = 1.08 
Found increased rate of suicide, but overall mortality 
not obviously increased 
(Desai, 







US 1994-98 121,933 people with 
SMI 
All ages No relative risks or 
SMRs reported 
Found that suicide was associated with short length of 
inpatient stay, poor continuity of care and lack of 
readmission in 6 months 
(Kisely, Smith 








221,048 people with 
SMI 
All ages All cause SMR for 
schizophrenia = 
2.2, for SMI = 1.7 
Found that mortality rate is increased in all people with 
SMI, not just in-patients 
(Heila, 







Finland 1980-96 58,761 people 
discharged with 
schizophrenia 
All ages All cause SMR for 
schizophrenia = 2.9 
Found no noticeable increase in mortality between 
1980-96, despite rapid decrease in the number of 
hospital beds 
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(Muller, 





Germany - 500 people with SMI All ages See summary Found that suicide attempts were associated with poor 
premorbid adjustment (OR=2.1), low age of onset 
(OR=0.95), low Goal Attainment Scaling (GAS) scores 
(OR=0.95) and childlessness in females (OR=2.5) 
 
(Hawton, 




    See summary Review of the risk factors for suicide in schizophrenia. 
29 case-control/ cohort studies included. Found 
evidence that previous depressive illness (OR=3), 
previous suicide attempts (OR=4), drug misuse 
(OR=3.2), agitation (OR=2.6), fear of mental 
disintegration (OR=12.1) and recent loss (OR=4) were 





Literature review      Literature review focused on where people with 
schizophrenia commit suicide. Found that 50% of 
suicides occurred during inpatient care, especially 
amongst the young, childless, and those with a history 
of multiple admissions, and paranoid subtype 
 
(Sinclair, 








1988-97 51 people with 
schizophrenia who 
committed suicide and 
82 controls who did not 
 
All ages See summary Found that depressive symptoms (OR = 2.6) and 
previous suicide attempts (OR= 2.7) are significant 
predictive factors 








US 1989-98 97 people with 
schizophrenia who died 
between 1989-98 
All ages No relative risks or 
SMRs reported 
Found that those who died of suicide experienced both 












>33 years HR for suicide in 
people with 
awareness of 
symptoms = 1.17 
(non-significant) 
 
Trial to find out what the effect of increasing awareness 
has on the suicide rates. Found a positive but complex 
relationship between awareness and suicide risk 
(Barak, 








756 people with 
schizophrenia. 
All ages OR of suicide in 
people with 
schizophrenia not 
taking a SGA = 3.5 
Study of the effect of second generation anti-psychotics 
on 5 year suicide rates. Found that risperidone and 
olanzapine may have some protective effects over 5 
years. Effects differ between different second 
generation anti-psychotics 
 
(Casey, Haupt Literature review       
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et al. 2004) 
 









1996-99 73 people with SMI who 
committed suicide and 
73 matched controls 
from the same ward 
who did not commit 
suicide 
 
All ages See summary Found increased risk of death from suicide post 
psychiatric hospital discharge, clustering in the first 30 
days, associations with unemployment (OR=12), past 
suicide attempts (OR=3.4), maternal mental illness 
(OR=13.4) and suicide ideation (OR=5) 
(Pompili, 
Girardi et al. 
2004) 
 









US 1995-99 1920 people with 
schizophrenia and 9600 
matched comparators  
All ages HR = 4.4 for 





Found that users of typical antipsychotics had a five-
fold increased risk of myocardial infarction than controls 
(Vythilingam, 






US 1977-90 110 depressed clients 
+/- psychotic symptoms 






Found that people with psychotic depression have a 
two-fold greater risk of mortality than do patients with 








US 1991-99 5352 long stay 
psychiatric patients 
All ages No relative risks or 
SMRs reported 
Found that the delivery of inpatient mental health 
services by the VA had changed dramatically during the 
1990s. They also found no substantially adverse 
changes in mortality rates or in the extent to which long-














100 people with 
schizophrenia 
All ages No relative risks or 
SMRs reported 
Study investigating the role of command hallucinations 
on suicide. Found that command hallucinations did not 













RR of suicide in 
people that have 
drug holidays 
compared to no 
drug holidays= 4.2 
 
Found that people who do not refill atypical 
antipsychotics in time can be identified from pharmacy 
records and are likely to be at increased risk of death 
from suicide 









Scotland 1977-94 6776 people 
discharged from long 
stay psychiatric in-
patient care with SMI 
>15 years All-cause SMR for 
SMI = 1.6 
Found that death rates from both natural and unnatural 
causes of death were increased 
(Duggan, 
Warner et al. 
2003) 
- UK - - - No relative risks or 
SMRs reported 
Methods paper offering a model to compare current 
levels of clozapine prescribing with a scenario in which 
all suitable clients with treatment-resistant 
schizophrenia received clozapine. Suggest that 53 lives 
could be saved in the UK each year. Concluded that the 
use of clozapine in treatment-resistant schizophrenia 
saves lives, frees resources and is cost-effective. 
 
(Hawton, Zahl 





1978-97 11583 people who had 
undertaken deliberate 
self-harm 
All ages RR of suicide in 1st 
year after episode 
of DSH = 66  
Found that there was a significant and persistent risk of 
subsequent suicide, which varies by age and sex. 
However mortality had not changed for this group over 
the period of the study 
 
(Morgan, 







Ireland 1992-99 72 people with 
schizophrenia followed-
up for 7 years 
20-83 
years 
All-cause SMR for 
schizophrenia = 2.1 
Found a higher all-cause mortality rate in those with 
schizophrenia 
(Rasanen, 










stay psychiatric patients 
30-90 
years 
All-cause SMR for 
SMI = 4.3 
Found that SMR was highest for young age groups. 
SMR decreases in older age groups 
(Pinikahana, 
Happell et al. 
2003) 
 
Literature review  1990-99    Literature review of suicide in people with schizophrenia 
(D'Avanzo, La 














All-cause SMR for 
SMI = 2.5 (males), 
2.4 (females) 
Found high all-cause mortality, but no excess deaths 
for cancer 
(Lawrence, 
Holman et al. 
2003) 








210,129 mental health 
service users 
All ages SMR for IHD in 
people with SMI 
over the period of 
the study = 1.9 
(men), 1.9 (women) 
Found little difference in hospital admission rates for 
IHD between psychiatric patients and the general 
community, but much lower rates of revascularisation 
procedures, particularly for people with psychoses. Also 
found mortality rate from IHD in psychiatric patients did 
not diminish over time compared to the general 
population 









France 1993-97 3474 people with 
schizophrenia 
All ages OR for all deaths = 














Finland 1982-94 4338 people with 
schizophrenia 
All ages Proportions of 
deaths in people 
discharged with 
SMI = 5% (1980), 
4.5% (1986), 6.4% 
(1990), 4.9% 
(1994), p value for 
trend = 0.38 
 
Study of four cohorts of people with schizophrenia 
admitted between 1982 to 1994. Found that despite 
decreasing bed numbers, mortality had remained the 














after one year in 
treatment and 
control groups = 
0.003, p= 0.96 
 
Study of integrated treatment versus treatment as usual 
to decrease 1 year post discharge suicide. Found no 
reduction in suicide attempts at 1-year in treatment 
group compared with controls 
(Kreyenbuhl, 







US 1989-98 15 people who 
committed suicide with 




All ages No relative risks or 
SMRs reported 
Utilised informant interviews to compare circumstances 
around the suicides. Found higher rates of depressive 
symptoms and more violent suicidal acts in those with 
schizophrenia 
(Angst, 
Stassen et al. 
2002) 







1959-97 406 consecutive 
admissions with 
depressive disorder 
All ages All-cause SMR for 
bipolar disorder = 
1.58 
Found increased SMR for suicide and CVD 
(Politi, 







1978-94 2148 consecutive 
admissions for SMI  
All ages SMR all-causes for 
SMI = 4.6 (men), 
3.4 (women) 
 
Found high all-cause mortality. Trend towards 
decreasing mortality over time, falling by 29% over the 
period of the study 
(Harrison, 
Hopper et al. 
2001) 
Cohort study 18 
countries 
- 15 and 25 yr outcomes 
in people with 
schizophrenia. 
All ages All-cause SMR for 
schizophrenia 
varied from 0 to 8.8 
Found that about 50% of surviving cases had 
favourable outcomes, but there was marked 
heterogeneity across geographic centres. Concluded 
that a significant proportion of treated incident cases of 
    278 
schizophrenia achieve favourable long-term outcome. 















1984-97 64 deaths in people 




No relative risks or 
SMRs reported 
Study of mortality in people maximum security prison 
with SMI in Spain. Found an association between 
cause of death and age 
(Druss, 






US 1994-95 88241 medicare 
patients who were 
hospitalized 
for clinically confirmed 
acute myocardial 
infarction 
65+ years HR for 1 year 
mortality = 1.10 
(95% CI 0.96-1.26) 
after controlling for 
quality indicators 
 
Study looking at the mortality one year after myocardial 
infarction in people with/ without SMI. Hazards rates 
calculated for differing levels of 5 established quality 
indicators. Found that deficit in quality care explained a 








Norway 1980-92 1998 people admitted 
with SMI 
All ages All-cause SMR for 
schizophrenia in 
1963-74 = 1.7 
(men), 2.3 
(women), 1980-92 
= 3.0 (men), 2.5 
(women) 
 
Found high SMR for all causes in people with SMI, 
especially cardiovascular disease and suicide 
compared with rates calculated from a similar sample in 
earlier periods 
(Hiroeh, 








Denmark 1973-93 72,208 people with SMI >15 years All-cause SMR for 
SMI = 6.1 (men), 
6.3 (women) 
Found increased risk of dying by homicide in men with 
schizophrenia and those with affective psychosis 
(Osby, Brandt 






Sweden 1973-95 15,386 people with first 
admission for bipolar 
disorder 
All ages All-cause SMR 
bipolar disorder = 
2.5 (men), 2.7 
(women) 









Finland 1977-97 7,217 people with 
mental illness 
>30 years All-cause RR of 
death for 
schizophrenia = 3.3 
(men), 2.3 (women) 
 
For people with schizophrenia only risk of respiratory 







Belgium 1973-94 63 people who 
committed suicide with 
schizophrenia and 63 
<30 years See summary Found that risk of suicide was higher in males, with 
chronic relapsing disease (OR=6), depressive 
symptoms (OR= 36) and previous suicide attempts 
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Hospital 
admission list 












Poland 1985-97 32 people with 
schizophrenia who had 
had dexamethasone 
suppression tests 
All ages No relative risks or 
SMRs reported 
Found association between suicide attempts and 
baseline and post-test cortisol levels, suggesting that 
hyperactivity of HPA axis may be implicated in suicide 
risk in people with schizophrenia 
 
(Khan, Khan 





US - 10,118 people with 
schizophrenia involved 
in RCT studies 




and controls groups 
= 0.99 (not 
significant) 
 
Study of suicide risk in participants with schizophrenia 
receiving placebo in antipsychotic RCTs. Found that 
risk of suicide did not differ between treated and 
placebo groups 










All ages Relative risk of 
suicide death in 
those with 
anhedonia = 1.7 
(non-significant) 
 
Found that anhedonia is not a significant risk factor for 
suicide 
(Mojtabai, 





India 1978-95 171 first contact 




Mortality rate ratio 
of 9.4 for people 




Found that poor outcomes at 2 years strongly predicted 
mortality at 15 years follow-up 
(Fontaine, 





US 1999 Used information from 
5209 respondents in 
the Framingham study 
to estimate the effects 
of anti-psychotic weight 
gain 
 
All ages Theoretical excess 
deaths calculated 
Suggested that 492 suicide deaths per 100,000 people 
with schizophrenia would be prevented over 10 years 
with the use of clozapine compared to 416 additional 

















Relative risk of 
sudden cardiac 
death = 2.39 
(moderate anti-
psychotic users) 
Found that moderate doses of antipsychotics had large 
relative and absolute increases in the risk of sudden 
cardiac death. 
(Babidge, 





1988-91 708 homeless people, 
of which 506 had 
All ages SMR for homeless 
= 3.7 (men), 3.1 
Found high rates of mortality in the homeless 
regardless of the diagnosis of schizophrenia 
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US 1992-95 2830 people with and 
1415 people without 
schizophrenia, all 
taking clozapine 










Study of clozapine treatment on 4-yr suicide rates. 
Found reduced all-cause mortality, mostly from reduced 
respiratory disease, no significant reduction in suicide 
rates 
(Brown, Beck 




admission list  
US 1975-95 6891 consecutive 
psychiatric outpatients 




All ages See summary Found that suicidal ideation (HR=3.87), the presence of 
major depressive disorder (HR=3.19) or bipolar disorder 
(HR=3.57) and unemployment status (HR=2.56) 
predicted risk of suicide 
(Brown, Inskip 



























Found high SMRs for both natural/ unnatural causes of 




Literature review      Literature review suggesting that atypical antipsychotics 
may exert therapeutic effects on depression and 
hostility as well as psychosis and that clozapine and 











Sweden 1978-85 41,134 people with 
schizophrenia admitted 
between 1978-82 and 
followed-up until 1983-
85 
All ages Reduced life 
expectancy = 22-
28% (men), 15-
22% (women)  
Found that life expectancies varied significantly by age. 
Suggested that reduction in mortality rates requires 
different strategies in different age groups and should 
be targeted at specific causes of death 
(Meltzer, 
Anand et al. 
2000) 
Literature review      Literature review of suicide risk in people with 
schizophrenia treated with cloazpine, and outline of 
methodology for the International Suicide Prevention 

















1980-95 131,105 people with 
SMI whose first contact 
with mental health 
services was between 
1980-95 
All ages SMR for SMI = 2.6 
(males), 2.2 
(females) 
Found high all-cause mortality, except for those treated 
in outpatient facilities. However second study using the 









Denmark 1973-93 54,103 people with 
affective disorder who 
attended psychiatric 
hospital for the first time 
between 1973-93. 
15 years+ SMR suicide for 
bipolar disorder = 
18.09, SMR natural 
causes for bipolar 
disorder = 1.5-2.4 
 
Found that mortality for all subgroups with affective 
disorder was raised. 
(Funahashi, 












1967-92 80 people with DSM3 




personality. Matched to 
group who committed 
suicide no evidence of 
schizophrenia 
 
All ages No relative risks or 
SMRs reported 
Found that risk of suicide increased in those with high 
levels of suicidal ideation, and anxiety 
(Osby, Correia 











All ages 1991-1995, SMR 
for schizophrenia = 




for schizophrenia = 
2.6 (men), 2.1 
(women) 
Mortality rate examined for 4 separate periods. Found 
increasing admissions for schizophrenia and increasing 
mortality rates compared the national population, 
especially for cardiovascular disease 
* study period includes the period of participant recruitment and follow-up 
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Appendix 3 – Methods of data linkage and data extraction 
 
Data linkage methods 
The information for this section has been drafted from the description of the methodology of 
building a national file or health and mortality data published by Leicester Gill (Gill 2004). 
This methodology is largely still used to construct the linked datasets used in this thesis. 
Permanent links between hospital records and death records have been created in the 
dataset to facilitate healthcare outcomes research. 
 
There are three primary stages in linking the health records together. The first stage requires 
the data to be cleaned and formatted, and the potential match-pairs to be brought together 
for comparison by sorting the file into various orders. The second stage involves comparing 
the potential match-pairs to decide whether they belong to the same person. This would 
generally use a deterministic or a probabilistic matching method. The third stage involves the 
collation of the person linked records into a person-linked file either by sorting or creating an 
index in a database system. 
 
The process started with two files, namely the HES datasets supplied by the DH and the 
mortality dataset supplied by the ONS. HES records for individual patients are stored as 
Finished Consultant Episodes (FCE), i.e. a period of admitted patient care under a consultant 
or allied healthcare professional within an NHS trust. Death records are stored as separate 
files. The first step in data linkage involves reformatting the mortality records were so that the 
corresponding fields on the ONS mortality record and on the HES record are stored in the 
same character position in the record. Initially each record was given a different person 
number, and after the matching and linking has been completed, all records that belong to 
the same person would have the same person number copied across them. 
 
Next the unmatched HES-ONS file was split into two files. The first file, referred to as the 
master matching file (MMF) contained only those variables that are used for matching, and 
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did not contain any clinical or other statistical data. This file was encrypted and stored on a 
different computing system to the statistical file. Some variables, for example, date of birth, 
sex and postcode which are required for analysis were aggregated up to age or local 
authority district level to minimise any attempt to identify an individual from the ensuing 
analyses. The second file, referred to as the statistical analysis file, contained the variables 
that are not used for matching but are used for statistical analysis. The two files of HES 
records were linked together using the unique accession number. 
 
Next a series of computer runs were undertaken to check data quality, including checking the 
frequency of matching variables and identifying erroneous and outlying values. Records 
containing such errors were tagged to prevent the erroneous variables being used for 
matching. Further details of the data quality of the unmatched datasets is published by Gill 
(Gill 2004). 
 
The first series of matching runs involves matching together all record pairs that have the 
same NHS number. The file was split into two parts, those with valid NHS numbers and 
those without. All records having the same NHS number were collected into a block and 
matched against each other using a recursive method, that is, matching first with all the 
remaining records in the block, second with the remaining records, and so on. An exact 
method of matching was used, namely a link is made only where the NHS number agrees 
exactly. This was augmented by a set of Boolean logical rules, this permitted the minor 
variations in date of birth and postcode to be taken into account. Each block was matched 
eight times using various combinations of the matching variables (Runs 1-8), and then further 
matched using a random sequence of Runs 1-8. The match rates for the NHS number match 
are published by Gill (Gill 2004). 
 
The second series of matching runs involved matching all record pairs that had the same 
date of birth, sex and postcode (DOB/SEX/PCD). The input file contained all the records that 
had previously been matched on NHS number together with the previous file that did not 
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contain an NHS number. The file was sorted into: date of birth, record type, sex, postcode 
and NHS number order. All records having the same DOB/SEX/PCD were collected into the 
same block. An exact method of matching was used matching records in each block against 
each other using a recursive method. This was augmented by a set of Boolean logical rules. 
Each block was matched three times using various combinations of date of birth, sex, 
postcode and the persons hospital record number (Runs 1-3), and then further matched 
using a random sequence of Runs 1-3. Records that did not have a valid postcode were 
excluded from the run, together with those records with dates of birth before 1875 or had the 
date 19010101. Records with a date of birth 19010101 were processed in a separate run. 
The match rates for the DOB/SEX/PCD match are published by Gill (Gill 2004).  
 
Following the matching runs, a number of measures were taken to check for errors in the 
matching process, including printing and manually checking all very large matched blocks to 
check that they belonged to the same person. Checks were also taken to identify possible 
twin births to make sure that the records related to two separate babies and efforts were 
made to identify people with two ONS mortality records. 
 
Following these error checks, records were brought together to provide statistics on the 
matched pairs including the number of good matches, non-matches, false positives and false 
negatives. The figures are published by Gill (Gill 2004).  
 
The matched records for a given person were collated together, sorted into person number 
order, and further sorted on record type and on episode dates within each person number 
set. The sort order ensured that the last record in every set was the mortality record or the 
last discharge/transfer. Namely data linkage allows FCEs to be grouped together into one 
record of a patient's entire inpatient stay, regardless of any inter-hospital transfers which may 
take place, known as a Continuous Inpatient Spell (CIP). A single CIP may contain 
information from one of more FCEs. Sorting allows CIP which consists of more than one 
FCE, to be arranged such that information from the first FCE for that individual’s inpatient 
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stay, including details of the diagnosis made, is considered the ‘admission record’, and the 
last record is considered the ‘discharge record’.  
 
A file used for analysis was created, containing all the administrative and clinical data, but 
excluding any of the matching variables. Variables used for analysis like sex, age and area 
code were aggregated and stored on the analysis file in such a manner that the record 
cannot be back-linked and the person identified. A record on the analysis file is referenced to 
its counterpart on the matching file using the accession number, and the matching file 
records are encrypted. 
 
Data extraction methods 
 
This section introduces the SAS macro and MS Excel scripts/ spreadsheets used extract the 
necessary data from the linked dataset and calculate the following statistics;   
 
1. Counts – admissions, discharges, post-admission or post-discharge events 
2. Unadjusted rates – post-admission or post-discharge event rates 
3. Age and sex truncated rates - post-admission or post-discharge age and sex truncated 
event rates 
4. Age and sex adjusted/ standardised rates - post-discharge age and sex truncated event 
rates 
 
The first three figures can be enumerated using the SAS macro and the Microsoft (MS) Excel 
macro written in visual basic (VBA) script. The last figures require the SAS macro and the all 
MS Excel spreadsheets. 
 
This section will describe the use of the following software analysis tools. 
 
1. SAS macros, called the persoyrs macro (see below for further details) 
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2. MS Excel macro, written in VBA script called HandleSASOutput 
3. MS Excel spreadsheets, called England all-cause mortality 1999-2008 and England 
specific cause mortality 1999-2008 
4. C# script called SASBatcher 
 
The basic concepts and definitions that are used in this section and in the data extraction are 
below. 
 
A. Time periods. There are a number of time periods that must be considered before using 
this program to define the boundaries of the analysis, including  
 
Inclusion period – this period of time in which patients can included in the study 
 
Follow-up period – is the period of time in which patients are followed for the outcome event 
of interest 
 
Study period – is equal to the inclusion period and the follow-up period 
 
Period at risk – is the period of time in which the patient is at risk of the outcome event. 
Ideally it should begin at the same time as the follow-up period to enumerate the total 
number of events in the period of risk. It should end when the patient is no longer at risk of 
the outcome event. The characteristics of the period of risk chosen determine the selection of 
the reference group used in the calculation of SMRs, as it should be theoretically possible for 
the people within the reference population to be at risk of the outcome event. If you are 
attempting to compare two populations against a reference population, then the period of risk 
from which the events are chosen must be fairly compared between the two study 
populations, this concept was considered in chapter 5 in discussion about suitable 
comparison groups. 
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These time periods are operationalised in the SAS program using the following markers (see 
Appendix 2, Figure 1) 
 
Study start – this is period from which the program starts counting 
Study end – this is the period from which the program stops counting 
Step – this is the inclusion period 
FU time – this is the follow-up time 
 
Note that step does not need to equal study end minus study start. Thus you could have 
multiple inclusion periods between the start and the end of the study. This is equivalent to 
having multiple consecutive inclusion periods, used for a trend analysis. 
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            |--------------- Inclusion period ------------------|-----------------------FU period--------------------| 
            |                                                   |                                                    | 
            |                                                   |                                                    | 
            |                                                   |                                                    | 
     (obs start)                                      (obs end) | (FU start)    (obs end)      (FU start)   (FU end) | (final date)  (FU end)   (final 
date) 
       calender        financial                      calender  |  calender      financial    financial     calender |   calender    financial    
financial 
      01.01.XXXX      01.04.XXXX                     31.12.XXXX |  01.01.XXXX    31.03.XXXX   01.04.XXXX  31.12.XXXX | 01.01.XXXX   31.03.XXXX   
01.04.XXXX 
            |                                                   |                                                    | 
            |                                                   |                                                    | 
            |                                                   |                                                    | 
        Start        Start + Step - 1 years  |  Start + Step       Start + Step + FUtime - 1 yr   |     Start + Step + FUtime years 
            |                                                   |                                                    | 
            |                                                   |                                                    | 
            |                                                   |                                                    | 
Macro      studst        studend   |   fust              fuend |  final 
Variables   |           |            | 
            |                                                   |                                                    | 
            |                                                   |                                                    | 
            |                                                   |                                                    | 
subone=1    |       Obs start-----------------------------------|----------------------------------------------------|------->not died 
subone=2    |       Obs start------------------------died       |                                                    | 
subone=3    |       Obs start-----------------------------------|------------------died                              | 
subone=4    |       Obs start-----------------------------------|----------------------------------------------------|---died 
subone=5    |       Obs start------------------readmitted       |                                                    | 
subone=6    |      Obs start-----------------------------------|------------------readmitted        | 
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B. Inclusion criteria. The program selects records to count using two types of inclusion 
criteria 
 
Fixed inclusion criteria are not usually changed by the user with each run. These include 
criteria such as selecting only England records to include. Other fixed inclusion criteria are – 
only including those with a date-of-birth (DOB) recorded after the study start, and only those 
with a gender recorded. 
 
User defined criteria are determined by the user for each study by either changing the 
SASstring or text inputs files that are needed for each run. These criteria include type of age 
ranges, time variables, admission source, diagnosis, etc. The diagnosis is selected using 
Boolean AND/ OR operators. 
 
C. Outcomes. All outcomes can be selected by the user by either changing the SASstring or 
text inputs files that are needed for each run, including the diagnosis with Boolean AND/ OR 
operators. 
 
D. Measures. There are a number of measures that are output or can be calculated using the 
program 
 
1. Counts - of the number of admissions and discharges by age and sex over a specified 
time period can be enumerated by running the SAS persoyrs macro 
Counts of the number of a specified event following admission or discharge by age and sex 
over a specified time period can also be enumerated by running the SAS persoyrs macro 
 
2. Proportions and unadjusted rates -  
 
The proportion of events in an admission or discharge population = number of events/ 
population at risk  
    290 
Rates of events in an admission or discharge population = number of events/ population at 
risk in specified time 
 
3. Age and sex standardised rates -  
 
Standardisation is a method of comparing rates from two different populations with different 
age and sex compositions. It is not a method of controlling for the effects of age/ sex on a 
disease outcome in one population. Instead it is a method of adjusting rates to give 
theoretical event rates for populations if they had the same mortality risk as a reference 
population. Commonly two different methods for standardising event rates are described, 
namely direct or indirect standardisation (Higham, Flowers et al. 2005); 
 
Direct standardisation – relies on applying an external reference population age/ sex 
structure to the study population’s event rates. This method is commonly used where the 
study population event rates are stable. It answers the following question – ‘what would the 
number of events be in my study population if it had the same age and sex structure as the 
reference population’ 
 
Indirect standardisation – relies on applying an external reference population event rates to 
the study’s population age/ sex structure. It is useful where the event rates in the study 
population are not stable/ robust, often due to the small rate of outcomes in the study 
population. It answers the following question – ‘what would the number of events be if my 
study population had the same mortality risk as the reference population. 
 
Indirect standardisation can give provide a simple measure of relative risk in the study 
population versus the reference population. This measure is the SMR = observed number of 
events/ expected number of events in period at risk 
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Where expected number of events = sum (population in each 5-year age band of study 
population * event rate for reference population each 5-year age band) 
 
Thus the numbers needed to calculate SMR are as follows (Higham, Flowers et al. 2005) 
1. study population in 5-year age bands, by sex 
2. observed number of events in 5-year age bands, by sex 
3. event rate in the reference population in 5-year age band, by sex 
 
Step-by-step guide to calculating SMRs using the persoyrs SAS macro and MS Excel tools 
1. define the time periods you are interested in looking at 
2. define and check the fixed inclusion criteria 
3. write the text files and SASstring that determine the user defined inclusion criteria 
4. write the text files that define the outcomes 
5. place the run into the input folder 
6. run the C# SASbatcher script 
7. pick up the results of the SAS run 
8. initiate the HandleSASOutput MS Excel macro on the results of the SAS run 
9. merge the results of the SAS run with the MS worksheet containing the relevant 
reference event rates 
 
Note that steps 1-8 are required to enumerate the study population and observed number of 
events. Step 9 is used to merge the observed number with the reference event rates to get 
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x 'cd O:\Uy\SAS\Output'; /* these two lines of code write the SAS log out to a folder */ 
 
proc printto log='O:\Uy\SAS\Output\Disch - AMI - outcome - all deaths.txt'; 
 
%personyrs (invariab =, /*where text files containing user defined inclusion criteria are found*/ 
  infixed =,  /*where text files containing fixed inclusion criteria are found*/ 
  typecars =, /*selects the type of care recorded included, in association with incg*/ 
  saslib =,  /*location of a small temporary workspace and where a sample study dataset is output*/ 
  datafiles =, /*location of the datafiles*/ 
  incg =, /*also used to select the type of care included*/ 
  seqnos=, /*selects the record number included*/ 
  yeartype =, /*selects the type of year, calendar or financial*/ 
  userstar =, /*defines the start of study, ie. When to start counting*/ 
  userend =, /*defines the end of study, ie. When to stop counting */ 
  step =, /*specifies the duration of inclusion for each study in years*/ 
  FUtime =, /*specifies the duration of FU for event outcomes in years*/ 
  tcarsrea =, /*used to define the type of outcome searched for*/ 
  calcpy =, /*whether to calculate person years of follow-up*/ 
  standard =, /*whether to produced standardised rates – this variable currently does not work*/ 
  mortali=, /*whether mortality events are searched for*/ 
  mortality =, /*used defined name for the output*/ 
  pdatedis =, /*whether to count the number of days from admission or discharge*/ 
  readm =,/*whether to look for readmissions*/ 
  runtitle =, /*used defined name for the output, in conjunction with mortality variable*/ 
  tmpwork =, /*main SAS workspace location*/ 
  inputfile=, /*name of the SAS data file*/ 
  strat=, /*1st level of stratification variables – where*/ 
  strata=, /*1st level of stratification variables - if*/ 
  stratt=, /*2nd level of stratification variables - where*/ 
  stratta=, /*2nd level of stratification variables - if*/ 
  clearlog=, /*whether to clear the internal SAS log*/ 
  indiviot = /*whether to output a sample study dataset for further analysis*/ 
  ) ; 
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Appendix 2, Figure 3 - Inputs into the SASstring 
/* Predictors (start counting obs from      |     macro variable name                     |     Outcome (count final event - mortali)           |   macro variable name 
 *             where, subdivided by what)   |                                             |                                                     | 
 * ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
 * All admissions to inpt care               pdatedis=jdoa,typecars=1,where incg=1         All readmissions to inpt care                          tcarsrea=1,mortali=readmit 
 * Specific admissions to inpt care          pdatedis=jdoa,typecars=1,where incg=0         readmissions to inpt care with specific diag           tcarsrea=1,mortali=shicdrea 
 * specific adm for operations               pdatedis=jdoa,typecars=1,where incg=0         readmissions to inpt care for operation                tcarsrea=1,mortali=shicdrea 
 *  
 * All discharges from daycare services      pdatedis=jdod,typecars=2,where incg=2         All subsequent contact with DC                         tcarsrea=2,mortali=readmit 
 * Discharge from DC with specific diag      pdatedis=jdod,typecars=2,where incg=0         subsequent contact with DC with specific diag          tcarsrea=2,mortali=shicdrea 
 * Discharge from DC after specific op       pdatedis=jdod,typecars=2,where incg=0         subsequent contact with DC for specific op             tcarsrea=2,mortali=shicdrea 
 *  
 * All inpatient discharges                  pdatedis=jdod,typecars=1,where incg=1         All subsequent contact with inpt or DC                 tcarsrea=3,mortali=readmit 
 * Inpt discharges following specific diag   pdatedis=jdod,typecars=1,where incg=0         subsequent contact with inpt/ DC with specific diag    tcarsrea=3,mortali=shicdrea 
 * Inpt discharges following operation       pdatedis=jdod,typecars=1,where incg=0         subsequent contact with inpt/ DC for operation         tcarsrea=3,mortali=shicdrea 
 *  
 * All discharges from DC or inpt care       pdatedis=jdod,typecars=3,where incg=3         All Deaths (from date of death on record)              tcarsrea=4,mortali=mortali 
 * discharges from DC or inpt care with Dx   pdatedis=jdod,typecars=3,where incg=0         specific deaths - UC1 (from death cert)                tcarsrea=5,mortali=deasui 
 * discharges from DC or inpt for Op         pdatedis=jdod,typecars=3,where incg=0         specific deaths - UC2 (from death cert)                tcarsrea=5,mortali=deasui 
 *                                                                                         specific deaths - both (from death cert)               tcarsrea=5,mortali=deasui 
 * First Record                              where seqnos = 1                              specific deaths - both (from coroners verdict)        tcarsrea=6,mortali=corsuicbr 
 * All Records                               where seqnos = 0          
 * 
 * Stratify rates by                         strat =  0 = no 1st level stratification 
 *                                                    1 = By country (England vs others) - where 
 *                                                    2 = By government office region - where 
 *                                            strata=  0 = no 1st level stratification 
 *             1 = By country (England vs others) - if 
 *                                                     2 = By government office region - if 
 * 
 * Stratify 2nd level rates by                stratt = 0 = no 2nd level stratification 
 *                                                     1 = By specialty on admission - where 
 *                                               2 = By specialty on discharge - where 
 *                                                     3 = By ethnicity - where 
 *                                                     4 = By Marital status - where  
 *                                                     5 = By Method of admission - broad categories - where 
 *                                            stratta  0 = no 2nd level stratification 
 *         1 = By specialty on admission - if 
 *                                               2 = By specialty on discharge - if 
 *                                                     3 = By ethnicity - if 
 *                                                     4 = By Marital status - if 
 *                                                     5 = By Method of admission - broad categories - if 
 * Indiviot      indiviot 0 = no individual output file for survival analysis 
 *                1 = yes individual output file for survival analysis 
 * Clearlog       clearlog 0 = no clearlog 
 *                1 = clears log after end of each loop 1 - allows iteration through user-defined date ranges  
 *        2 = clears log after end of each loop 2 - allows iteration through a number of post-discharge FU ranges 
 *        3 = clears log after end of each loop 3 - allows iteration through the stratification variable 
 *        4 = clears log after setting up the input files and before the datafile is entered 
 *        5 = clears log between single and cumulative loops 
 * Readmission (for death outcomes)    Readm   0 = don't include readmissions, edate is date of death 
 *         1 = do include readmissions, edate is date of admission of subsequent admission 
 * 
 */ 
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Step 1 
 
The following variables in the SASString define the study time parameters 
 
 userstar = study start, year when the program starts counting  
 userend = study end, year when the program stops counting 
 step = inclusion period in years,  
 FUtime = determines the totality of the follow up period in years,  
 
The FU time can also be further stratified by the user, by writing non-overlapping time 
periods in the following text file ‘furange.txt’ and copying this to the location for user defined 
text files. 
 
You will also have to define the period of risk if you wish to calculate the standardised rates. 
Note as mentioned earlier in the thesis this program automatically stops counting when the 




England only records, records with DOB and gender are all inclusion criteria that are hard-
wired into the SAS code. Text files that define the other fixed inclusion criteria that do not 
vary with each run are in the location defined by the SASstring variable called infixed. The 
files in this folder include the following; 
 
- fixed inclusion txt files 
 
disposalA.txt – fixed inclusion criteria for disposal method when inca = 1 
disposalB.txt - fixed inclusion criteria for disposal method when incb = 1 
disposalC.txt - fixed inclusion criteria for disposal method when incc = 1 
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note that inca, incb and incc are currently set to 0 in the persoyrs macro, however they can 
be set to 1 depending on which disposal method is chosen. 
 
typecar1.txt – fixed inclusion criteria for type of care 
typecar2.txt – fixed inclusion criteria for type of care 
typecar3.txt – fixed inclusion criteria for type of care 
 
please note that typecar1, typecar2 and typecar3 are currently not used. Inclusion criteria for 
type of care is determined by inputs into the SASstring as described below 
 




- Format files  
 
ADM_TYPE.txt – defines labels for admission type 
Admimeth.txt – defines labels for admimeth, elective and emergency admissions 
AGEUNITS.txt – defines labels for age units 
ASOURCE.txt – defines labels for admission source 
BEDSIZE.txt – defines labels for bedsize 
Carestate.txt – defines labels for care status 
Corverdict.txt - defines labels for coroner’s verdict 
Country.txt and countr.txt - defines labels for country 
DISCSTAT.txt - defines labels for discharge status 
dispos1a.txt - defines labels for disposal 
ESOP1.txt - defines labels for occupation 
ESOP2.txt - defines labels for occupation 
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Familystate.txt – defines labels for family status 
icd9cat.txt – defines labels for ICD9 categories 
inclusion.txt – defines labels for inclusion criteria 
LAtoSHA.txt – defines labels for LA codes 
Legalstatus.txt – defines labels for legal status 
LOSFLAG.txt – defines labels for LOS dichotomous variable 
Marriages.txt – defines labels for married or not 
Marstate.txt – defines labels for marital status 
NEWBORN.txt – defines labels for newborns 
Ones.txt – used for file management 
onesPY.txt – used for file management 
Onesstand.txt – used for file management 
OWNER.txt – defines labels used for record ownership 
previousIPtreat.txt – defines labels used for previous in-patient treatment 
RACE.txt - defines labels used for race 
REGION.txt - defines labels used for region 
Resgor.txt and GOR.txt - defines labels used for government office region 
Sex.txt – defines labels used for gender 
Sexband.txt – defines labels used for gender 
SHA.txt - defines labels used for Strategic Health Authority 
Standageband.txt – defines labels used for the standard age bands 
Typecare.txt – defines labels used for the type of care 
Typeofadm.txt – defines labels used for the type of admission 
 
Step 3 and 4 
 
User-defined inclusion criteria that vary with each run are specified by either inputs into the 
SASstring or the text files located in the folder defined by the SASstring variable invariab.  
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They include the following inclusion criteria; 
 
- File locations 
 
a. The location of the log file is determined by inputs into the 1st two lines of the 
SASstring, as described above 
b. The location of user defined text files is determined by the SASstring variable invariab 
c. The location of the SAS datafiles is determined by the SASstring variable datafiles 
d. The name of the SAS datafile is determined by the SASstring variable inputfile 
e. The location of the SAS workspace is determined by the SASstring variables tmpwork 
(main workspace on a dedicated disk) and saslib (minor workspace on the same disk 
as the SAS output 
f. The location of SAS output is also determined by the SASstring variable invariab 
(note that the output and the user defined text files and SASstring are all contained to 
the same folder) 
 
- Age band 
 
The analysis is stratified by sex automatically. Age stratification is determined by the user, by 
selecting non-overlapping age bands. There are 19 default age bands as per UHCE 
protocols. However any age bands can be defined by writing ‘ageband.txt’ and copying this 
to the location for user defined text files. 
 
- Selection of records to include – admission/ discharge records, type of care, record 
sequence number and diagnosis 
 
The type of record selected, i.e. whether an admission/ discharge record is selected, what 
type of care is included and the record number included is all determined by inputs into the 
SASstring 
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The specific diagnosis of records to include is determined by the following text file inputs 
located in the folder defined by the SASstring variable invariab; 
 
Diagnosis on admission – Main (i.e. position 8), ICD10 codes - ICDdiagdis10mainadm.txt 
  Any (i.e. positions 8 to 14), ICD10 codes - ICDdiagdis10anyadm.txt 
Main (i.e. position 8), ICD9 codes - ICDdiagdis9mainadm.txt 
  Any (i.e. positions 8 to 14), ICD9 codes – ICDdiagdis9anyadm.txt 
Main (i.e. position 8), ICD8 codes – ICDdiagdis8mainadm.txt 
  Any (i.e. positions 8 to 14), ICD8 codes – ICDdiagdis8anyadm.txt 
 
Diagnosis on discharge – Main (i.e. position 1), ICD10 codes - ICDdiagdis10maindis.txt 
  Any (i.e. positions 1 to 7), ICD10 codes - ICDdiagdis10anydis.txt 
Main (i.e. position 1), ICD9 codes – ICDdiagdis9maindis.txt 
Any (i.e. positions 1 to 7), ICD9 codes – ICDdiagdis9anydis.txt 
Main (i.e. position 1), ICD8 codes – ICDdiagdis8maindis.txt 
Any (i.e. positions 1 to 7), ICD8 codes – ICDdiagdis8anydis.txt 
 
Diagnosis anywhere on the record –i.e. positions 1 to 14, ICD10 codes - ICDdiagdis10any.txt 
i.e. positions 1 to 14, ICD9 codes – ICDdiagdis9any.txt 
i.e. positions 1 to 14, ICD8 codes – ICDdiagdis8any.txt 
 
Operative codes –  positions 1 to 12, OPCS 4 codes - OPCSdiagdis4.txt 
positions 1 to 12, OPCS 3 codes – OPCSdiagdis3.txt 
positions 1 to 12, OPCS 2 codes – OPCSdiagdis2.txt 
positions 1 to 12, OPCS 1 codes – OPCSdiagdis1.txt 
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Note that the text files are structured in such a way as to allow Boolean AND/ OR selection of 
diagnosis within one ICD version, as well as combinations of diagnostic and operative codes 
across different ICD/ OPCS versions 
 





o dischargsum  
o dischargsumm 
 
An accompanying MS word file named ‘DISCHARG_table.doc’ in the SAS macro folder 
contains a list of the specific sequence of diagnosis selected to facilitate debugging these 
files. 
 
- Selection of the type of outcome recorded – all-cause mortality, all readmissions and 
specific event outcomes 
 
Outcomes that are selected can also determined by user input into the SASstring and the 
user defined text files, especially the SASstring variables tcarsea and mortali (see above). If 
all readmissions or all deaths are selected in the SASstring then the text files will not be used 
to select specific diagnosis. If a specific diagnosis outcome is selected the record chosen is 
determined by the following text file inputs in the folder defined by the SASstring variable 
invariab; 
 
Admission diagnosis on readmission –  
Main (i.e. position 8), ICD10 codes - ICDdiagrea10mainadm.txt 
 Any (i.e. positions 8 to 14), ICD10 codes - ICDdiagrea10anyadm.txt 
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Main (i.e. position 8), ICD9 codes - ICDdiagres9mainadm.txt 
 Any (i.e. positions 8 to 14), ICD9 codes – ICDdiagres9anyadm.txt 
Main (i.e. position 8), ICD8 codes – ICDdiagres8mainadm.txt 
 Any (i.e. positions 8 to 14), ICD8 codes – ICDdiagres8anyadm.txt 
 
Discharge diagnosis on readmission –   
Main (i.e. position 1), ICD10 codes - ICDdiagrea10maindis.txt 
 Any (i.e. positions 1 to 7), ICD10 codes - ICDdiagrea10anydis.txt 
Main (i.e. position 1), ICD9 codes – ICDdiagrea9maindis.txt 
Any (i.e. positions 1 to 7), ICD9 codes – ICDdiagrea9anydis.txt 
Main (i.e. position 1), ICD8 codes – ICDdiagrea8maindis.txt 
Any (i.e. positions 1 to 7), ICD8 codes – ICDdiagrea8anydis.txt 
 
Diagnosis anywhere on the record on readmission–  
i.e. positions 1 to 14, ICD10 codes - ICDdiagrea10any.txt 
i.e. positions 1 to 14, ICD9 codes – ICDdiagrea9any.txt 
i.e. positions 1 to 14, ICD8 codes – ICDdiagrea8any.txt 
 
Operative codes on readmission –   
positions 1 to 12, OPCS 4 codes - OPCSdiagrea4.txt 
positions 1 to 12, OPCS 3 codes – OPCSdiagrea3.txt 
positions 1 to 12, OPCS 2 codes – OPCSdiagrea2.txt 
positions 1 to 12, OPCS 1 codes – OPCSdiagrea1.txt 
 
Specific causes of death –   
Underlying cause 1 (i.e. position 1), ICD10 - ICDoutcome10uc1.txt 
 Underlying cause 2 (i.e. position 11), ICD10 - ICDoutcome10uc2.txt 
 Underlying cause 1 or 2 (i.e. positions 1 to 16), ICD10 - ICDoutcome10all.txt 
Underlying cause 1 (i.e. position 1), ICD9 – ICDoutcome9uc1.txt 
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 Underlying cause 2 (i.e. position 11), ICD9 – ICDoutcome9uc2.txt 
 Underlying cause 1 or 2 (i.e. positions 1 to 16), ICD9 – ICDoutcome9all.txt 
Underlying cause 1 (i.e. position 1), ICD8 – ICDoutcome8uc1.txt 
 Underlying cause 2 (i.e. position 11), ICD8 – ICDoutcome8uc2.txt 
 Underlying cause 1 or 2 (i.e. positions 1 to 16), ICD8 – ICDoutcome8all.txt 
 
Note again that the text files are structured in such a way as to allow Boolean AND/ OR 
selection of diagnosis within one ICD version, as well as combinations of diagnostic and 
operative codes across different ICD/ OPCS versions 
 










The MS word file named ‘DISCHARG_table.doc’ in the SAS macro folder also contains a list 
of the specific sequence of diagnosis selected by these macros to facilitate debugging these 
files. 
 
- Selection of the specific type of analysis – year type, stratification by geographical area 
 
The analysis can be performed by calendar year or financial year depending on whether 
cadatecal or fndatecal is specified in the SASstring respectively. The analysis can be 
stratified by geographical region depending on the inputs to the SASstring variable strat (see 
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above). Person years of follow-up can be calculated by specifying the SASstring variable 
calcpy (currently not working). 
 
- Naming the run 
 
The folder names are determined by the user. The filenames in the output folder is 
determined automatically. The heading within each file is determined by the SASstring 
variable runtitle. The sub-heading is determined by the SASstring variable mortality. 
 
- other user defined criteria 
 
Lastly the SASstring variable clearlog allows users to specify when the internal SAS log is 
cleared (see above). This will not affect the log file written to an external txt file. Users can 
specify a sample dataset output into the folder location specified in the SASstring variable 
saslib to double check the analysis and to conduct survival analysis, by setting the SASstring 




Once the SASstring and text files are finalised, then copy the contents into the input folder. 
 
Step 6 and 7 
 
Run the C# script named SASBatcher. It will automatically pick the contents of the input file, 
move the contents to the default output folder, run SAS, and activate the SAS macro named 
persoyrs. Once the analysis has finished it will automatically move the files from the output 
folder and the saslib folders back to the input folder 
 
Step 8 
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Once the analysis is complete the following files should be in the moved from the output 
folder to the input folder automatically by the C# script named SASBatcher. 
 
- List of files divided by year of included records, and follow-up periods for events of interest.  
 
The files should also be divided into singular and cumulative analysis. Singular analysis 
records the number of events between the start of each FU stratification period and the date 
of the outcome or the end of the next FU stratification period, ie counts from the start of the 
FU stratification period rather than the start of the study. Cumulative analysis looks at the 
cumulative number of events from the date that records were included until the outcome, or 
the end of the FU stratification period, i.e counts from the start of the study. 
 
Run the HandleSASoutput MS Excel VBA script. This will bring all the files containing 
singular analysis together, and all the files containing cumulative analysis together. Into the 
following files 
 
Singular analysis –   
 
indSummary_sing – gives the demographic profile of the cohort being examined at the start 
of each FU stratification period 
totSummary_sing – gives the count of the number of records and people in the cohort, and 
the number of events at the FU stratification period 
 
Cumulative analysis –  
 
indSummary_cum – gives the demographic profile of the cohort being examined since the 
start of the study 
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totSummary_cum – gives the count of number of records and people in the cohort, and the 
number of events since the start of the study and the end of the FU stratification period in 
question 
 
Counts and unadjusted event rates can be calculated from spreadsheet totsummary_cum, as 
explained above. In order to calculate adjusted rates then proceed to step 9. 
 
The spreadsheet totsummary_cum contains the following worksheets 
 
Worksheet 1 – contains a cumulative count of all the records (spells if the CIPS file is being 
used, FCEs if the FCE file is being used) by sex, age band and FU stratification period 
Worksheet 6 – contains a cumulative count of the number of people by sex, age band and 
FU stratification period 
Worksheet 2 – contains a cumulative count of the observed number of events by sex, age 




In this booklet I shall focus on the calculation of age/ sex standardised mortality rates. Note 
that we are standardising to the English national population using the ‘indirect method’ to 
enable the calculation of a standardised mortality ratio, SMR. 
 
Open the excel spreadsheets totsummary_cum, and England all-cause mortality 1999-2008 
or England specific cause mortality 1999-2008 depending on whether you are calculating 
standardised all-cause mortality rates or specific cause mortality rates.  
 
Copy the contents of the worksheet named ‘Mortality Rates’ from the spreadsheet England 
all-cause mortality 1999-2008 or England specific cause mortality 1999-2008 into the 
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spreadsheet totsummary_cum. ‘Mortality Rates’ contains the national/ reference mortality 
rates rate by sex, and age band. 
 
Apply these national mortality rates to the number of people in the study cohort in each sex 
and each age band. This will give you the expected number of events in each sex and age 
band. Sum the expected number of events in each sex and age band to get a total number of 
expected events. 
 
The SMR is the total observed number of events/ total expected number of events. 
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o dischargsum  
o dischargsumm 
 
 cadatecalsing  

















- nostandardsing  
- directorlssing  
 
o summarysing 
o sumstandsing  
 graphsing 
 graphstandsing 
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Function of the macros in the persoyrs collection 
          
SAS macro – personyrs, stratify and cips 
 
1. extract of ORLS (1979-1999) and HES (2000-2005) data with suitable variables 
 
2. appending ORLS and HES to create a combined dataset covering all hospital discharges 
between 1979 and 2005 
 
3. Applying exclusion criteria to the combined dataset (inc missing DOB, sex, and type of 
discharge/ disposal) 
 
4. Identifying a suitable cohort of records (i.e. flagging predictor variables) 
 
5. Stratifying the dataset by the where or if statement 
 
SAS macros - cadatecal* (calendar year) & fndatecal* (financial year) 
 
6. splitting the combined dataset into suitable time periods to facilitate examination of time 
trends. This will involve decisions regarding suitable periods to observe cohorts of patients 
who were discharged from hospital and suitable periods following the end of sampling to 
continue to observe the cohort for outcomes 
 
SAS macro – ratecal* (cumulative and singular) 
 
7. identifying relevant age groups in which to tally outcomes and calculate rates 
 
8. identifying relevant FU periods in which to tally outcomes and calculate rates 
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Note that these boundaries enable the calculation of person years of follow-up 
 
SAS macro – Direct* & nostandard* - Sum* - graph* 
 
9. Counting the number of events in specified age groups and over the specified FU periods 
following hospital discharge 
 
10. Counting the number of individuals to calculate the event rate per 1,000 individuals over 
the period of time 
 
11. Tallying the total FU time to enable the calculation of event rates per person years of FU 
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    318 
Appendix 5 - Proposed causes of avoidable (amenable and preventable) 
mortality: ICD–10 codes and age limits 










    
Intestinal infectious diseases  A00–A09  0–14  ●   
Tuberculosis  A15–A19, B90  0–74  ●  ●  
Other infections (diphtheria, other 
tetanus, acute poliomyelitis)  
A35– A36, A80  0–74  ●  ●  
Whooping cough  A37  0–14  ●  ●  
Selected invasive bacterial and 




G03, L03  
0–74  ●   
Measles  B05  1–14  ●  ●  
Viral hepatitis  B15–B19  0–74   ●  
HIV/AIDS 
 
B20–B24  All   ●  
Neoplasms  
    
Malignant neoplasm of lip, oral cavity 
and pharynx 
C00–C14  0–74   ●  
Malignant neoplasm of oesophagus  C15  0–74   ●  
Malignant neoplasm of stomach  C16  0–74   ●  
Malignant neoplasm of colon and 
rectum  
C18–C21  0–74  ●   
Malignant neoplasm of liver  C22  0–74   ●  
Malignant neoplasm of trachea, 
bronchus and lung  
C33–C34  0–74   ●  
Malignant melanoma of skin  C43  0–74  ●  ●  
Other malignant neoplasms of skin  C44  0–74  ●  ●  
Malignant neoplasms of breast  C50  0–74  ●   
Malignant neoplasm of cervix uteri  C53  0–74  ●   
Malignant neoplasm of corpus uteri 
and uterus unspecified  
C54–C55  0–44  ●   
Malignant neoplasm of testis  C62  0–74  ●   
Malignant neoplasm of bladder  C67  0–74  ●   
Malignant neoplasm of thyroid gland  C73  0–74  ●   
Hodgkin’s disease  C81  0–74  ●   
Leukaemia  C91–C95  0–44  ●   
Benign neoplasms 
 
D10–D36  0–74  ●   
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Nutritional, endocrine and 
metabolic  
    
Disorders of thyroid gland  E00–E07  0–74  ●   
Diabetes mellitus  E10–E14  0–49  ●   
Drug use disorders  
    
Alcohol related diseases, excluding 




K73, K74 (excl. 
K74.3–K74.5), 
K86.0  
0–74   ●  
Illicit drug use disorders  F11–F16, F18– 
F19  
 
0–74   ●  
Neurological disorders  
    
Epilepsy and status epilepticus  
 
G40–G41  0–74  ●   
Cardiovascular diseases  
    
Rheumatic and other valvular heart 
disease  
I01–I09  0–74  ●   
Hypertensive diseases  I10–I15  0–74  ●   
Ischaemic heart disease  I20–I25  0–74  ●  ●  
DVT with pulmonary embolism  I26, I80.1–
I80.3, I80.9, 
I82.9 
0–74   ●  
Cerebrovascular diseases  I60–I69  0–74  ●   
Aortic aneurysm and dissection  
 
I71  0–74   ●  
Respiratory diseases  
    
Other respiratory  J00–J08, J20–
J39, J47 – J99  
1–14  ●   
Influenza (including swine flu)  J09–J11  0–74  ●  ●  
Pneumonia  J12–J18  0–74  ●  ●  
Chronic Obstructive Pulmonary 
Disorder  
J40–J44  0–74  ●  ●  
Asthma 
 
J45– J46  0–74  ●   
Digestive disorders 
 
    
Gastric and duodenal ulcer  K25–K28  0–74  ●   
Acute abdomen, appendicitis, 
intestinal obstruction, cholecystitis / 







0–74  ●   
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Genitourinary disorders  
    
Nephritis and nephrosis  N00–N07, 
N17–N19, N25, 
N27  
0–74  ●   






0–74  ●   
Maternal & infant  
    
Pregnancy, childbirth and the 
puerperium  
O00 – O99  All  ●   
Complications of perinatal period  P00–P96, A33  All  ●   
Congenital malformations, 
deformations and chromosomal 
anomalies  
 
Q00–Q99  0–74  ●   
Unintentional injuries  
    
Transport Accidents  V01–V99  All   ●  
Accidental Injury 
 
W00–X59  All   ●  
Intentional injuries  
    
Suicide and self inflicted injuries * X60–X84, 
Y10–Y34  
All   ●  
Homicide/ Assault  X85–Y09, 
U50.9  
All   ●  
Misadventures to patients during 




All  ●   
* Note that deaths from suicide and intentional injuries (ICD10 codes - X60–X84, Y10–Y34) 
was counted within our calculations where this cause was recorded anywhere on the death 
certificate, as opposed to the underlying cause only.  
 
